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Abstract 
 
Environmental changes and genetic variations are two important drivers of biological 
diversity. In complex traits, a multitude of genetic and environmental factors interact and 
combine in cryptic ways to direct the phenotypic variation. Sleep is a classic illustration of a 
complex trait that is vital and heritable but still poorly understood. Many aspects of sleep like 
the timing, duration and quality are regulated by the interaction of two processes: the circadian 
oscillations and the sleep homeostasis.  
In the context of a study that aimed at uncovering more clearly the molecular pathways 
regulating the sleep homeostat through the ambiguous relationship that exists between sleep-
wake cycle and metabolism, we built, assembled, analyzed an extensive multi-scaled dataset 
using the systems genetics design. Machine learning algorithms and novel high-throughput 
sequencing technology permit to appraise more precisely and broadly the plethora of 
physiological and molecular phenotypes that contribute to sleep under disparate circumstances 
and genetic background, in order to build novel hypotheses based on data-driven discoveries. 
This dataset is composed of 33 recombinant inbred lines (RIL) from the BXD panel that were 
interrogated under sleep deprivation and undisturbed conditions for 341 sleep-wake related 
physiological phenotypes, 124 blood plasma metabolites, and cortical and liver transcriptomics. 
First analyses pointed out the pervasive effects of sleep deprivation and genetics both at the 
molecular and behavioral level and the complex interaction between genetic and environmental 
factors at all phenotypic layers. Then, two novel integrative methods were developed, the first 
to prioritize candidate genes within large associated genomic regions for physiological or 
metabolic phenotypes and the second to visualize the meta-dimensionality of the molecular 
network using the deterministic structure of hiveplots. Our findings led to the discovery of a 
bidirectional relationship between fatty acid turnover and sleep homeostasis but also between 
brain slow-waves activity and ionotropic glutamate receptor transport. Using markup language 
and cloud-based technologies, we aimed at transforming this resourceful, multidisciplinary 
dataset into an exploitable digital research object. The generation of dynamic analysis reports 
and workflow metadata promoted the reproducibility this data-object. In addition, tools were 
developed for the exploration and mining of integrated data. The resulting database and 
associated web interface ensures the reusability of this dataset and associated methodologies. 
10 
 
Résumé 
 
La diversité biologique est dirigée par deux opérateurs importants, les changements 
environnementaux ainsi que les variations génétiques. Pour les traits dits complexe, leur 
variation est le fruit de nombreux facteurs génétiques et environnementaux qui vont interagir et 
se combiner, souvent de manière cryptique. Le sommeil est un exemple-type de trait complexe, 
il est vital et héritable mais fondamentalement méconnu. La régulation de nombreux aspects du 
sommeil comme sa durée, timing ou qualité fait intervenir deux processus : les oscillations 
circadiennes et l’homéostasie du sommeil.  
Afin de mieux cerner les voies qui régulent le mécanisme d’homéostasie du sommeil, en 
particulier celle mêlant le métabolisme, nous avons créé, assemblé et analysé un grand set de 
données en utilisant une approche dite de génétique des systèmes. Avec l’aide d’algorithmes 
d’apprentissage automatique et de nouvelles technologies de séquençage à haut-débit, nous 
avons pu mesurer dans des conditions et contextes génétiques différents de nombreux 
phénotypes moléculaires ou physiologiques qui contribuent à la régulation du sommeil. Notre 
approche étant ainsi principalement axée sur la construction d’hypothèse guidée par les 
données. Ce set est composé de 33 lignées de souris consanguines recombinantes (BXD) dont 
on a examiné, dans des conditions de privation de sommeil et de contrôle : 341 phénotypes 
physiologiques liés au sommeil et à l’éveil, 124 métabolites du plasma sanguin, ainsi que leur 
transcriptome du cortex et du foie. Les premières analyses ont pointé l’effet aigu de la privation 
de sommeil, de la génétique ainsi que leur interaction sur tous les niveaux de phénotypes. 
Ensuite, deux nouvelles méthodes d’intégration ont été développées, la première pour prioritiser 
les gènes opérateurs du sommeil et du métabolisme à l’intérieur de grande région génomique, 
la deuxième pour visualiser la méta-dimensionalité des données moléculaires via une structure 
de ‘hiveplot’. Nous avons mis en avant une relation bidirectionnelle entre les modifications 
d’acides gras et l’homéostasie du sommeil, ainsi que l’activité des ondes lentes du cerveau et 
le transport de récepteur au glutamate ionotropique. En utilisant le langage de balisage ainsi 
que des technologies basées sur le cloud, nous avons cherché à transformer ce jeu de données 
en un objet de recherche numérique. La reproductibilité de cet objet a été améliorée par la 
génération de rapports d'analyse dynamiques ainsi que de métadonnées. De plus, des outils ont 
été développés pour l'exploration et l'extraction de données via une interface web et assurent 
ainsi la réutilisation de ce set et de ces méthodologies associées. 
11 
 
Chapter 1. Introduction 
 
1.1 Complex Systems 
1.1.1 Genetic & environmental contributions 
The origin of biological variability has been studied for centuries. Scientists have explored 
the causes for phenotypes to differ from a predefined normality that in many cases fit the 
standard gaussian distribution (Büttner 1998), with still unresolved and debated questions about 
the exact origin of this observed variation, nature vs nurture or most likely both. These questions 
are immediately relevant for issues concerning health and sensitivity or resistance to develop 
disease (Theodoratou, Timofeeva et al. 2017) but also for some of our innate characteristics 
like physical ability (Issurin 2017), aging (Merkwirth, Jovaisaite et al. 2016, Ryu, Mouchiroud 
et al. 2016) and propensity to sleep (Viola, Archer et al. 2007). 
In biology, many major breakthroughs helped to apprehend and confine the genetics and 
environmental factors driving phenotypic variability. On the genetics side, the discoveries of 
Gregor Mendel’s laws of inheritance, the uncovering of the DNA structure together with the 
development of high-throughput sequencing technologies are but a few examples that have 
greatly improved our understanding of how and what constitutes some of the predetermined 
characteristics and that are transmitted to next generations. The DNA variations that are 
encountered between individuals, like Single Nucleotide Polymorphism (SNP), Insertion-
Deletion (Indels) or Structural Variation (SV) can alter gene expression or protein structure and 
are components of the Mendelian or polygenic inheritance of traits. On the environmental side, 
the interaction between the organism and its environment directly influences its biology. 
Already in the XI century in China, it was observed that humans that were intentionally 
inoculated by smallpox became resistance to this disease before spreading to western world 
(Riedel 2005). Organisms can undergo molecular adaptation upon a challenge thereby gaining 
novel characteristics that can be either short- or long-lived through diverse mechanisms like 
epigenetics (Hunter 2012).  
Several approaches have been used to investigate environmental and genetic variables 
independently. The environmental factors contributing to phenotypic variance are generally 
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symbolized by E and the genetic factors by G. Organisms with identical genomes are used 
worldwide to study environmental driven hypotheses. The representative organism are clonal 
cell lines or animal models that are maintained and distributed by organization such as the co-
isogenic C57BL/6J mouse, an inbred strain maintained by the Jackson Laboratory that is fully 
sequenced. On the human side, monozygotic twins are commonly used to remove the genotypic 
factors diversity from the experiment as they share common DNA. They are also compared 
with dizygotic twins to calculate the contribution of genetic factors and estimate the heritability 
of a trait like sleep as they often share common environment (Linkowski 1999). Two distinct 
types of heritability can be estimated, the narrow-sense (h2) and the broad-sense (H2). Narrow-
sense heritability represents the additive contribution of independent genetic factors and broad-
sense represents the contribution of all genetic factors and their combined effects, including 
recessive/dominant relationship and epistasis (GxG). 
Two general approaches were used in genetics to uncover the relationship between 
phenotypic variation of interest and the causative genetic factor(s): forward and reverse 
genetics. The forward approach aimed at determining the causative genetic variation that 
underlie an observed phenotype (from phenotype-to-gene). Many designs exist like using 
natural occurring variation within a population or random mutagenesis screening. On the other 
hand, reverse genetics uses a gene-to-phenotype approach by targeting specific genes and 
observing the consequences of a gain or loss of function. Again, many designs exist using a 
gene partial or complete knock-out, or more recently, enhanced and precise approaches were 
developed like gene editing using CRISPR/Cas9 (Shah, Davey et al. 2015, Gurumurthy, Grati 
et al. 2016).    
These two concepts of genetic and environmental factors have been widely investigated 
independently using reductionist approaches, where their respective roles on biological 
phenotypes were investigated separately. However, a huge number of interactions underlie 
biological systems, which led to e.g. the now well-known issue of the missing heritability in 
Genome Wide Association Studies (GWAS). GWAS (a forward genetics approach) associated 
many genetic markers with a given traits like height (Maher 2008) or diabetes (Stančáková and 
Laakso 2016). Even so the heritability was high (80%), the collection of markers could only 
explain for a very small amount of the variance (5%). In the same way, biological interaction 
can greatly affect single marker effect as observed within our own data, where an association 
with a biogenic amine was found with genotypes on chromosome 2 in mice (Figure 1 left), but 
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measures on other lines from the same panel could display highly divergent concentration of 
this metabolite given the first hypothesis (Figure 1 right). A simple SNP-phenotype association 
is often not enough for a biological systems characterization that is consistent with genetics and 
environmental background that were not yet observed.  
 
 
1.1.2 Toward systems approaches: 
Novel experimental designs and associative methods were proposed to improve the classical 
reductionist approaches and examine in more detail the results of the E and G factors 
interactions. A few simplified examples related to health, sleep and life style are illustrated here 
to apprehend the general complexity and high connectivity that can be found behind polygenic 
phenotypes. In section 1.3, the sleep regulatory systems will be addressed more profoundly. As 
mentioned previously, the large effect of E and G factors on their own were highlighted using 
epidemiological studies or GWAS. Currently, our life style under high stress (E) have negative 
Figure 1 : Alpha-amino adipic acid (α-
AAA) level in BXD panel. 
Left: Plasma blood concentration of the α-
AAA within the mouse BXD/RwwJ panel, 
ordered by concentration [µM]. Genotype-
Phenotype linkage analysis revealed a QTL on 
chromosome 2 that explains 72.5% of the α-AAA 
variance within the investigated mouse 
population. The QTL includes Dhtkd1, encoding 
an enzyme subunit involved in lysine degradation 
known to controls α-AAA levels in BXD lines 
(Wu, Williams et al. 2014). Color indicates 
parental strains and the allele carried by the BXD 
on the associated region, grey = C57BL/6J allele, 
beige = DBA2/J allele. Right: Identical values 
used on the left panel, now including to 3 older 
BXD/TyJ strains (BXD32, BXD05, BXD029). 
BXD032/TyJ is a DBA2/J allele-carrier but the 
α-AAA blood concentration is 10 times higher 
than other BXD. This excessive concentration is 
replicable in BXD032 and unique in our 124 
different metabolites population. This difference 
could be explained by higher-order interaction 
(GxG) or differences within generated BXD 
population (see BXD section and discussion).  
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repercussions on our health (Kopp, Stauder et al. 2008), furthermore artificial light generated 
by recent technologies tends to disrupt our sleep (Falbe, Davison et al. 2015) which reduces its 
restorative function. The combination of diverse risk factors as mentioned (E x E) can have 
multiplicative negative repercussion on our health, as emphasized in (Ding, Rogers et al. 2015) 
where long/short sleep duration, prolonged sitting, and physical inactivity increased 
significantly the risk of mortality. We often associate these risk factors with other side effects 
like with weight gain (Bayon, Leger et al. 2014) and type-2 diabetes (Shan, Ma et al. 2015). 
The negative consequences of stress and sleep perturbation can be viewed as a singular event 
or be considered as a causal chain, where chronic disorder and the inability of biological 
systems to return to a balanced state can induce other complications at longer term (E → E), 
highlighted using temporal disease trajectories (Jensen, Moseley et al. 2014). Therefore, a 
central question is to know which pathways are perturbed, how they are balanced, and which 
genetic factors may increase or reduce the chances of complications. The accumulation of 
visceral fat during weight gain for example is associated with increased type-2 diabetes risk 
(Sabag, Way et al. 2017) and is under genetic control (G) (Fox, Liu et al. 2012).  
At a mechanistic level, the underlying molecular phenotypes (transcript or protein) 
responsible for this phenotype could be driven by cis-regulation or trans-regulation (G → G), 
but the complete regulatory system involved is more complex. These interactions are also 
highly likely to be epistatic (G x G) given the millions of molecular interactions that exist only 
at the protein level (Szklarczyk, Franceschini et al. 2015). Even minor genetic differences 
between individuals may highly reshape molecular networks and phenotypic outcome, like the 
genetically closed mouse sub-strains: C57BL6/J and C57BL6/N that only distinguish for 34 
SNPs, 2 indels and 15 SVs (Simon, Greenaway et al. 2013), but these few variations led to 
different observations for levels of a hepatotoxic biomarker and results interpretation (Bourdi, 
Davies et al. 2011). At the molecular level, both environmental and genetic factors (G x E) 
influence the organism transcriptional environment. In diploid organism, the gene Allelic 
Specific Expression (ASE) depend on both GxE and cis-/trans- regulatory element (Buil, Brown 
et al. 2015).  
This highly interactive architecture limits the development of preventive medicine 
(Narimatsu 2017) such as in coronary artery disease (CAD) (Lanktree and Hegele 2009) using 
reductionist approaches or current genetic-based predictive models (Schrodi, Mukherjee et al. 
2014). It was also proposed to be the cause of the GWAS missing heritability problem, that 
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could be solved by integrating intermediate phenotypes (Blanco-Gómez, Castillo-Lluva et al. 
2016), epigenetics (Trerotola, Relli et al. 2015), epistasis (G x G) (Zuk, Hechter et al. 2012) 
and host-microbiome interaction (G x E) (Sandoval-Motta, Aldana et al. 2017). It is 
hypothesized that biological complexity arises from the non-additive interactions among the 
factors driving biological variability resulting in a system that is far more complex than the sum 
of its individual constituent parts. This phenomenon, referred to as emergence (Macklem 2008), 
necessitates to explore life’s complexity as an ensemble/systems rather than a collection of 
isolated entities. 
Therefore, the understanding of the underlying E and G factors interactions within a 
molecular system context was intended to be a major step toward better precision medicine and 
insight on disease co-occurrence (Carlsten, Brauer et al. 2014, Hu, Thomas et al. 2016), but 
also for an enhanced comprehension of normal traits. Thus, to “deciphering the dark matter” 
(Crawford 2016) surrounding these complex traits caused by the vast number of molecular 
interactions ubiquitous in regulatory networks, systems genetics was proposed as a novel 
multidimensional, population based, experimental model (Civelek and Lusis 2014). In this 
design, intermediate phenotypes such as transcriptomics, proteomics, metabolomics or 
microbiome are integrated in parallel of the end-phenotypes of interest. These phenotypes are 
measured under the different genetic backgrounds from the population observed (G) and 
different condition (E). The systems genetics approach was successfully used in human for 
epilepsy, neuronal development, obesity or CAD (Johnson, Behmoaras et al. 2015, Johnson, 
Shkura et al. 2015, Talukdar, Foroughi Asl et al. 2016, He, Sun et al. 2017), F2 and 
Recombinant Inbred (RI) lines of mouse for stress and fear behavior (Park, Gale et al. 2011, 
Jiang, Scarpa et al. 2015), drosophila (Ayroles, Carbone et al. 2009), plants (Basnet, Del Carpio 
et al. 2016), and virus (Kollmus, Wilk et al. 2014) in host-pathogen interaction. The population 
genetics and different environmental conditions are the motor of phenotypic variation that is 
then used for associative statistical methods, like Quantitative Trait Locus (QTL), gene co-
expression (Plaisier, Horvath et al. 2009, Park, Gale et al. 2011, Langfelder, Castellani et al. 
2012) or Bayesian network inference (Jiang, Scarpa et al. 2015). The phenotyping approach 
demands precise and broad measurement, both of molecular and of physiological phenotypes, 
to uncover the mechanisms underlying a trait of interest. The efforts in next generation 
sequencing and quantitative mass-spectrometry favored sensitivity and specificity of 
intermediate molecular phenotype measurement in genomics, transcriptomics, proteomics and 
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metabolomics. But ultimately disease/physiological responses also demand efforts on the 
phenotyping strategy (Großkinsky, Svensgaard et al. 2015) to improve the accuracy and our 
understanding on genotypic-phenotypic contribution (Ala-Korpela, Kangas et al. 2011). These 
approachs require novel protocols and computational approaches like image-analysis or 
Machine Learning (ML) (Singh, Ganapathysubramanian et al. 2016) for large dataset 
assimilation and classification.  
Finally, the quality of acquired data is a major step toward data integration between the 
different actors of the systems genetics community. Multiple phenotypes can be recorded by a 
single group and/or experiments, but the combination and integration of multiple independent 
dataset is a key step toward reproducible and improved molecular pathways discovery. 
Approaches using a single QTL association were already shown to be successful in parental 
behavioral (Bendesky, Kwon et al. 2017), hypoglycemia (Picard, Soyer et al. 2016) or glaucoma 
(Chintalapudi, Maria et al. 2017)  traits but the need of intermediate phenotype is often required 
for candidate gene identification and further validation.  Moreover, these types of approaches 
require significant association of sufficient effect size which are expected to be less present in 
complex traits because of the underlying polygenic structure, whereas large integrative 
initiative would better to detect low effect size associations. The current problems and solutions 
for data generation, integration, reusability and generally the bioinformatic data-management 
strategy of systems genetics design are further described in section 1.4 and chapter 3. 
A proper animal model must be selected to privilege data-sharing, the use of F2 mice 
designed for a single experiment like (Jiang, Scarpa et al. 2015) impose some limitation for the 
data integration by others as these mouse are not maintained and/or widely distributed. 
Furthermore, they have a limited amount of recombination event which led to large associated 
region that can contains sometimes hundreds of genes.  
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1.2 The BXD mouse panel:  
Animal models have been used for a long time to study complex traits as their use offers 
many advantages compared to humans with respect to e.g. controlling both environmental and 
genetic factors (Schughart, Libert et al. 2013) and tissue sampling for quantification of the 
intermediate phenotypes driving complex traits that could not be properly controlled or 
measured in humans. Despite some controversial use for translating mouse mechanisms to 
human mechanisms in traits like inflammation (Seok, Warren et al. 2013, Takao and Miyakawa 
2015), mice were proposed to be a good model for mechanism discovery related to sleep 
disorder (Toth and Bhargava 2013) and sleep physiology (Franken, Malafosse et al. 1999). On 
the genetic side, the use of a Genetic Reference Population (GRP) seems to be the most 
appropriate choice to build a systems genetics resource because of their known and fixed 
genotypes for reusable and reproducible mapping results. 
 
The BXD genetic reference population is one of the most advanced GRP in mouse that was 
specifically bred for complex traits investigation and QTL analysis. Other mouse populations 
with higher genetic diversity exist and are further described in the Discussion. Multiple batches 
of BXD have been produced since 1971 and are still generated with up to date 198 available 
lines. This panel contains Recombinant Inbred (RI; BXD/TyJ lines 1-42) and Advanced 
Recombinant Inbred (ARI; BXD/RwwJ lines 43-220) lines that were generated from two co-
isogenic strains: C57BL6/J (B6 or B) and DBA2/J (D2 or D). The ARI lines were published in 
2004 (Peirce, Lu et al. 2004) and contained twice more recombination events compared to 
conventional RI. The older lines should be considered separately from the new lines (Figure 2) 
as they show behavioral differences and significant different mapping results (Philip, Duvvuru 
et al. 2010). One explanation is that BXD were generated with two different DBA sub-strains: 
DBA2/Rj and DBA2/J, due to genetic drift that have accumulated over the years (Taylor, Wnek 
et al. 1999, Shin, Pandey et al. 2014). Each BXD mouse represents a unique combinatorial 
mixture of C57BL/6J and DBA2/J genotypes (with mitochondrial and Y chromosome 
exception) and by consequence with unique transcriptional, metabolomic and behavioral 
signatures. 
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1.2.1 Phenotype-Genotype association 
For genome-wide association, statistical power is strongly affected by sample number, allelic 
frequency and effect size (Manolio, Collins et al. 2009, Arnar, Andersen et al. 2016), therefore 
QTL mapping in mouse compared to GWAS offers some advantages (Flint and Eskin 2012). 
Compared to GWAS which require thousands of samples in order to each the 5e-8 p-value 
threshold for significant association (Fadista, Manning et al. 2016), the BXD panel can use less 
than 40 samples to reach an acceptable statistical power (Andreux, Williams et al. 2012). To 
diminish rare variants number, GWAS can focus on isolated population (Zeggini 2011, Jeong, 
Alkorta-Aranburu et al. 2014) which limit studies to specific phenotypes of interest or use more 
Figure 2 : The BXD mouse population 
 
The BXD mouse panel are Recombinant 
Inbred (RI) and Advanced Recombinant Inbred 
(ARI) lines developed by crossing DBA2/J and 
C57BL6/J co-isogenic strains. These two strains 
differ for around 5 million sequence variants 
(Wang, Pandey et al. 2016). Some variations 
can explain part of observed phenotypic 
divergence, for example Nnt functional allele in 
DBA2/J enhance insulin secretion (Yeadon 
2014). BXD/TyJ 1-42 (RI) were developed 
using conventional F2 sib-mating for at least 20 
generation. BXD/RwwJ 43-103 (ARI) were 
generated using advanced intercross lines (9-14 
intercross generations) followed by 14-18 
generations of sib-mating for genetic 
stabilization. ARI have approximately twice as 
many recombination events compared to RI 
lines. Before 1984, BXD lines were generated 
using the DBA/2JRJ sub-strain as parental strain 
which contains other variations, like functional 
Klrd1 (CD94). DBA2/J sub-strain used after 
1984 have a deletion on the last exon of Klrd1. 
The BXD family contains mainly DBA2/J 
maternal mitochondrial chromosome and 
C57BL6/J paternal Y chromosome, with 
exceptions for 10 lines that should be 
considered as DXB (see discussion).  
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genetically homogeneous population, whereas in BXD only a few regions have a low allelic 
frequency in the complete panel. 
However, the associated region of the BXD are large linkage disequilibrium (LD) blocks of 
a few mega base-pairs (Mbps) that may contain lots of genes (Figure 3) using interval mapping 
methods, therefore a lot of effort was done on increasing recombination rate in the BXD panel 
and decreasing associated region size. On the other side, current GWAS methods can use direct 
marker association which is more precise for candidate gene identification but can be 
problematic in case of allelic heterogeneity, however novel techniques using machine learning 
methods for pattern mining may change this last issue (Mieth, Kloft et al. 2016, Llinares-López, 
Papaxanthos et al. 2017). Another analytical simplification of the BXD panel is the genomic 
homozygosity that is found in a majority of loci, with a few exceptions of heterozygosity.  
Homozygosity reduces complexity of the model, by removing the possibility for allelic specific 
expression that is found in non-inbred diploid organism, and the dominant-recessive effect can 
be inspect using F1 lines.  
 
 
  
Figure 3 QTL analysis for glucagon ratio in BXD. 
 Example of interval QTL mapping for genotype-phenotype association in the BXD panel. Left: The 
association test is performed genome-wide by likelihood ratio test given gaussian distribution 
parameters estimation by Expected-Maximization (EM) algorithm. False Discovery Rate (FDR) is 
estimated using 1000 permutations, red line indicates significant threshold (FDR<0.05), blue line 
indicates suggestive threshold (FDR<0.63). Right: Confident interval (green markers) for the true QTL 
location is appraised using 1.5 log odd (LOD) difference from the peak (red marker). Adapted from 
(Picard, Soyer et al. 2016)  
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1.3 Sleep regulation 
1.3.1 Fundamentals of sleep regulation:  
In biology, one of the most enigmatic phenomena is sleep, while this behavior seems to be 
universally conserved among species and quite easy to master: “one sleeps when one is tired — 
mostly at night—and awakens the next day usually feeling rested and refreshed” (Spiro 2005), 
its function (Krueger, Frank et al. 2016), regulation and the molecular processes involved still 
remain elusive (Mignot 2008). In mammals, we observed a large variety of sleep parameters 
like duration (Ollila, Kettunen et al. 2014), brain activity (Franken, Malafosse et al. 1998) or 
restorative benefit (Wilkinson and Shapiro 2012) that can be quite difficult to fully capture and 
comprehend due to the multi-factorial processes involved. Time is an essential factor, in human, 
for most of us a third of our lifespan will be occupied sleeping, more during development in 
new-born thus with age-related changes (Dijk, Duffy et al. 2000) but also with seasonal effects 
(Kume, Makabe et al. 2017) and long perturbation after sleep loss (Fifel, Meijer et al. 2018). In 
addition, the genetics and environmental factors such as jet-lag, night-shift work or technology 
can modify important sleep properties, which can lead to chronic sleep disorders (Nunn, 
Samson et al. 2016) with consequences on our health (Altevogt and Colten 2006). 
In mammals, some sleep attributes can be defined by cortical activity recording and the 
identification of vigilance states over prolonged periods. Two sleep states should be 
distinguished: (i) Rapid-Eye-Movement sleep (REM, or paradoxical sleep) characterized in the 
mouse by the prevalence of theta oscillation (6-9 Hz) in the EEG and muscle atonia and (ii) 
non-REM (NREM) sleep, the predominant sleep state, with a high contribution of slow 
oscillations (0.75-4.5 Hz) in the EEG. The third state is wakefulness (Wake) with a higher 
variability in EEG and EMG. The transformation from a time domain signal into a frequency 
domain signal to identify the prevailing frequencies to a complex waveform such as the EEG 
is performed using Fast Fourier Transform (FFT) (Figure 4). This transformation allows for 
signal transformation to perform power spectrum analysis but also computational automation. 
The annotation of spectral data can be done with visual inspection by an expert where the time 
to perform this task will mostly depend on the length of the epoch (time-window or annotation 
resolution) and period of recording. Several classification machine learning algorithms were 
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developed to help the annotator (Lampert, Plano et al. 2015) or automatically annotate signals 
(Sunagawa, Séi et al. 2013). The main difficulties of classification is signal normalization 
(Katsageorgiou, Lassi et al. 2015), misclassification by single classifier approach (Gao, Turek 
et al. 2016) and the great diversity of EEG/EMG power bands when different mouse strains are 
used (Franken, Malafosse et al. 1998). 
 
A model for sleep regulation was proposed 35 years ago (Borbély 1982), known as the two-
process model (Figure 5) where sleep-wake cycle is controlled by two distinct mechanisms, 
circadian rhythm (C) and sleep homeostasis (S). Process C will dictate the optimal time in the 
day for a resting phase and process S will compensate for the sleep loss through the 
accumulation of sleep pressure during wakefulness and its decrease during sleep. Sleep 
homeostasis will attempt to maintain the level of required sleep close to a set-point and 
compensate by negative feedback loop for deviation due to the everyday activity or disturbance 
like sleep deprivation. From a mechanistic point of view, the circadian process (C) was shown 
to be mainly driven by the SupraChiasmatic Nucleus (SCN) of the hypothalamus that acts as a 
master circadian pacemaker (Dibner, Schibler et al. 2010) via clock genes (Franken and Dijk 
Figure 4 : EEG/EMG signal during Wake, NREM sleep and REM sleep 
Examples EEG/EMG signal in the time domain and EEG spectral power transformation into 
frequency domain using FFT during wakefulness, NREM sleep and REM sleep. Adapted from (Xie, 
Dumas et al. 2005)  
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2009),  that set internal and peripherical rhythms  and is synchronized daily by external factors 
(Zeitgebers) like the 24h light-dark cycle of our planet. The increase need of sleep (Process S) 
can be measured by the increase of the prevalence and amplitude of EEG slow-wave (delta 
Figure 5 : The two-process model 
 The two-process model for sleep-wake regulation as proposed by Borbély. Circadian rhythm 
oscillations (C) are entrained by external factors (Zeitgebers) to favor the optimal time for propensity 
to sleep or be awake during the day (in rodent, light will induce sleep). Sleep homeostasis (S) process 
maintains the adequate quantity of sleep that is needed by the organism through the accumulation of a 
sleep pressure by time spent awake, and a decrease during sleep. As a homeostatic regulatory process,  
3 essentials component are expected to regulate sleep need in a feedback loop: (i) a sensor for sleep 
pressure, (ii)  a controller for a mediated response compared to an optimal set-point and (iii) an effector 
that modify the sleep behavior (Mang and Franken 2013). Adapted from (Daan, Beersma et al. 1984) 
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waves: 0.75-4.5 Hz) during NREM sleep that follow sleep-wake distribution (Tobler and and 
clinical 1986) or the increase of time spent asleep after challenging the sleep homeostat by sleep 
deprivation (Mang and Franken 2015). Unlike the SCN driving circadian rhythms, studies 
focusing on brain structure or core mechanisms regulating the sleep homeostasis process did 
not reveal similar ‘master’ regulators. The two-process model was described as two interactive 
processes (Borbély 1982, Daan, Beersma et al. 1984) that allows the organism at the 
physiological level to stay awake during its waking phase despite an increasing sleep propensity 
and sleep during its resting phase despite a decreasing need for sleep (Dijk and Franken 2005). 
And at the molecular level some clock genes like Per2 were shown to participate at both 
processes using forward and reverse genetics approach, reviewed in (Mang and Franken 2015). 
Furthermore the desynchrony of sleep wake-cycle and circadian rhythm in human strongly 
affect molecular balance (Archer, Laing et al. 2014) and is suspected to be involved in 
depression that could be treated with the help of the two-process model (Borbély, Daan et al. 
2016). The complete underlying mechanisms and relations between these two processes are still 
unclear. 
 
1.3.2 Genetics of sleep: 
The contribution of genetic factors to many aspects of sleep phenotypes was revealed to be 
particularly important. In twins, the estimated heritability of  NREM sleep power spectra 
between 8-16 Hz (De Gennaro, Marzano et al. 2008) was found to be 96%, making EEG 
spectral content one of the most heritable traits in human. Other sleep-wake aspects were found 
to be determined by genetic factors such as sleep disorder (Kimura and Winkelmann 2007, ), 
neurobiology of vigilance state via neurotransmitters (Crocker and Sehgal 2010,) or clock genes 
(Franken 2013). Therefore, forward and reverse genetic approaches were often used to 
disentangle the genetics behind the different sleep parameters (Franken and Tafti 2003, 
Andretic, Franken et al. 2008) and identify single variation effects. For instance, with the help 
of the BXD1-32/TyJ mouse panel, QTLs were associated with delta power increase after sleep 
deprivation (Dps1) (Franken, Chollet et al. 2001) and Homer1a was proposed as a probable 
candidate gene (Maret, Dorsaz et al. 2007, Mackiewicz, Paigen et al. 2008). Homer1a, a 
metabotropic glutamate receptor regulator (Kammermeier and Worley 2007), was suggested to 
link sleep homeostasis and synaptic down-scaling  (Diering, Nirujogi et al. 2017), which is a 
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proposed function of NREM sleep for the Synaptic Homeostasis Hypothesis (SHY) involved 
in synaptic plasticity and memory (Tononi and Cirelli 2003, Tononi and Cirelli 2006, Tononi 
and Cirelli 2014). Among the proposed molecular pathways for sleep homeostasis and synaptic 
plasticity regulation, the product of AMPA-type glutamate receptors cascade (Shepherd 2012) 
are being explored. Other genetic approaches have been used, e.g. random mutagenesis 
screening (Funato, Miyoshi et al. 2016) identified Sik3 and Nalcn with large effect over 
reciprocally sleep need and REM sleep amount. 
 
1.3.3 Sleep and metabolism interplay: 
Extensive research was performed on brain circuitry and brain molecular machinery during 
sleep and wakefulness using mainly EEG signals (Brown, Basheer et al. 2012). However 
alternative mechanisms were also highlighted, to be part of, or a co-factor of the sleep 
regulatory system (Frank 2012, Frank 2013). Other physiological systems like temperature 
(Franken, Dijk et al. 1991), glucocorticoid (Gronfier, Luthringer et al. 1997, Mongrain, 
Hernandez et al. 2010) or immune systems and cancer disease (Berger and Redline 2014) were 
connected to sleep characteristics.  
Obesity and type-2 diabetes on their side, were associated with sleep disorders and prolonged 
bad sleep behavior (Spiegel, Knutson et al. 2005, Spiegel, Tasali et al. 2009) leading to the 
notion of possible interconnected physiological processes, between sleep regulation and 
metabolism, with shared circuits (Adamantidis and de Lecea 2008). This is also supported by 
forward genetics approaches that identified common loci between sleep disturbance and 
metabolic trait by GWAS (Lane, Liang et al. 2017).  
On one side, sleep restriction shows that the human metabolome was sensitive to the increase 
of sleep pressure (Davies, Ang et al. 2014), which would hint that the organism’s metabolism 
is driven by sleep-wake cycle. On the other hand, other examples suggested another direction, 
the sleep regulation driven by metabolic disruption. In BXD mouse, a short acyl-CoA 
dehydrogenase enzyme, Acads, was selected as a candidate gene within a QTL for REM sleep 
theta peak frequency (Tafti, Petit et al. 2003), important for memory consolidation (Boyce, 
Glasgow et al. 2016). In drosophila, lipid metabolism was shown to modify sleep homeostasis 
and learning using a reverse genetics approach involving the bmm and Lsd2 genes, homologues 
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of lipid regulatory genes in human (Thimgan, Suzuki et al. 2010). Muscle metabolism was also 
suggested to directly be connected to sleep regulation, by Bmal1 rescuing expression 
specifically in the muscle, restoring mouse rhythmicity, while Bmal1 rescuing in the brain did 
not rescue mouse rhythmicity (Ehlen, Brager et al. 2017). The bidirectional relationship found 
between sleep-wake cycle and metabolism homeostasis was largely reviewed through the 
interplay other factors such as clock genes (Bass and Takahashi 2010), stress (Hirotsu, Tufik et 
al. 2015), brain circuitry (Huang, Ramsey et al. 2011).  
With the systems genetics approach, we aimed at deciphering the close relationship that 
exists between sleep-wake cycle and metabolism. The quantification of liver transcriptomics 
and plasma blood targeted metabolomics in addition to EEG/behavioral phenotyping and cortex 
transcriptomics permit a broad and precise capture of the mouse metabolic environment to 
associate with sleep aspects.  
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1.4: Data life cycle management: 
With the development of computational power, communication protocols and high-
throughput technologies, biology has now acceded to the area of big-data. It is expected that 
around 2025, genomics data only will generate near 2-40 Exabytes per year (1018 bytes) 
representing 1 zetta-basepairs (1021) sequenced per year (Stephens, Lee et al. 2015). This data 
explosion requires many innovations and novel bioinformatics paradigms for better information 
manipulation and extraction, including computational infrastructures with cloud-based data 
distribution or in an algorithmic context with ingenious, reproducible analysis pipelines and 
integrative methods (Muir, Li et al. 2016, He, Ge et al. 2017). The systems genetics designs as 
presented in previous sections generate typical features of big-data dataset, with large and 
heterogeneous amount of data characterized by an important variability as dint of high-
throughput omics use and EEG/EMG signals recording but also by the fundamental complexity 
of this regulatory system. While the predictive capacity of big-data approach is questioned, in 
particular using blind data collection without accurate mathematical model of dynamic systems 
(Coveney, Dougherty et al. 2016), the power of these datasets lies through exploration, 
discovery and mechanistic hypothesis building, which is ameliorated by a data-driven and 
(semi-)hypothesis free research (McCue and McCoy 2017) in combination with data integration 
(Zierer, Menni et al. 2015).  
  
1.4.1 Data integration: 
Data integration is the combination of multiple sources from a same system to improve 
knowledge. It is now seen as one of the most challenging approaches of big-data that can be 
viewed from two different but ultimately linked perspectives, with distinct problems to solve 
for the functions of “data-exploitation” and “data-source-discovery” (Gomez-Cabrero, 
Abugessaisa et al. 2014). The objective function of data-exploitation is the detection of relevant 
interactions between the integrated resources to gain new insight in a biological system. The 
methodological challenges surrounding this function of data integration are the development 
and implementation of novel mathematical, statistical, computational (Gligorijević and Pržulj 
2015) or visualization (Nekrutenko and Taylor 2012) strategies. The function of data-source-
discovery is more community related, with the improvement of the communication and of the 
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knowledge sharing systems surrounding a resource, meaning the possibility for the public and 
collaborative projects to find and maximize the use an already existing relevant resource and 
thereby increasing the value of this resources for the benefit of the scientific community. 
The many steps required for a correct data manipulation, integration and sharing urged the 
need for initiatives and guidelines promoting better data-handling. For example, complete meta-
data documentation about the organisms and environmental conditions at the origins of the 
resources in combination with standardization of methods and common file formats diminish 
errors, allowing correction for stochastic noise and unwanted heterogeneity that can be 
misleading (Ward, Schmieder et al. 2013, Alyass, Turcotte et al. 2015, Lapatas, Stefanidakis et 
al. 2015). These procedures for a planned and active supervision of the digital data, from their 
collection to their processing, analysis, preservation, publication, reproducibility and reusability 
are gathered under the term of Data Life-Cycle Management (DLCM).  
 
Initiatives like the FAIR principles developed by FORCE11 (Wilkinson, Dumontier et al. 
2016) focused on human or computer knowledge sharing by proposing data objects to be 
Findable, Accessible, Interoperable and Reusable through many guidelines, notably by 
extensive metadata annotation. Other initiatives have integrated the FAIR data principles as a 
core component of their development strategy, like the Big Data To Knowledge (Margolis, Derr 
et al. 2014, Jagodnik, Koplev et al. 2017) framework of the National Institute of Health (NIH) 
or the ELIXIR program in Europe (Jiménez, Kuzak et al. 2017) for the maximization of 
biomedical dataset use through software and infrastructure development. Conjointly, open and 
reproducible science have also shown many possibilities for improvement through entire data 
life cycle (Munafò, Nosek et al. 2017). Only a few biomedical journals currently have an 
explicit data-sharing requirement (Vasilevsky, Minnier et al. 2017) or reproducibility policy 
(Iqbal, Wallach et al. 2016). However, the current demand for reproducible research (eLife Jul 
14, 2017) articles have encouraged journals to support actively open technologies for 
publication (eLife Sep 7, 2017). The implementation of these initiatives can be quite time 
consuming in the working process, simply moving to a reproducible workflow can take up to 
many years (Lowndes, Best et al. 2017), but data-sharing and open analytical pipelines are 
essential for the reusability and reproducibility of the datasets. 
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PhD objectives & goals 
 
The research initiated by the group of Prof. Paul Franken on genetics of sleep and the tight 
relationship highlighted between sleep processes and peripheral factors such as corticosterone 
or cellular metabolism serve as foundation for decrypting the regulatory pathways linking 
metabolism and sleep homeostasis using the systems genetics approach with in the BXD panel. 
The amount of data to treat, analyze and manage from the plasma metabolomic, cortical + liver 
transcriptome and EEG/EMG signal recording necessitated the collaboration with the group of 
Prof. Ioannis Xenarios for the many bioinformatics elements that needed to be incorporated and 
developed in this project. My work was at the interface of this collaborative association between 
sleep research, systems biology and bioinformatics with a main component toward 
computational and statistical methods. My objectives for this interdisciplinary project were: 
• The apprehension, implementation and enhancement of a supervised deep machine 
learning algorithm designed by Dr. Nicolas Guex for the semi automation of EEG/EMG 
signal annotation for over 262 BXD mice and 22.5 million epochs. 
• The processing and analysis of multiomics datasets for gene quantification and 
construction of genotype maps. 
• Identify and implement the most adapted statistical methods for genetics association and 
appraise the sleep deprivation consequences on all data-types. 
• Develop a framework for data integration and visualization in the interest of the 
identification of key driver genes and pathways for hypothesis building and 
experimental validation. 
• The generation of a reproducible & reusable dataset with the implementation of an 
explicit interactive report and the development/supervision of a web resource interface 
for data-mining. 
• Participation to the bioinformatics and sleep research life through group meetings, 
corresponding topic-oriented conferences and sleep deprivation experiments. 
• Annex projects: I participated in annex projects that helped for the generation and 
follow-up of this dataset: (i) Evaluation of variant callers performance in the context of 
DREAM challenges, (ii) help with QTL mapping for diabetic related traits in BXD and 
(iii) set-up an ATAC-seq peak calling pipeline. 
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Chapter 2 presents this resource with the experimental design performed for *omics and 
physiological data extraction, followed by some analysis and first results interpretation. The 
principal focus of the resulting paper was the sleep deprivation consequences coupled with 
genetics interaction (GxE) and candidate genes that link sleep regulation and fatty acid 
metabolism. 
Chapter 3 presents in more detail the bioinformatics strategies and data-management 
methodologies implemented during the project to maximize the resource reusability, 
reassessment and value. 
Finally, a short annex presents a first view on the epigenetics modification that arose from sleep 
deprivation in C57BL/6J using ATAC-sequencing and the consequences on the sleep-wake 
driven or circadian genes. This project is still under preparation for publication and will direct 
follow-up experiments for epigenetics modification within the BXD panel, to complement our 
resource for better mechanistic characterization of the sleep loss and genetics interactive effect 
on transcriptome. 
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Chapter 2. Explore the sleep regulatory 
pathways through the prism of systems genetics. 
 
2.1 Results summary 
In this paper, we present the strong genetic contribution and the pervasive effect of short 
sleep loss, in addition to their interaction for each the BXD mice intermediate phenotype and 
their implication on physiological and behavioral end-phenotype. The estimated narrow-sense 
heritability for physiological, behavioral and metabolic phenotypes was overall high with a 
median value above 0.5. An association mapping revealed 61 significant QTL for 
behavioral/EEG and metabolic phenotypes, as well as more than 5000 genes driven by a cis-
eQTL. The short 6h disruption of sleep extensively reshaped the BXD phenotypic landscape by 
altering 60-78% of the liver and cortical transcriptomes, 60% of the plasma blood metabolome, 
and many physiological phenotypes such as NREM sleep amount or EEG delta power. We 
showed that genetic affects both the magnitude and direction of change induced by sleep 
deprivation (G x E) on genes expression, for example on enzyme promoting mitochondrial 
fatty-acid oxidation (Mlycd), but also on metabolite level such as the acylcarnitine C18:1. Two 
integrative methods were developed in this project, the first to identify candidate gene driving 
the behavioral/EEG and metabolic phenotypes, the second to visualize the meta-dimensional 
network underlying behavioral/EEG phenotype. The combination of both methods first 
identified the implication of cortical AMPA-receptor trafficking and DNA-helicase amplitude 
change for the physiological phenotypes of the EEG delta-power bands during the recovery 
phase, a correlate of sleep pressure. In a second time, we identified an intriguing relationship 
between branched-amino acid and arachidonic-acid (ARA) metabolism for the shift of theta-
peak frequency in REM sleep, an important aspect of memory consolidation. It leaved open 
question about the potential relationship between synthesis and derivates of ARA, like 
prostaglandins and endocannabinoids on the synaptic plasticity. Finally, we identified a large 
fatty acid turn-over after sleep deprivation, with effect on the NREM sleep recovery during the 
active phase of mice (dark) where most of NREM sleep loss was catched up. The implication 
of the associated acyl-CoA thioesterase enzyme (Acot11) was tested using knock-out and 
showed a deficiency in NREM sleep gain compared to their wild-type controls in the dark. 
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2.2 Contribution 
Beside my contributions mentioned in PhD objectives & goals (i.e. participation to 
EEG/EMG annotation automation, bioinformatics analyses and methods development), I 
participated to the results interpretation and paper writing with the help of all co-authors, I 
generated and formatted all figures (with exception of Fig5A & 6A) with comments/inputs of 
Prof.Paul Franken, Dr. Shanaz Diessler and Dr. Charlotte Hor and I participated to sleep 
deprivation experiment for Acot11 validation 
 
2.3 Publication:  
Shanaz Diessler, Maxime Jan, Yann Emmenegger, Nicolas Guex, Benita Middleton, Debra J. 
Skene, Mark Ibberson, Frederic Burdet, Lou Götz, Marco Pagni, Martial Sankar, Robin Liechti, 
Charlotte N. Hor, Ioannis Xenarios, Paul Franken. An integrative systems genetics analysis of 
sleep regulation in the mouse.  In Review  
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SUMMARY 
Sleep is essential for optimal brain functioning and health, but the biological substrates 
through which sleep delivers these beneficial effects remain largely unknown. We used a 
systems genetics approach in the BXD genetic reference population of mice and assembled a 
comprehensive experimental knowledge base comprising a deep ‘sleep-wake’ phenome, central 
and peripheral transcriptomes, and plasma metabolome data, collected under undisturbed 
baseline conditions and after sleep deprivation. We present analytical tools to interactively 
interrogate the database, visualize the molecular networks altered by sleep loss, and identify 
driver genes. We found that a one-time, short disruption of sleep already extensively reshaped 
the systems genetics landscape by altering 60-78% of the transcriptomes and the metabolome 
with numerous genetic loci affecting the magnitude and direction of change. Systems genetics 
integrative analyses drawing on all levels of organization imply AMPA-receptor trafficking and 
fatty acid turn-over as substrates of the negative effects of insufficient sleep. Our analyses 
demonstrate that genetic heterogeneity and the effects of insufficient sleep itself on the 
transcriptome and metabolome are far more widespread than previously reported.  
 
Keywords:  
Sleep deprivation / Electroencephalogram / Genome / Transcriptome / Metabolome 
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INTRODUCTION 
Insufficient or disrupted sleep are widespread in our 24/7 society and represent a serious 
public health concern, as it is associated with increased risk for e.g. obesity, diabetes and high 
blood pressure, and impairs cognitive performance, which in turn increases the likelihood of 
accidents, medical errors, and loss of productivity (Liu et al, 2016; Schmid et al, 2015). Several 
hypotheses concerning sleep’s still elusive function converge on the notion that staying awake 
imposes a burden that can only be efficiently alleviated during sleep (Benington & Heller, 1995; 
Krueger et al, 2008; Maquet, 1995; Tononi & Cirelli, 2014; Xie et al, 2013). This concept of a 
need for sleep accumulating during wakefulness and recovering while asleep is central in sleep 
research and is referred to as sleep homeostasis. Insight into the molecular substrates of the 
sleep homeostatic process is instrumental in advancing our basic understanding of sleep need 
under both physiological and pathological conditions.  
 The impact of acute sleep deprivation on recovery sleep and cognitive performance is under 
strong genetic control (Dissel et al, 2015; Franken et al, 2001; Kuna et al, 2012; Lo et al, 2012; 
Mang & Franken, 2015; Urry & Landolt, 2015), and genetic approaches therefore seem 
promising in uncovering the molecular pathways important in sleep homeostasis. Reductionist 
studies in mice and flies deleting genes through gene targeting [for review see (Mang & 
Franken, 2015)] or in mutagenesis screens (Cirelli et al, 2005a; Funato et al, 2016; Koh et al, 
2008) have demonstrated that single genes can have large effects on various aspects of sleep, 
including its homeostatic regulation. Such large single gene (Mendelian) effects, often assessed 
on one genetic background only, are however likely to be the exception. Indeed, susceptibility 
to sleep loss in the general population is assumed to be determined by the interactions of many 
genes, their natural allelic variants, and their interaction with the environment (lifestyle), a 
complexity that only recently has begun to be appreciated. Such complexity can best be 
assessed in so-called Genetic Reference Populations (GRPs), which are designed for the study 
of complex traits inherited in a non-Mendelian fashion. The BXD panel of advanced 
recombinant inbred lines (ARIL) is the largest and best characterized GRP to date, consisting 
of well over 100 lines in which two parental [C57BL/6J (B6) and DBA/2J (D2)] now fully 
sequenced genomes are segregating [www.genenetwork.org; (Peirce et al, 2004)]. As each line 
represents a reproducible clone of animals, many mutually reinforcing datasets can be collected 
and compared at multiple levels across many biological systems. This approach has been termed 
‘systems genetics’, which in essence allows for making inferences about biological phenomena 
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by assessing the flow of information from DNA-to-phenotype at the level of a population, and 
how this flow is perturbed by environmental challenges. Because systems genetics generalizes 
results to a population level, it is considered critical towards predicting disease susceptibility 
(Civelek & Lusis, 2014). Systems genetics has been applied with great success in the BXD set 
for e.g. mitochondrial function and metabolic- and aging-related phenotypes (Andreux et al, 
2012; Merkwirth et al, 2016; Williams et al, 2016).  
 Systems genetics approaches for sleep have been pioneered in the fly and mouse (Harbison 
et al, 2009; Jiang et al, 2015), but neither study reported on effects of sleep loss and its impact 
on intermediate phenotypes such as the metabolome and transcriptome. Here we present an 
extensive and comprehensive dataset interrogating the BXD set at the levels of the genome, the 
brain and liver transcriptomes, the plasma metabolome, and finally, the phenome including 
sleep-wake state, EEG-, and locomotor activity-related phenotypes, both under undisturbed 
baseline conditions and after an acute sleep deprivation challenging the sleep homeostatic 
process. We observed that sleep deprivation profoundly impacted all three phenotypic levels, 
and that genetic background not only determined the magnitude, but also the direction of the 
sleep-deprivation evoked changes. The molecular pathways underlying some of these effects 
will be illustrated here to introduce our integrated data resource. The molecular signaling 
circuitry underlying the equally profound phenotypic differences observed under baseline 
conditions will be reported in subsequent molecular driven validations.  
 Systems genetics is an emerging field, and innovative ways to improve data access, 
portability, and reproducibility, tools to display and mine these data, as well as statistical models 
to extract the multi-dimensional relationships across datasets are an area of intense research 
(Baliga et al, 2017). The size and complexity of our current dataset necessitated the 
development of new analytical tools and data sharing strategies such as (i) a supervised machine 
learning based algorithm to annotate sleep-wake states on EEG/EMG tracks, (ii) a gene 
prioritization strategy that draws on all levels of the experimental dataset to assist the search 
for candidate genes within QTL intervals, (iii) the implementation and integration of a recently 
developed systems genetics visualization tool (Krzywinski et al, 2012) in a dynamic web-based 
interface which, in addition, provides access to the data presented and enables interactive data-
mining (https://bxd.vital-it.ch). 
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RESULTS 
Study design  
We subjected mice from 33 BXD/RwwJ lines (see https://bxd.vital-it.ch; Downloads, 
General_Information.xlsx for a listing), the two parental strains (B6 and D2), as well as F1 
individuals from reciprocal crosses between the parental lines, to a deep behavioral and 
molecular phenotyping across four levels of organization. The BXD lines were randomly 
chosen from the then available, newly generated ARIL panel (Peirce et al, 2004), although lines 
with documented poor breeding performance were not considered. In one set of mice, we 
recorded sleep-wake behavior, brain activity (by electroencephalography or EEG), and 
locomotor activity (LMA) during 4 days (Figure 1, Experiment 1). On day 3, mice underwent 
a sleep deprivation challenge (SD) during the first 6 hours of the light period when mice 
normally sleep most of the time. We refer collectively to EEG and LMA derived measures as 
‘EEG/behavioral’ phenotypes. A second set of mice, representing the same lines, was processed 
in parallel for collection of brain, liver, and plasma (Figure 1, Experiment 2). Half these animals 
underwent a sleep deprivation alongside animals of Experiment 1, while the other half were left 
undisturbed and used as controls (Ctr). We measured gene expression in cortex and liver, and 
metabolites in plasma. These transcriptomic and metabolomic data are collectively referred to 
as (intermediate) molecular phenotypes. The phenotypic variability in EEG/behavioral and 
molecular phenotypes was assessed in relation to the genetic variation present in the BXD panel 
using Quantitative Trait Locus (QTL) analysis. The resulting QTLs were divided into ph-, m-, 
and eQTLs, for phenotype (EEG/behavioral), metabolite, and expression QTLs, respectively. 
The entirety of the multi-level dataset was integrated in a systems genetics analysis to chart 
molecular pathways underlying the many facets of sleep and the EEG, using newly developed 
computational tools to (i) interactively display results and pathways, and (ii) to identify driver 
genes. 
 
EEG/behavioral phenotyping  
From the EEG and LMA recordings we could extract a comprehensive set of 341 
EEG/behavioral phenotypes (see https://bxd.vital-it.ch; Downloads, General_Information.xlsx) 
in 227 mice (~6 mice/line, see Methods). These phenotypes were separated into 3 main 
biological categories related to: (i) LMA, (ii) EEG signal features, and (iii) the prevalence and 
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time structure of sleep-wake state [i.e., wakefulness and its substate theta-dominated 
wakefulness (TDW), NREM sleep, and REM sleep], collectively referred to as ‘LMA’, ‘EEG’, 
and ‘State’, respectively. Sleep-wake states were semi-automatically derived from the 
EEG/EMG signals using a specifically developed supervised machine learning based algorithm 
(see Methods and Appendix Figure S1). The 3 phenotypic categories were divided further into 
sub-categories (Figure 2A) and by experimental condition (baseline, sleep deprivation, and 
recovery). Because some phenotypes were tightly linked (e.g., the time spent in NREM sleep 
and wakefulness), we estimated the total number of distinct phenotypic classes to be 148 
(Appendix Figure S2 and Methods). However, we still used all available phenotypes in our 
analyses to detect potential regulatory differences among even closely related phenotypes and 
to avoid analysis bias arising from selecting a ‘representative’ phenotype. 
 
Molecular phenotyping  
We quantified 124 metabolites (see https://bxd.vital-it.ch; Downloads, 
General_Information.xlsx) in 249 blood plasma samples (~3 samples/line/condition, see 
Methods) using targeted metabolomics. Although targeted metabolomics does not provide a 
comprehensive assessment of the entire metabolome, it does cover important metabolite classes 
(i.e., amino acids, biogenic amines, acylcarnitines, sphingolipids, and glycerophospholipids) 
and the results obtained using this method are highly reproducible and readily interpretable 
(Siskos et al, 2017).  
 Cortex and liver transcript levels were measured using RNA-sequencing (RNA-seq). Gene 
boundaries and names used were extracted from the Refseq database to ensure reusability of 
the data. We detected 14.9K expressed genes in the cortex and 14.1K genes in the liver after 
filtering and normalization. Although for both tissues, the RNA-seq samples passed all quality 
thresholds and among-strain variability was small, more reads were mapped in cortex than in 
liver (Appendix Figure S3A), and we observed a somewhat higher coefficient of variation in 
the raw gene read count in liver than in cortex (Appendix Figure S3B).  
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Genotyping  
We used the RNA-seq alignments also to genotype the lines to verify that no mix-up 
occurred during the breeding and data collection phase, and to increase mapping resolution. 
The GATK variant-calling pipeline (McKenna et al, 2010) was used for genotyping, and we 
compared the 500K detected genotypes with the publicly available 3.5K genotype set for the 
same BXD lines from GeneNetwork (2005 release; see Methods). We observed only a ~1% 
discrepancy and merged both genotype sets, resulting in a set of 11K tag variations which 
increased the number of haplotype blocks from 551 (GeneNetwork) to 1071 (RNA-seq + 
GeneNetwork). All analyses we report here were based on our merged map (see 
https://bxd.vital-it.ch; Downloads, Genotypes.GeneNetwork2005AndRNAseq.geno). Of note, 
by the completion of this publication, an updated set of BXD genotypes was released with an 
estimated haplotype block number of 816 for the specific lines we used (GeneNetwork, 2017 
release http://genenetwork.org). Of the 61 significant phQTLs we detected (see below), 54 were 
also detected using either GeneNetwork genotypes (the 2005 or 2017 release), while the 
remaining 7 significant phQTLs were unique to our merged genotype map.  
 Although overall, a close to 50/50 balance between B6 and D2 genotypes was observed 
across the genome, a minority of sites displayed a strong imbalance towards either genotype 
(Appendix Figure S4a). We also confirmed a minor but general trend towards more D2 than B6 
genotypes per strain (Appendix Figure S4Bb), which was also found in the GeneNetwork 
genotypes for the BXD strains used in our study.  
 
Heritability and QTLs 
To obtain a first sense of the contribution of genetic factors to the phenotypic variability 
contained within our BXD set, we examined the heritability of the EEG/behavioral and 
metabolic phenotypes. The estimated narrow sense heritability (Hegmann & Possidente, 1981) 
among the EEG/behavioral phenotypes was high overall (median h2=0.68, Figure 2A), 
consistent with what has been reported in previous human and mouse studies (Andretic et al, 
2008). We also confirm that various aspects of the EEG signal are among the most heritable 
traits with, in our dataset, theta-peak frequency (TPF) in REM sleep ranking highest (h2=0.89). 
The heritability for differential EEG/behavioral phenotypes (i.e., recovery vs. baseline; green 
symbols in Figure 2A) were consistently lower by ca. 0.2 points compared to the heritabilities 
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obtained for recovery or the baseline values per se. We found that this effect did not simply 
reflect increased variability due to combining recovery and baseline values, and might thus 
suggest a smaller genetic contribution to the response to sleep loss. The overall heritability of 
plasma metabolite levels was somewhat lower than for EEG/behavioral phenotypes (median 
h2=0.50) with alpha-aminoadipic acid (α-AAA) displaying the highest heritability (h2=0.88; 
Figure 2A).  
 Average-to-high heritabilities are a requirement to attribute phenotypic variation to gene 
loci, but even then there is no guarantee to find genome-wide significant QTL(s); e.g., for the 
TPF in REM sleep phenotype mentioned above, only 4 suggestive phQTLs of small effect size 
were identified (see https://bxd.vital-it.ch; Downloads, QTL_Mapping.xlsx) that together could 
nevertheless account for 58% of the variance, suggesting that perhaps higher order loci 
interactions (e.g. epistasis), which cannot be captured using the single marker linkage analysis 
we used here, underlie differences in this EEG trait. Genome scans revealed a total of 61 
‘significant’ (FDR≤0.05), 65 ‘highly suggestive’ (0.05<FDR≤0.10), and 923 ‘suggestive’ 
(0.10<FDR≤0.63) (Burgess-Herbert et al, 2008; Lander & Kruglyak, 1995) phQTLs and 21 
significant, 40 highly suggestive, and 528 suggestive mQTLs (Figure 2B). Given the large 
number of EEG/behavioral and metabolic traits of average-to-high heritability, the number of 
significant QTLs might seem a modest yield. We assume, however, that most of the traits are 
complex/polygenic and thus influenced by many smaller effect-size QTLs. The high number of 
suggestive QTLs might reflect this. Because for each genome scan one suggestive QTL is 
expected to be found by chance, the 1556 suggestive ph- and mQTLs obtained are 2.2 times 
higher than the number expected by chance alone, given the 713 EEG/behavioral and metabolic 
phenotypes analyzed. These suggestive QTLs are therefore expected to be biologically 
meaningful, each having a small contribution to the variance of polygenic traits. The large 
portion of the variance explained by the 4 suggestive phQTLs associated with REM sleep TPF 
(see above) attests to this.  
 Several phenotypes from distinct phenotypic categories were associated with overlapping 
genomic regions. For example, differences in baseline wake consolidation, gain in REM sleep 
time after sleep deprivation, EEG delta power (1.0-4.0 Hz) in REM sleep, baseline levels of 
serotonin and PC-aa-C34:4, and levels of PC-aa-C34:4 and PC-aa-C36:6 after sleep 
deprivation, all mapped to one 30Mb region on chromosome 10 (50-80 Mb), each with a 
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significant or highly-suggestive QTL (Figure 2B). These overlapping QTLs may point to 
pleiotropic effects of one underlying gene or close but distinct underlying QTLs.  
 We also performed QTL analysis for gene expression, but because many more linkage tests 
were required for transcriptome mapping, we used a more suitable method than for ph- and 
mQTL mapping. The format for reporting eQTLs will therefore differ from that used for ph- 
and mQTLs (see Methods). The expression of individual genes was mapped separately for cis-
eQTLs with genetic markers within a 2 Mb window, and trans-eQTLs with markers positioned 
throughout the genome (see Methods). The transcriptome of BXD mice showed strong linkage 
with genotypic variation. For example, in the cortex, the expression of 5704 genes (i.e., 38% of 
all expressed genes) was significantly driven by a cis-variation (Figure 2C and https://bxd.vital-
it.ch; Downloads, cis_eQTL.xlsx). Moreover, 2465 (34%) of all genes under cis-eQTL effect 
in both tissues passed the 0.05 FDR cutoff in a single condition and tissue. Factors contributing 
to this tissue/condition specificity are the absence of gene expression in one of the two tissues, 
or a different gene regulatory environment on which sleep deprivation had pervasive effects 
(see below). This important tissue/condition specificity also applied to trans-eQTLs with 5537 
(53% of 10450) being under trans-eQTL effect only in one specific tissue or condition. 
Although the observation that a large portion of eQTLs reached significance in one tissue and 
condition only does suggest wide-spread gene x environment interactions regulating gene 
expression, reaching the 0.05 FDR threshold or not, does not prove this. We therefore compared 
linkage strength of significant cis-eQTLs that were specific for one tissue and condition with 
that in the 3 other RNAseq sets. Among the 870 genes with a significant cis-eQTL effect in 
sleep deprived cortex only (Figure 2C), 175 (20%) showed a significant difference in linkage 
signal (FDR<0.05). This proportion was similar in the control cortex and liver (19 and 21%, 
respectively) and somewhat higher in sleep deprived livers (32%). 
 
Systems genetics visualization  
The complexity of multi-level networks can only be appreciated through visual aids. Because 
the widely used ‘hairball’ representation, in which biological factors are represented as ‘nodes’ 
and their interconnections as ‘edges’, is hardly interpretable due to its non-deterministic 
structure (Figure 3A), we opted for a structured representation more suitable for the 
visualization of complex systems, namely ‘hiveplots’ (Krzywinski et al, 2012). The hiveplots 
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were laid out as follows (Figure 3B, see Methods for details): each plot represents one 
EEG/behavioral phenotype and its underlying associated molecular network, i.e. only the genes 
and metabolites strongly associated with a given phenotype are displayed. Each hiveplot is 
composed of 3 radial axes containing the molecular data with nodes assigned to the 2 bottom 
axes for genes expressed in the cortex (Figure 3B Left in blue) and liver (Figure 3B Right in 
red), while nodes on the vertical axis (Figure 3B Top in yellow) represent metabolites. On top, 
we added a separate ‘genetic’ axis (Figure 3B Top white) containing the genotypes. The node 
position on the 3 (molecular) radial axes was determined by the response to sleep deprivation, 
i.e. molecules positioned closer to the center were down-regulated more strongly, while more 
up-regulated genes/metabolites can be found closer to the axes’ perimeter. Edges connecting 
nodes represent positive/negative correlations (red/blue, respectively) between measurements 
of expression/metabolite levels. Genetic markers linked to genes by eQTLs connect the genetic 
and molecular space.  
 The hiveplot representation allows investigation of the underlying network of an 
EEG/behavioral phenotype in a structured manner, and comparison of phenotypes using all 
intermediate phenotypic layers available in the dataset. The difference in presence or absence 
of nodes/edges between 2 phenotypes indicates which association was gained or lost. 
Furthermore, the importance of the sleep deprivation effect on these nodes can be visually 
estimated by their position along the axis (Figure 3C). Although the inter-phenotype 
connectivity present in the hairball representation is lost in the printed format of these hiveplots, 
this aspect can be easily accessed through our web interface (https://bxd.vital-it.ch) by 
highlighting common edges. The web interface also allows for an in-depth exploration of the 
data by displaying node details such as gene and metabolite name, and variation identifiers. It 
also lets the user modify the parameter settings used to generate the hiveplots (see Appendix 
Figure S5 and the tutorial on https://bxd.vital-it.ch; Help).  
 
Systems genetics prioritization  
We developed an unbiased, data-driven approach to identify candidate genes underlying our 
EEG/behavioral and metabolic phenotypes. We focused mainly on genes located in the 
associated genomic regions found by QTL analyses (see Figure 2B). To investigate these often 
quite large regions (mean=9.8 Mb, range=0.7-34.7 Mb for significant and highly suggestive 
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phQTLs), we implemented a scoring strategy inspired by the ‘similarity profiling prioritization 
strategy’ (Moreau & Tranchevent, 2012), which combines multiple sources to prioritize a gene. 
For each gene, we computed an integrated score comprised of (i) the genomic position of the 
gene with respect to the ph-/mQTL peak, (ii) a detected cis-eQTL driving the expression of the 
gene, (iii) a protein-damaging annotation of a variant, (iv) differential expression after sleep 
deprivation, and (v) correlation between expression and phenotype of interest (Figure 3D, see 
Methods for details). Our prioritization strategy thus aimed at identifying genes which are 
sensitive to sleep loss, correlated with the phenotype being evaluated, and associated to a cis-
eQTL, and/or carrying a protein-damaging variant that could contribute to trait variance. A 
Henikoff weighting algorithm was applied to correct for intrinsic correlations among the 5 
analysis scores. The integrated score for each gene was computed with the given formula 
(Figure 3D) and a FDR was computed by performing 10K permutations (Appendix Figure S6 
and Methods). For each QTL, we kept the gene with the highest significant integrated score. 
This scoring strategy was applied to cortex and liver data separately. 
 To illustrate our prioritization algorithm, we applied it to the metabolite with the highest 
heritability, α-AAA (see above), and for which we obtained a highly significant mQTL on 
chromosome 2 [LOD=9.25, 1-11Mb]. We readily identified Dhtkd1 as the top-ranked 
significant candidate gene in liver within the chromosome 2 mQTL (Figure 3E), because of (i) 
the strong correlation of Dhtkd1 expression with α-AAA levels, (ii) Dhtkd1 is under a cis-eQTL 
effect (rs222492362, chr2: 5.8 Mb, q=1.5e-17), (iii) the marker of the cis-eQTL is located 
within the peak of the mQTL, and (iv) both α-AAA and Dhtkd1 levels are affected similarly by 
sleep deprivation. This result can be taken as a first validation of our scoring strategy, because 
Dhtkd1 encodes an enzyme subunit involved in lysine degradation known to control α-AAA 
levels in BXD lines (Wu et al, 2014). Although with the examples that will be highlighted below 
we primarily focus on regions associated with significant QTLs, our prioritization strategy also 
allows identification of candidate genes within suggestive QTL intervals as shown for the ‘δ1 
power gain’ phenotype (see below and Figure 5). 
 
Pervasive effects of sleep deprivation at all levels  
The EEG/behavioral and molecular phenotypes were assessed both under undisturbed 
baseline conditions and after 6h sleep deprivation. Sleep deprivation profoundly and 
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significantly impacted a majority of measurements at all levels. We observed the well-known 
increase in EEG delta power (1.0-4.0 Hz) during NREM sleep as well as the increase in the 
time spent asleep (Figure 4A), both reflective of an accumulated homeostatic sleep pressure 
during sleep deprivation. The gain in time spent in NREM sleep was strongest during the initial 
12h following the sleep deprivation, with an average gain of +23 minutes (compared to values 
reached during corresponding baseline hours) during the first 6h after the SD [ZT6-12] and +32 
minutes during the first 6h of the following dark period [ZT12-18]. The most strongly affected 
sleep phenotype concerned time spent in REM sleep, which displayed a 3.3-fold gain during 
the first 6 hours of darkness [ZT12-18] after sleep deprivation (Figure 4A). Sleep deprivation 
thereby doubled the proportion of REM sleep to NREM sleep in this interval. Locomotor 
activity and waking phenotypes were generally decreased during the light period immediately 
following the sleep deprivation (ZT6-12).  
 In addition, the plasma metabolome was profoundly altered by sleep deprivation. Of the 124 
measured metabolites, 75 (60%) were significantly up- or down-regulated. The levels of all 
amino acids were significantly altered after sleep deprivation, the majority being down-
regulated with the exception of glutamine, glutamate, and tryptophan, which were up-regulated 
(Figure 4B). A recent publication reported similar effects on amino acid levels in brain 
dialysates of sleep deprived rats (Marini et al, 2017) suggesting that plasma can report on central 
changes in amino acid levels. By contrast, tryptophan was the only amino acid that was found 
significantly changed during sleep deprivation in humans using the same methodology (Davies 
et al, 2014). The two acylcarnitines present in our dataset (C18:1 and C18:2) were both strongly 
up-regulated with a greater than two-fold change. Similar results were found in humans, with 
acylcarnitines levels increased in blood and carnitines increased in urine after sleep loss (Davies 
et al, 2014; Giskeødegård et al, 2015).  
 The transcriptome was especially sensitive to sleep deprivation, with 78% of all expressed 
genes being differentially expressed in cortex and 60% in liver. In cortex, the most strongly 
differentially expressed genes were Arc, Egr2, and Plin4, with an almost 8-fold increase in 
expression after sleep deprivation (see Appendix Table S1). Arc (Activity regulated 
cytoskeletal-associated protein) is an immediate early gene crucial for long-term synaptic 
plasticity and memory formation (Korb & Finkbeiner, 2011). Arc is among the most 
consistently up-regulated transcripts after sleep deprivation (Wang et al, 2010a) and features in 
a short-list of 78 genes the expression of which we found reliably and significantly changed by 
45 
 
extended wakefulness under a number of experimental conditions (Mongrain et al, 2010). 
Forty-nine other genes in this short-list also featured among the top 5% most affected transcripts 
of the current experiment (Appendix Table S1 and blue symbols in Figure 4C Left). Similarly, 
Egr2 (Early growth response 2) is one of three Egr genes that are rapidly induced by sleep 
deprivation in several species (Wang et al, 2010a). Egr1 and -3 appear on our short-list and all 
3 Egrs are among the top 100 differentially expressed cortical genes in the current study 
(Appendix Table S1). The Egr family are immediate early genes encoding transcription factors 
important in neuronal plasticity (O'Donovan et al, 1999). Plin4 (Perilipin 4), which encodes a 
lipid-droplet associated protein involved in lipid storage (Itabe et al, 2017), has not been 
reported previously as part of the sleep deprivation response. Ttll8 (tubulin tyrosine ligase-like 
family, 8) encoding a ligase which glycylates microtubules (Rocha et al, 2014), and Fam107a 
(family with sequence similarity 107, A) a stress- and glucocorticoid-regulated gene (Masana 
et al, 2015; Schmidt et al, 2011), were the top differentially expressed genes in liver (Appendix 
Table S2). Although the short-list was based on forebrain samples, 17 genes were also present 
in the top 5% differentially expressed genes in the liver (blue dots Figure 4C Right). Moreover, 
13 genes were common to the top 5% list in cortex, liver, and the 78 genes of the short-list 
(Hspa1a/b, Cirbp, Fos, P4ha1, Chordc1, Dusp1, Slc5a3, Hsph1, Creld2, Tra2a, Zbtb40, and 
Pfkfb3). These genes might be interesting candidates for tissue-independent biomarkers of 
sleep pressure. 
 
Genetics of the effects of sleep deprivation  
In the context of our project, a key question to be addressed is whether genetic background 
modifies these pervasive effects of sleep deprivation. We found evidence for this at all 3 levels 
of organization and detected genomic loci predicting differences not only in the magnitude of 
the response to sleep deprivation, but also in the direction of the response (illustrated in Figure 
4D-F). In the analyses, we included both the levels reached after the sleep deprivation, and 
these levels contrasted to their baseline levels. These contrasts will be referred to as ‘change’, 
‘increase’, ‘gain’, 'decrease', or ‘differential expression’ (DE).  
 For 7 EEG/behavioral ‘gain’ phenotypes we discovered a significant QTL (https://bxd.vital-
it.ch; Downloads, QTL_Mapping.xlsx). Illustrated in Figure 4D is the gain in time spent in 
REM sleep which mapped significantly to chromosome 18 (LOD=3.9; 57-62 Mb) with B6-
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allele carriers gaining more REM sleep than D2-carriers (genotype-SD interaction: p=2.0e-5). 
Three more ‘gain’ phenotypes will be discussed in detail below (see Figures 5-7). Also 
illustrated in Figure 4D is an EEG/behavioral gain phenotype with a pronounced genotype 
effect on the direction of change. The sleep-deprivation induced changes in EEG activity in the 
fast gamma band (55-80 Hz) in NREM sleep mapped suggestively to chromosome 6 
(LOD=2.83; 77-89 Mb) with a majority of B6-allele carriers at the QTL peak position having 
a significant decrease in fast gamma while several D2-allele carriers showed a significant 
increase (genotype x SD interaction: p=1.0e-5). Examples of two genetically driven metabolic 
responses to sleep deprivation are illustrated in Figure 4E. The change in phosphatidylcholine 
acyl-alkyl 32:2 (PC-ae-C32:2) after sleep deprivation mapped significantly to chromosome 5 
(LOD=3.6; 58-69 Mb; genotype x SD interaction: p=2.0e-3). The change in acylcarnitine 
C18:1, the strongest among all metabolites assayed (Figure 4B), mapped suggestively to 
chromosome 18 (LOD=3.6; 73-75 Mb; genotype x SD interaction: p=2.0e-3). For an additional 
79 metabolites, a significant genotype x SD interaction was obtained that mapped at the 
suggestive level (see https://bxd.vital-it.ch; Downloads, Genotype_SD_Interaction.xlsx). 
Finally, significant cis-eQTLs were detected for the differential expression (DE, i.e. recovery 
vs. control) of 195 genes after sleep deprivation (see https://bxd.vital-it.ch; Downloads, 
Genotype_SD_Interaction.xlsx). The strongest cis-allele was found for the DE of cortical 
Pla2g4e (rs47077493, chr2: 118.3 Mb, q=1.2e-9) with a down-regulation that was 2-fold larger 
in B6- than in D2-allele carriers (genotype x SD interaction: p=1.0e-9; Figure 4F). Also 
illustrated are the effects of sleep deprivation on Mlycd expression for which a cis-eQTL was 
identified (rs33610973, chr8: 120.8 Mb, q=1.9e-5). In BXD lines carrying a B6-allele at the 
cis-eQTL position, a down-regulation of Mlycd was observed, while the opposite was true for 
D2-allele carriers (genotype x SD interaction: p=2.0e-4; Figure 4F). Pla2g4e (phospholipase 
A2, group IVE) encodes a phospholipase promoting the formation of free-fatty acids, while 
Mlycd (malonyl-CoA decarboxylase) encodes an enzyme promoting mitochondrial fatty-acid 
oxidation. One last example of a significant differential cis-eQTL, for Wrn, will be discussed 
in detail below (see Figure 5). 
 
Systems genetics of the effects of sleep deprivation  
In the following 4 sections, we highlight 4 phenotypes during recovery from sleep 
deprivation that emerged from our systems genetics analyses because of the presence of strong 
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genetic evidence at all levels of organization, allowing causal/meaningful relational networks 
to be built linking the flow of information from DNA to phenotype. Two concern the levels of 
EEG delta power reached after sleep deprivation, one concerns the gain in time spent in NREM 
sleep during recovery, and, as a last example, the changes in TPF during REM sleep in recovery. 
While for the first 3 phenotypes abundant evidence exists documenting their change with sleep 
deprivation and their relevance in optimal day-time functioning and health, the latter phenotype, 
which has not been reported on previously, illustrates that depending on genotype, a phenotype 
can either increase or decrease after sleep loss. Moreover, this example shows that phenotypes 
considered strictly ‘central’ (i.e., the frequency of hippocampal theta oscillations during REM 
sleep) are strongly associated with genomic loci affecting gene expression in the periphery and 
not in the brain. Finally, it is important to point out that the genomic loci identified for these 4 
recovery phenotypes appear after sleep deprivation only and not (even at the suggestive level) 
under baseline conditions. 
 
Example 1: Genetic heterogeneity in the gain of slow and fast EEG delta power after sleep 
deprivation.  
 
 The prevalence and amplitude of EEG oscillations in the delta frequency range (1.0-4.0 Hz) 
during NREM sleep can be quantified as EEG delta power. The sleep-wake dependent changes 
in EEG delta power have been widely used as a marker of the sleep homeostatic process and 
form the basis of leading hypotheses on sleep-wake regulation and function (Daan et al, 1984; 
Krueger et al, 2008; Tononi & Cirelli, 2014). In the older BXD panel (BXD1-42/TyJ), we 
previously mapped a significant QTL on chromosome 13 (Dsp1; MGI: 2135996) that could 
explain a large portion of the variance in the increase (or gain) in EEG delta power (compared 
to the lowest values reached in baseline between ZT8-12) during NREM sleep immediately 
following a sleep deprivation (Franken et al, 2001). Subsequent studies identified Homer1 as a 
credible candidate gene (Mackiewicz et al, 2008; Maret et al, 2007), and specifically its short 
isoform Homer1a might mechanistically link sleep homeostatic drive to one proposed function 
of NREM sleep, namely synaptic down-scaling (Diering et al, 2017). In the current BXD set 
(BXD43-161/RwwJ), we could not replicate the Dps1 QTL. Among the many possible 
explanations for the differences between the two studies are (i) the strong bias in allele 
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frequency toward the B6 genotype at the Dps1 region in the 33 BXD lines we used in the current 
study (28/33 lines, Figure S3A), a situation which decreases statistical power for QTL detection 
and is also thought to contribute to replication issues among QTL studies (Gatti et al, 2009), 
(ii) the two BXD sets were derived from two different DBA/2 sub-strains [i.e., DBA/2Rj vs. 
DBA/2J; new vs. old (Shin et al, 2014)], (iii) genetic drift (Reardon, 2017; Shifman et al, 2006), 
(iv) interaction with other loci that are differently represented in the two BXD sets, and (v) 
differences in phenotyping. In an attempt to address some of these issues, we re-phenotyped 
two of the older BXD lines, namely BXD5/TyJ and BXD32/TyJ, which ca. 17 years earlier 
gave the highest and lowest EEG delta power increase after sleep deprivation, respectively 
(Franken et al, 2001). While for BXD5, which carries a B6-allele at Dps1 as well as for the B6 
parental strain, we obtained a close to perfect match (B6: 221.2 vs. 223.1%, BXD5: 223.3 vs. 
223.6% over baseline, current vs. previous), for BXD32, a D2-allele carrier at the Dsp1 locus, 
and the D2 parental line we observed notable discrepancies (D2: 168.9 vs. 179.5%; BXD32: 
159.2 vs. 133.0%, current vs. previous). Thus each BXD set must be regarded as a GRP in its 
own right and QTL analyses can lead to different sets of equally valid genetic associations due 
to genetic drift and other above-mentioned reasons.  
 In the current dataset, we did not find loci with strong linkage for the gain in EEG delta 
power after sleep deprivation when analyzed for the entire delta frequency range (1.0-4.0 Hz). 
We previously noticed that this increase in EEG power after sleep deprivation is, however, not 
homogeneous across the delta band (Franken et al, 2006; Vassalli & Franken, 2017) and 
therefore divided it into a slow (δ1: 1.0-2.25 Hz) and a fast (δ2: 2.5-4.25 Hz) delta band. As a 
neurophysiological correlate of increased EEG activity in δ1 after sleep deprivation, increased 
noradrenergic tone in the cortex has been proposed (Cirelli et al, 2005b). In addition, the 
acceleration of the clock-like delta oscillations generated by thalamocortical neurons at 
increasing levels of hyperpolarization that accompany deep NREM sleep could contribute to 
increases in δ2 activity (Amzica & Steriade, 1998; Dossi et al, 1992). In the current dataset, we 
confirmed that EEG activity in the two bands respond differently to sleep deprivation. E.g., 
lines that showed the lowest/highest gain in δ1 power (i.e., BXD81 and -67, respectively; Figure 
5A Bottom) only ranked 12th and 23rd (out of 33) for the gain in δ2 power. Moreover, we found 
different genetic loci contributing to their respective increases over baseline. The separation of 
delta in a δ1 and a δ2 band increased the number of QTLs detected: while one suggestive QTL 
(LOD = 2.58; chr1: 165-176 Mb) was found using the full, 1.0-4.0 Hz band, we detected one 
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suggestive QTL on chromosome 8 (LOD = 2.86; 18-37 Mb) for the gain in δ1 power explaining 
33% of the phenotypic variance across the BXD lines, and 5 suggestive QTLs for δ2 power 
gain, none of which overlapped with the δ1 and ‘full’ delta power gain QTLs. Although each 
of these 5 QTLs explained only <5% of the total variance in δ2 power gain, together they 
explained no less than 75% of the variance. These genetic findings extend our previous 
observations that δ1 and δ2 power gain are regulated through distinct signaling pathways.  
 Gene prioritization significantly scored the DNA-helicase Wrn (Werner syndrome RecQ 
like helicase) as a candidate for δ1 power gain, while no significant candidates were found for 
the full delta gain and for the δ2 power gain, probably due to the low effect size for each of the 
5 suggestive QTLs. Wrn is located within the suggestive QTL on chromosome 8 (Figure 5B 
Bottom) and its expression was strongly associated with a long phosphatidylcholine (PC-ae-
C38:5; Figure 5C Bottom). We found that Wrn expression in the cortex specifically was driven 
by a cis-eQTL (rs51740715, chr8:35.2 Mb, q=1.9e-7) with D2-allele carriers having higher 
expression levels than B6 carriers under control conditions. Moreover, this same cis-eQTL 
region determined the magnitude of the sleep-deprivation induced decrease in Wrn expression, 
such that after sleep deprivation D2-allele carriers now displayed lower levels than B6-allele 
carriers (genotype x SD interaction: p=5.2e-10; Figure 5D Right). Moreover, a higher gain in 
δ1 power was associated with a stronger down-regulation of Wrn after sleep deprivation (Figure 
5E Right).  
 Wrn encodes a DNA-repair protein involved in several aging-related diseases (Muftuoglu 
et al, 2008) and is regulated by Sirt1 (Lee et al, 2015) which, in turn, is involved in redox 
homeostasis, senescence, and wakefulness (Mouchiroud et al, 2013; Panossian et al, 2011). 
Down-regulation of Wrn alters redox homeostasis through a metabolic shift, impacts glucose 
metabolism and increases oxidative stress (Li et al, 2014; Massip et al, 2006). Wrn helicase 
mutants also showed up-regulation of long phosphatidylcholines (Aumailley et al, 2015) 
relevant for the significant association between Wrn expression and PC-ae-C38:5 we reported 
above. The down-regulation of Wrn after sleep deprivation and its association with the sleep-
wake dependent changes in EEG delta power raise questions concerning its involvement in the 
known sleep-loss related increases in oxidative stress (Everson et al, 2014; Villafuerte et al, 
2015) and the age-related reduction in EEG delta power (Dijk, 2010; Hasan et al, 2012). 
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Example 2: The level of fast delta activity in the NREM sleep EEG after sleep deprivation  
Apart from the sleep-wake driven gain in EEG delta power discussed above, the prevalence 
and magnitude of the delta oscillations per se are under strong genetic control both in human 
and mouse (Landolt, 2011; Maret et al, 2005). These two aspects of EEG delta power represent 
two unrelated EEG phenotypes governed by different genetic factors (Franken, 2012). 
Accordingly, the QTLs associated with the gain in δ1 power and in δ2 power presented above, 
did not associate with levels of δ1 power and δ2 power reached after sleep deprivation. 
Moreover, as for the δ1 and δ2 gain phenotypes, the levels in delta power measured after sleep 
deprivation differed between the δ1 and δ2 frequency bands. For example, the lowest/highest 
delta power values for the δ2 band were found in BXD75 and -44, respectively (Figure 5A 
Top), while these two lines ranked 2nd and 14th (out of 33) for δ1 power. For δ2 power after 
sleep deprivation, a significant QTL was identified on chromosome 2 (LOD = 3.87; 136-144 
Mb) that explained 42% of the variance. This QTL was specific for recovery sleep and did not 
associate with δ1 power for which no QTL was found. We did however find a suggestive QTL 
at the same locus for the power in the full delta band explaining a mere 2% of the variance in 
the full delta band.  
 Our prioritization strategy revealed Kif16b (Kinesin family member 16B) as the top 
significant candidate gene for δ2 power after sleep deprivation (Figure 5B Top). The high 
prioritization score was based on the strong cis-eQTL associated with Kif16b expression in 
both cortex and liver (Figure 5C highlight; novel marker, chr2:142.4 Mb, q=1.3e-15 in cortex, 
q=7.13e-5 in liver), the pronounced down-regulation of Kif16b expression in cortex after sleep 
deprivation (Figure 5D Left), and the positive correlation between δ2 power after sleep 
deprivation and Kif16b expression (Figure 5E Left). Lines carrying a B6-allele at the 
chromosome 2-associated region displayed higher δ2 power after sleep deprivation and a 
significantly higher Kif16b expression compared to D2-allele carriers (Figure 5E Left).  
 Kif16b encodes a kinesin involved in early endosome and receptor transport, including of 
receptors that play a role in sleep regulation such as fibroblast growth factor (FGF) (Ueno et al, 
2011), nerve growth factor (NGF) (Yasuda et al, 2007), and ionotropic glutamate (AMPA) 
(Farkhondeh et al, 2015) receptors. AMPA receptor (AMPA-R) levels are sleep-wake driven, 
associated with changes in EEG delta power, and have been explored as therapeutic targets to 
counter the deleterious effects of sleep deprivation on cognition (Boyle et al, 2012; Del Cid-
Pellitero et al, 2017; Lanté et al, 2011; Porrino et al, 2005; Vyazovskiy et al, 2008). Our results 
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thus corroborate a link between fast delta EEG activity after sleep deprivation and AMPA-R 
trafficking, and implicate Kif16b as a candidate molecular go-between. Of interest, given the 
large changes in Arc expression after sleep deprivation reported above, is that increased Arc 
expression reduces the number of AMPA-Rs through its direct interaction with components of 
the endocytic pathway, thereby contributing to homeostatic synaptic scaling (Korb & 
Finkbeiner, 2011; Rial Verde et al, 2006). Whether Arc-dependent AMPA-R trafficking 
through the endocytic pathways involves Kif16b’s role in the localization of early endosomes 
requires further study.  
 
Example 3: Sleep deprivation shifts theta peak frequency (TPF) in the REM sleep EEG  
The EEG during REM sleep in the mouse is dominated by an almost single-frequency theta 
oscillation in the 5 to 9 Hz range of hippocampal origin (Buzsáki, 2002), the main frequency of 
which can be easily determined with a Fourier transformation (Figure 6A). Theta activity during 
REM sleep is important for memory consolidation (Boyce et al, 2016). Our current data (see 
h2 analysis above) confirm our previous observations that most of the variance in theta-peak 
frequency (TPF) among inbred strains of mice can be explained by additive genetic factors 
(Franken et al, 1998; Tafti et al, 2003). Here we discovered that increased sleep pressure shifts 
REM sleep TPF (compared to REM sleep TPF in corresponding baseline hours, i.e. ZT6-12) 
and that the direction of this shift strongly depends on genetic background (Figure 6A).  
 For this phenotype, we found a significant QTL on chromosome 4 (LOD = 4.94, 104-123 
Mb; 50% variance explained) and a suggestive QTL chromosome 8 (LOD=2.73, 0-15 Mb; 32% 
variance explained; Figure 6C Top). The prioritization strategy identified Cyp4a32 
(Cytochrome P450, family 4, subfamily a, polypeptide 32) as the top candidate gene in the liver 
(Figure 6C Bottom). Cyp4a32, which was not expressed in cortex, is located within the 
associated chromosome 4 phQTL region, is under strong cis-eQTL effect (rs27480007, chr4: 
115.2 Mb, q=1.0e-12) greatly increasing its expression in D2-allele carriers, and contains a non-
synonymous protein-damaging variation in the coding region of the D2 allele (V314E, 
PolyPhen2 score = 1.0, see Methods). Sleep deprivation causes TPF to accelerate in carriers of 
the D2-allele at the Cyp4a32 cis-eQTL locus and to slow down in B6 carriers. Cyp4a32 
expression in D2-allele carriers is high in baseline and increases further after sleep deprivation, 
while remaining low and stable under both conditions in B6-allele carriers (Figure 6D). The 
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two F1 hybrids both have a positive TPF-shift, suggesting a dominance of the D2 allele, 
although some D2-allele carrying lines did show a negative TPF-shift (Figure 6F), indicating 
that this variation is not sufficient and possibly interacts with other loci, such as the suggestive 
QTL on chromosome 8, and with metabolites. Hiveplot visualization revealed that the TPF-
shift was associated with several amino acids (Figure 6B), which were all significantly down-
regulated after sleep deprivation (see above and Figure 4B). The 3 top-ranked associated amino 
acids were the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine. Plasma 
levels of valine, in turn were significantly linked to Cyp4a32 expression (Figure 6E highlight) 
although no common mQTL was found. Cyp4a32, and its human ortholog CYP4A11, are part 
of the Cyp4a gene family encoding cytochrome 450 liver enzymes that can ω-hydroxylate fatty 
acids and which are induced by starvation and diabetes (Kroetz et al, 1998). Cyp4a32 encodes 
a peptide targeting the degradation of arachidonic acid (ARA) specifically. ARA is abundant 
in the brain, but its levels largely depend on supply by blood (Bazinet & Layé, 2014). ARA and 
its metabolites, such as prostaglandins and endocannabinoids, are involved in many processes 
in the brain including signaling, synaptic plasticity, long-term potentiation, and neurogenesis, 
and have been associated in cognitive performance, mood, and neurodegenerative disease 
(Bazinet & Layé, 2014; DeCostanzo et al, 2010; Williams et al, 1989). The relation between 
TPF and fatty acid metabolism has already been suggested with the identification of Acads, an 
acyl-CoA dehydrogenase involved not only in fatty-acid β-oxidation but also in BCAA 
degradation (KEGG: mmu00280), as the causative gene explaining REM sleep TPF differences 
between two inbred strains (but not the sleep deprivation induced shift in TPF reported here) 
(Tafti et al, 2003). BCAAs, in turn, are involved in fatty acid biosynthesis (Crown et al, 2015; 
van der Hoeven & Steffens, 2000) and are also implicated in insulin resistance (Newgard, 
2012). These results suggest a pathway relating the sleep deprivation effects on BCAA, and 
possibly arachidonic acid, through fatty acid metabolism in the periphery, with the marked 
sleep-deprivation induced changes in TPF during REM sleep. 
 
Example 4: Compensation for NREM sleep time lost  
During recovery sleep, mice compensate for the sleep lost during the preceding sleep 
deprivation not only by sleeping deeper (quantified as the increase in EEG delta power 
discussed above), but also by sleeping more (Franken et al, 1999). We quantified the gain in 
NREM and REM sleep time over the 24h recovery period following the sleep deprivation by 
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contrasting these recovery values to time-matched baseline values within individual mice. We 
found that the gain for both NREM and REM sleep was largest in the first 6h of the recovery 
dark period (ZT12-18; Figure 7A), consistent with our earlier observations (Franken et al, 
1999). However, only for the NREM sleep gain during that period did we identify a significant 
QTL on chromosome 4 [LOD=4.38; 103-110 Mb] explaining 45% of the variance in this trait 
(Figure 7C). A second, suggestive QTL was found on chromosome 1 [LOD=3.14; 169-173 
Mb]. Together the two loci explained 55% of the variance in NREM sleep gain. Neither QTL 
was associated with the gain in REM sleep during this period (not even at the suggestive level), 
further underscoring the different regulation, both genetic and physiological, of these two sleep 
states.  
 Hiveplot visualization of NREM sleep gain over the 24h recovery period readily revealed 
the contrasting systems genetics ‘landscapes’ for the four consecutive 6h recovery intervals 
with the ZT12-18 interval yielding far more connections at all 4 levels of analysis (Figure 7B). 
For instance, during this interval, 36 metabolites were highly correlated to NREM sleep gain, 
while in the second half of the recovery dark period (ZT18-24) only 2 remained correlated. Of 
these 36 metabolites, 32 were phosphatidylcholines and for 2 among those [PC-ae-C38:2 
(LOD=3.27; chr4: 101-110 Mb; 37% variance explained) and PC-ae-C42:5 (LOD=3.02; chr4: 
101-110 Mb; 31% variance explained)] suggestive mQTLs were identified both mapping to the 
chromosome 4 phQTL for NREM sleep gain (Figure 7C). Gene prioritization identified Acot11 
as the top candidate gene independently for the gain in NREM sleep and for PC-ae-C38:2 levels 
(Figure 7C), while for PC-ae-C42:5 no gene passed the prioritization FDR threshold. 
Nevertheless, both metabolites were significantly linked to Acot11 expression, as can be seen 
in the hiveplot highlight for NREM sleep gain at ZT12-18, along with 13 other metabolites 
(Figure 7D).  
 A significant cis-eQTL was found that explained the differences in Acot11 (acyl-CoA 
thioesterase 11) expression levels among BXD lines in liver after sleep deprivation 
(rs28135130, chr4:106.3Mb, q=1e-13), but not in cortex. Liver Acott11 expression in mice 
carrying the D2-allele at the cis-eQTL region was close to zero (Figure 7E,F). This near-zero 
expression in D2-allele carriers was even more pronounced for the shorter Acot11 isoform 
(NM_025590), which was the more abundant isoform in the liver of B6-allele carriers. By 
contrast, the D2-allele did not alter the expression of the short isoform in the cortex, and in both 
genotypes its expression was higher than that of the longer isoform (Appendix Figure S7). 
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Moreover, expression of the less prevalent, longer isoform (NM_001347159) was not affected 
by genotype. Besides the tissue- and isoform-specific regulation of Acot11 expression, sleep 
deprivation differentially modified Acot11 expression in cortex and liver. The strong cis-eQTL 
effect associated with Acot11 expression in the liver after sleep deprivation was not present in 
the cortex for the control condition (q=0.5) and only marginal after sleep deprivation (q=7e-4). 
Acot11 was down-regulated in liver after sleep deprivation, but up-regulated in the cortex 
(Figure 7F).  
 D2-allele carriers display lower plasma PC-ae-C38:2 levels and have a larger NREM sleep 
gain during ZT12-18 (Figure 7E). While the majority of the BXD lines compensated by 
sleeping significantly more than baseline during ZT12-18 (+33.0 minutes on average), only 
BXD83 showed a negative gain (-1.3 minutes, Figure 7A). BXD83 is also the line with the 
highest PC-ae-C38:2 plasma levels and the 3rd highest Acot11 expression in liver after sleep 
deprivation (Figure 7E). It is intriguing that the NREM sleep gain and PC-ae-C38:2 levels 
measured in the parental strains are closer to that in BXD lines carrying the opposite allele 
(Figure 7A,E). This reinforces the idea that these phenotypes are due to multiple gene x gene 
interactions. It should be kept in mind that in these analyses the metabolome and transcriptome 
data were obtained in tissues collected immediately after the sleep deprivation (ZT6), while the 
gain in NREM sleep time was quantified in the ensuing recovery. Thus, changes in Acot11 
expression and/or PC-ae-C38:2 levels seem to predispose to differences in NREM sleep 
recovery occurring later.  
 Acot11 is an acyl-CoA thioesterase which catalyzes the hydrolysis of long fatty acyl-CoAs 
to form free fatty acids and therefore important in the homeostatic regulation and turn-over of 
free fatty acids (Cohen, 2013). Acot11 knockout mice show increased energy expenditure and 
are resistant to diet-induced obesity and its metabolic consequences (Zhang et al, 2012). We 
used these Acot11 knockout mice to verify the causal involvement of Acot11 in NREM sleep 
gain in mice. In the line used, the knock-out allele was brought onto a B6 background through 
repeated (>20) backcrossing. Both heterozygous and homozygous null allele carriers were 
deficient in NREM sleep gain compared to their wild-type littermate controls (Figure 7G), 
confirming that Acot11 is causally implicated in NREM sleep recovery. The difference in 
NREM sleep gain occurred, however, in the second half (ZT18-24) and not, as was the case in 
the BXD panel, in the first half (ZT12-18) of the recovery dark period.  
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 In humans, sleep deprivation induces an increase in circulating free fatty acids (FFA) 
(Broussard et al, 2015). Because both elevated plasma FFA levels (Boden, 2003; DeFronzo, 
2004) and sleep restriction (Buxton et al, 2010; Spiegel et al, 2005) can lead to insulin resistance 
and predispose to metabolic disease including type 2 diabetes, Broussard and colleagues 
proposed that the effects of sleep restriction on FFA levels might present a mechanism by which 
sleep restriction causes insulin resistance and increased type 2 diabetes risk (Broussard et al, 
2015). Our data implicate Acot11 as a molecular player in this mechanistic link between sleep 
restriction and its adverse effects on fatty acid metabolism. 
 
DISCUSSION 
We have generated a rich multi-dimensional experimentally determined knowledge base 
drawing on 4 levels of organization from the DNA level, to steady-state RNA levels in brain 
and liver, circulating metabolites, and a deep phenome of sleep-wake related phenotypes, all 
under two experimental conditions. At the core of this knowledge base is the BXD ARIL 
resource. This mouse GRP provides a ‘population model’ with a controlled and stable degree 
of genetic variation, each line carrying a fixed and unique pattern of recombination of the two 
parental chromosomes (Peirce et al, 2004). The panel segregates for ~5.2 million sequence 
variants corresponding to about half of all common genetic variation among classic laboratory 
mouse strains (Wang et al, 2016). This level of genetic complexity exceeds that in many human 
populations, such as the Icelandic and Finnish populations that have been so useful in genetics 
of disease (Arnar et al, 2016; Milani et al, 2015; Peltonen et al, 2000). Our results underscore 
the power of the BXD panel in discovering the genetic and molecular underpinnings of 
clinically relevant traits already demonstrated in other research fields (Andreux et al, 2012; 
Merkwirth et al, 2016; Williams et al, 2016).  
 We extracted 341 sleep-wake related phenotypes belonging to 148 distinct phenotypic 
classes from each individual mouse. Half of these phenotypes had a higher than 0.68 
heritability, indicating that they are amenable to genetic dissection even when using only 33 
ARI lines. Although numerous knockout studies have shown that (lack of) single genes impact 
many of the phenotypes we quantified [for review see (Franken & Tafti, 2003; Mang & 
Franken, 2015)], we demonstrate here that even highly heritable traits are determined by the 
interaction of several small effect loci. Two striking examples of such traits are TPF during 
REM sleep and the gain in δ2 power after sleep deprivation for which we identified 4 and 5 
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suggestive QTLs, respectively, that together explained 58 and 75% of the overall variance in 
these 2 traits. Thus, while reductionist approaches have been successful at identifying genes 
affecting sleep in a Mendelian fashion, when studied at a more natural, population level most 
of these phenotypes represent complex traits, and Mendelian (null) alleles are likely to play a 
lesser role. To systematically explore these non-additive, multi-loci interactions at the level of 
the whole genome, innovative algorithms in the area of machine learning are needed. Currently, 
more than 2-way epistatic interactions are computationally challenging. We are therefore now 
exploring novel multi-loci epistatic approaches to extract this type of information [see e.g. (He 
& Parida, 2016; Llinares-Lopez et al, 2015)].  
 With the 4 examples described, we could only illustrate a fraction of all the novel 
information contained in our experimentally derived knowledge base. Here we focused on the 
effects of sleep loss exclusively, because systems genetics resources in this research domain 
are lacking and because of the immediate clinical relevance of these effects. Importantly, the 
pathways we identified were unique to the sleep-deprivation condition and did not explain 
phenotypic variance of the respective traits under undisturbed baseline conditions. This 
illustrates that already a relatively mild sleep disruption (preventing sleep during half of the rest 
phase) extensively reshapes the systems genetics landscape.  
 The power of systems genetics lies in generating hypotheses. In the current dataset, several 
observations imply sleep deprivation to challenge fatty acid turnover. Besides Acot11, which 
regulates the levels of free fatty acids and, as we show here, the recovery of NREM sleep, also 
Cyp4a32, which contributes to the sleep-deprivation induced shift in the frequency of theta 
oscillation in REM sleep, encodes an enzyme regulating fatty acid levels. This frequency shift 
was strongly correlated with levels of the branched amino acids leucine, isoleucine, and valine, 
which, in turn, are part of a fatty acid biosynthesis pathway. The link between Cyp4a32 and the 
dominant frequency of theta oscillatory activity also illustrates the importance of a peripheral 
molecular pathway in regulating brain activity, as Cyp4a32 was not expressed in brain. This 
finding is of relevance because although many studies have emphasized the deleterious effect 
of sleep loss on peripheral systems, research on the substrate of sleep need largely remains brain 
centric. In addition, Pla2g4e and Mlycd, the two genes with the strongest cis-eQTL effect for 
their differential expression after sleep deprivation, both encode enzymes affecting fatty acid 
metabolism. Acot11, the Cyp4a gene family, free fatty acid levels, and sleep restriction have 
all been linked to obesity and insulin resistance (Boden, 2003; Buxton et al, 2010; DeFronzo, 
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2004; Kroetz et al, 1998; Spiegel et al, 2005; Zhang et al, 2012). Another pathway of importance 
in mediating the effects of sleep loss concerns AMPA-R trafficking supported by the 8-fold 
increase in cortical Arc expression and Kif16b’s role in shaping δ2 power after sleep 
deprivation. Both genes encode proteins involved in the endosomal trafficking of AMPA-Rs 
(see Results) that have already been explored as therapeutic targets to counter the deleterious 
effects of sleep deprivation on cognition (Boyle et al, 2012; Porrino et al, 2005). Finally, Wrn‘s 
association with EEG slow waves during NREM sleep offers a model system to mechanistically 
study the molecular pathways underlying the characteristic age-related decrease in the 
prevalence of EEG slow waves and sleep quality.  
 Hypotheses concerning the involvement of the pathways in the sleep homeostatic process 
we discovered need to be further tested experimentally. With a reverse genetics approach, we 
could already confirm Acot11’s role in the recovery of sleep time lost. This approach is, 
however, not always informative or possible because a lack of protein on a given genetic 
background is unlikely to mimic the impact of an allelic variant in a genetically diverse 
population, or the knock-out might be lethal as is the case for Kif16b (Ueno et al, 2011). Efforts 
to comprehensively phenotype (including sleep), knockouts for all known and predicted mouse 
genes by the International Mouse Phenotyping Consortium (IMPC; www.mousephenotype.org) 
are ongoing, but unfortunately, no knockouts for the 4 genes we highlight here have been 
submitted for phenotyping. Another important community resource is the mostly mouse 
oriented database GeneNetwork (www.genenetwork.org), which hosts a massive amount of 
phenotypic and molecular information collected by the many researchers using the same BXD 
resource. We are in the process of structuring our database to enable sharing the integrated data 
in GeneNetwork according to the FAIR data management concepts (Wilkinson et al, 2016). 
Furthermore, cross-species validation in, e.g., humans, flies, and C. elegans and GWAS and 
biobank database searches are important additional ways of validating and extending our mouse 
observations. According to the human GWAS databases grasp.nhlbi.nih.gov and 
www.ebi.ac.uk/gwas/, SNP variants in Acot11 are significantly associated with (among others) 
the rate of cognitive decline in Alzheimer disease, behavioral disinhibition, cardiovascular 
disease, and triglyceride levels. Variants in Wrn are associated with aging and time-to-death, 
cardiovascular disease, cholesterol, and daytime rest. Finally, variants in the human ortholog of 
Cyp4a32, CYP4A11, are associated with blood metabolite levels including amino acids and 
acyl carnitines, and Kif16b variants with intelligence.  
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 A first evaluation of the systems genetics field has highlighted a clear need for better 
communication, ‘open science’, and collaboration among groups (Baliga, Björkegren et al. 
2017). Towards this aim, we have shared our results and analyses through an easily accessible 
and reproducibility-oriented web interface that accompanies this publication. We hope that the 
interactivity of the web interface will encourage the reader to further mine our data, thereby 
reproducing our conclusions and, hopefully, discovering other key regulators and pathways. In 
our analyses, we have also strived to follow the concepts of the FAIR data management 
approach (Wilkinson et al, 2016), resulting in a data life-cycle management plan, open access 
provided by the web interface for datamining, and, importantly, interoperability. The 
implementation of the FAIR approach will be illustrated in an accompanying publication.  
 In summary, we have applied a systems genetics approach to uncover new genes and 
pathways associated with the effects of sleep loss, an approach thought critical towards 
predicting disease susceptibility (Civelek & Lusis, 2014). This integrative, multi-level approach 
allowed us to follow the flow of information from DNA variants, to molecular intermediate 
phenotypes, to behavioral and electrophysiological end phenotypes, and to assess how this 
network of multi-scale effects is perturbed by an environmental challenge. The information 
gained could not have been achieved through other genetic approaches that are based on the ‘1-
gene-to-1-phenotype’ approach. Moreover, with the tools and web interface we developed, our 
open access knowledge base provides a unique resource which goes well beyond merely 
cataloguing and ranking ph-, m-, and eQTLs. Furthermore, owing to the use of a GRP, the 
database and its content are easily scalable. A first challenge will be to complement the dataset 
with females of the same lines. In addition, we are expanding the database with an additional 
intermediate phenotype namely the sleep-deprivation induced changes in chromatin 
accessibility, aiming to identify the variants in non-coding regulatory elements that could 
predict the varying molecular and phenotypic response to sleep loss. Adding proteome, 
microbiome, and inflammasome data are obvious other intermediate phenotypes that will 
further strengthen this knowledge base and increase its value to e.g. assist with identifying 
biomarkers gauging sleep pressure and potential therapeutic targets for sleep-wake related 
disorders. 
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MATERIALS & METHODS 
Animals, breeding, and housing conditions  
Experiments were approved by the local veterinary authorities (SCAV authorization #2534). 
We phenotyped 33 BXD RI strains originating from the University of Tennessee Health Science 
Center (Memphis, TN, USA). Two breeding trios per BXD strain were purchased from a local 
facility (EPFL-SV, Lausanne, Switzerland) and bred in-house until sufficient offspring was 
obtained. The parental strains [DBA/2J (D2) and C57B/6J (B6)] and their reciprocal F1 
offspring [B6D2F1 (BD-F1) and D2B6F1 (DB-F1)] were bred and phenotyped alongside. 
Suitable (age and sex) offspring was transferred to our sleep recording facility where they were 
singly housed with food and water available ad libitum, at a constant temperature of 25°C, and 
under a 12h light/12h dark cycle [LD12:12, fluorescent lights, intensity 6.6cds/m2, with 
Zeitgeber time ZT0 and -12 designating light and dark onset, respectively]. Male mice aged 11-
14 weeks at the time of experiment were used for phenotyping with a mean of 12 animals per 
BXD line among all experiments. Note that 3 BXD lines had a lower replicate number [n] with 
respectively BXD79 [n=6], BXD85 [n=5], and BXD101 [n=4] because of poor breeding 
success. For the remaining 30 BXD lines, replicates were distributed as follows: for 
EEG/behavioral phenotyping (Experiment 1 in Figure 1) [mean = 6.2/line; 5≤n≤7] and for 
molecular phenotyping (Experiment 2 in Figure 1) [mean = 6.8/line; 6≤n≤9]. Additionally, to 
assess the stability of outcome variables over time, parental lines and reciprocal F1 offspring 
were phenotyped twice; i.e., at the start (labelled B6-1 and D2-1) and end (labelled B6-2 and 
D2-2) of the breeding and data-collecting phase which spanned 2 years (March 2012 - 
December 2013). To summarize, distributed over 32 experimental cohorts, 227 individual mice 
were used for behavioral/EEG phenotyping (Experiment 1) and 256 mice for tissue collection 
for transcriptome and metabolome analyses (Experiment 2), the latter being divided into sleep 
deprived (SD) and controls (Ctr; see Experimental design section below). We strived to 
randomize the lines across the experimental cohorts so that biological replicates of one line 
were collected/recorded on more than one occasion, while also ensuring that an even number 
of mice per line was included for tissue collection so as to pair SD and Ctr individuals within 
each cohort (for behavioral/EEG phenotyping each mouse serves as its own control). 
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Experimental design 
Figure 1 summarizes the experimental design which consisted of two experiments; i.e., 
Experiment 1 and 2. Animals of both experiments were maintained under the same housing 
conditions. Animals in Experiment 1 underwent surgery and, after a >10-day recovery period, 
EEG and locomotor activity (LMA) were recorded continuously for a 4-day period starting at 
ZT0. The first two days were considered baseline (B1 and B2). The first 6h of Day 3 (ZT0-6), 
animals were sleep deprived in their home cage by “gentle handling” (Mang & Franken, 2012). 
The remaining 18h of Day 3 and Day 4 were considered recovery (R1 and R2). Half of the 
animals included in Experiment 2 were sleep deprived (SD) alongside the animals of 
Experiment 1. The other half was left undisturbed in another room (i.e., control or Ctr). Both 
SD and Ctr mice of Experiment 2 were sacrificed at ZT6, i.e., immediately after the end of the 
sleep deprivation, for sampling of liver and cerebral cortex tissue, as well as trunk blood. All 
mice were left undisturbed for at least two days prior to sleep deprivation.  
Experiment 1: EEG/EMG and LMA recording and analysis: EEG/EMG surgery was 
performed under deep anesthesia according to our standard methods (Mang & Franken, 2012). 
EEG and EMG signals were amplified, filtered, digitized, and stored using EMBLA (Medcare 
Flaga, Thornton, CO, USA) hardware (A10 recorder) and software (Somnologica). Locomotor 
activity (LMA) was recorded by passive infrared (PIR) sensors (Visonic Ltd, Tel Aviv, Israel) 
at 1-min resolution for the duration of the 4-day experiment using ClockLab (ActiMetrics, IL, 
USA).  
 Offline, the sleep-wake states wakefulness (W), rapid-eye movement (REM) sleep, and non-
REM (NREM) sleep were annotated on consecutive 4-s epochs, based on the EEG and EMG 
patterns. To assist the annotation of this extensive dataset (ca. 20 million 4-s epochs), we 
developed a semi-automated scoring system. The 4-day recordings of 43 mice (19% of all 
recordings), representing animals from 12 strains, were fully annotated visually by an expert 
according to established criteria (Mang & Franken, 2012). Due to large between-line variability 
in EEG signals, even after normalization, a partial overlap of the different sleep-wake states 
remained, as evidenced by the absolute position of the center of each state cluster which differed 
even among individuals of the same line, precluding the use of one ‘reference’ mouse, even per 
line, to reliably annotate sleep-wake states for the others (Appendix Figure S1A). To overcome 
this problem, one day out of 4 (i.e., Day 3 or R1, which includes the sleep deprivation) was 
visually annotated for each mouse. These 4-s sleep-wake scores were used to train the semi-
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automatic scoring algorithm, which took as input 82 numerical variables derived from the 
analyses of EEG and EMG signals using frequency- (Discrete Fourier Transform or DFT) and 
time-domain analyses performed at 1-s resolution. We then used these data to train a series of 
Support Vector Machines (SVM) (Meyer et al, 2014) specifically tailored for each mouse using 
combinations of the 5 or 6 most informative variables out of the 82 input variables. The best 
performing SVMs for a given mouse were then selected based on the upper-quartile 
performance for global classification accuracy and sensitivity for REM sleep (the sleep-wake 
state with the lowest prevalence), and used to predict sleep-wake states in the remaining 3 days 
of the recording. The predictions for 4 consecutive 1-s epochs were converted into one 4-s 
epoch. Next, the results of the distinct SVMs were collapsed into a consensus prediction using 
a majority vote. In case of ties, epochs were annotated according to the consensus prediction of 
their neighboring epochs. A representative example of prediction is shown in Appendix Figure 
S1B. To prevent over-fitting and assess the expected performance of the predictor, only 50% 
of the R1 manually annotated data from each mouse was used for training. The classification 
performance was assessed by comparing the automatic and visual scoring of the fully manually 
annotated 4-day recordings of 43 mice. The global accuracy was computed using a confusion 
matrix (Kuhn et al, 2014) of the completely predicted days (B1, B2, and R2; Appendix Figure 
S1C). For all subsequent analyses, the visually annotated Day 3 (R1) recording and the 
algorithmically annotated days (B1, B2, and R2) were used for all mice, including those for 
which these days were visually annotated.  
 We quantified 341 phenotypes based on the sleep-wake states, LMA, and the EEG signal, 
constituting three broad phenotypic categories. The 96h sleep-wake sequence of each animal 
was used to directly assess traits in three ‘state’-related phenotypic subcategories: (i) duration, 
e.g., time spent in wakefulness, NREM sleep, and REM sleep, both absolute and relative to 
each other, such as the ratio of time spent in REM vs NREM, (ii) aspects of their distribution 
over the 24h cycle, e.g., time course of hourly values, midpoint of the 12h interval with highest 
time-spent-awake, and differences between the light and dark periods, and (iii) sleep-wake 
architecture, e.g. number and duration of sleep-wake bouts, sleep fragmentation, and sleep-
wake state transition probabilities. Similarly, overall activity counts per day as well as per unit 
of time-spent-awake, and the distribution of activity over the 24h cycle were extracted from the 
LMA data. EEG signals of the 4 different sleep-wake states [wakefulness, NREM sleep, REM 
sleep, and theta dominated waking (TDW), see below] were quantified within the 4s epochs 
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matching the sleep-wake states using DFT (0.25Hz resolution, range 0.75-90 Hz, window 
function Hamming). Signal power was calculated in discrete EEG frequency bands, i.e. delta 
(1.0-4.25 Hz, δ), slow delta (1.0-2.25 Hz; δ1), fast delta (2.5-4.25; δ2), theta (5.0-9.0 Hz; θ), 
sigma (11-16 Hz; σ), beta (18-30 Hz; β), slow gamma (32-55 Hz; γ1), and fast gamma (55-80 
Hz; γ2). Power in each frequency band was referenced to total EEG power over all frequencies 
(0.75-90 Hz) and all sleep-wake states in days B1 and B2, to account for inter-individual 
variability in absolute power. Moreover, the frequency of dominant EEG rhythms was extracted 
as phenotypes. In particular, a sub-state of wakefulness, referred to as TDW, was quantified 
according to the prevalence of theta-activity (6.0-10.0 Hz) in the EEG during waking (Buzsáki, 
2002; Welsh et al, 1985), according to the algorithm described in (Vassalli & Franken, 2017). 
We assessed the time spent in this state, the fraction of total wakefulness it represents, and its 
distribution over 24h. Finally, discrete, paroxysmal events were counted, such as sporadic 
spontaneous seizures and neocortical spindling, which are known features of D2 mice (Ryan, 
1984), which we also found in some BXD lines. 
All phenotypes were quantified in baseline and recovery separately, and the effect of sleep 
deprivation on all variables was computed as recovery vs. baseline differences or ratios. The 
recovery-to-baseline contrasts are the focus of this paper. Obviously, some of the 341 
phenotypes are strongly correlated (e.g. the time-spent-awake and –asleep in a given recording 
interval), resulting in identical QTLs (albeit with different association strengths). To estimate 
the number of unique phenotypes, we clustered highly correlated phenotypes into modules. We 
then counted the number of phenotype categories and subcategories within each module 
(Appendix Figure S2). We estimated 148 separable groups of phenotypes. Please see the 
‘Swiss-BXD’ web interface (https://bxd.vital-it.ch; Downloads, General_Information.xlsx) for 
a full listing of all phenotypes quantified.  
Experiment 2: Tissue collection and preparation. Mice were sacrificed by decapitation after 
being anesthetized with isoflurane, and blood, cerebral cortex, and liver were collected 
immediately. The whole procedure took no more than 5 minutes per mouse. Blood was 
collected at the decapitation site into tubes containing 10 ml heparin (2U/µl) and centrifuged at 
4000 rpm during 5 min at 4°C. Plasma was collected by pipetting, flash-frozen in liquid 
nitrogen, and stored at -80°C until further use. Cortex and liver were flash-frozen in liquid 
nitrogen immediately after dissection and were stored at -140°C until further use. 
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 For RNA extraction, frozen samples were homogenized for 45 seconds in 1 ml of QIAzol 
Lysis Reagent (Qiagen; Hilden, Germany) in a gentleMACS M tube using the gentleMACS™ 
Dissociator (Miltenyi Biotec; Bergisch Gladbach, Germany). Homogenates were stored at -
80°C until RNA extraction. Total RNA was isolated and purified from cortex using the 
automated nucleic acid extraction system QIAcube (Qiagen; Hilden, Germany) with the 
RNeasy Plus Universal Tissue mini kit (Qiagen; Hilden, Germany) and were treated with 
DNAse. Total RNA from liver was isolated and purified manually using the Qiagen RNeasy 
Plus mini kit (Qiagen; Hilden, Germany) which includes a step for effective elimination of 
genomic DNA. RNA quantity, quality, and integrity were assessed utilizing the NanoDrop ND-
1000 spectrophotometer (Thermo scientific; Waltham, Massachusetts, USA) and the Fragment 
Analyzer™ (Advanced Analytical). The 256 mice initially sacrificed for tissue collection 
yielded 222 cortex and 222 liver samples of good quality.  
 Equal amounts of RNA from biological replicates (same strain and experimental condition) 
were pooled, yielding 78 samples for library preparation. RNA-seq libraries were prepared from 
500ng of pooled RNA using the Illumina TruSeq Stranded mRNA reagents (Illumina; San 
Diego, California, USA) on a Caliper Sciclone liquid handling robot (PerkinElmer; Waltham, 
Massachusetts, USA). Libraries were sequenced on the Illumina HiSeq 2500 using HiSeq SBS 
Kit v3 reagents, with cluster generation using the Illumina HiSeq PE Cluster Kit v3 reagents. 
A mean of 41M 100-bp single-end reads were obtained [29M ≤n≤ 63M]. 
Targeted metabolomics analysis was performed using flow injection (FIA) and liquid 
chromatography/mass spectrometry (LC/MS) as described in (Davies et al, 2014; Isherwood et 
al, 2017). To identify metabolites and measure their concentrations, plasma samples were 
analyzed using the AbsoluteIDQ p180 targeted metabolomics kit (Biocrates Life Sciences AG, 
Innsbruck, Austria), and a Waters Xevo TQ-S mass spectrometer coupled to an Acquity UPLC 
liquid chromatography system (Waters Corporation, Milford, MA, USA). The kit provided 
absolute concentrations for 188 endogenous compounds from 6 different classes, namely acyl 
carnitines (ACT), amino acids (AA), biogenic amines (BA), hexoses, glycerophospholipids 
(GPL), and sphingolipids (SM). Plasma samples were prepared according to the manufacturer’s 
instructions. Sample order was randomized and 3 levels of quality controls (QCs), run on each 
96-well plate. Data were normalized between batches using the results of QC level 2 (QC2) 
repeats across the plate (n=4) and between plates (n=4) using Biocrates METIDQ software 
(QC2 correction). Metabolites below the lower limit of quantification or the limit of detection, 
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as well as above the upper limit of quantification, or with standards out of limits, were discarded 
from the analysis (Isherwood et al, 2017). Out of the 188 metabolites assayed, 124 passed these 
criteria across samples and were used in subsequent analyses. Out of the 256 mice sacrificed 
for tissue collection, 249 plasma samples were used for this analysis. An average of 3.5 animals 
[3 ≤ n ≤ 6] per line and experimental condition were used (except for BXD79, -85, and -101 
with respectively 2, 1 and 1 animal/condition used; see above under ‘Animals’). Note that in 
contrast to the RNAseq experiment, samples were not pooled, but analyzed individually.  
 In the same plasma samples, we determined corticosterone levels using an enzyme 
immunoassay (corticosterone EIA kit; Enzo Life Sciences Inc, Lausen, Switzerland) according 
to the manufacturer’s instructions. All samples were diluted 40 times in the provided buffer, 
kept on ice during the manipulation, and tested in duplicate. BXD lines were spread over 
multiple 96-well plates in an attempt to control for possible batch effects. In addition, a ‘control’ 
sample was prepared by pooling plasma from five C57BL/6 mice. Aliquots of this control were 
measured along with each plate to assess plate-to-plate variability. The concentration was 
calculated in pg/ml based on the average net optical density (at λ = 405 nm) for each standard 
and sample.  
RNA-sequencing analyses  
RNA sequencing (RNA-seq) data were processed using the Illumina Pipeline Software 
version 1.82. All RNA-seq samples passed FastQC quality thresholds (version 0.10.1) and 
could thus be used in subsequent analysis. For gene expression quantification, we used a 
standard pipeline that was already applied in a previous study (Picard et al, 2016). Reads were 
mapped to MGSCv37/mm9 using the STAR splice aligner with the 2pass pipeline  (Dobin et 
al, 2013). Count data was generated using htseq-count from the HTseq package using 
parameters ‘stranded=reverse’ and ‘mode=union’ (Anders et al, 2015). Gene boundaries were 
extracted from the mm9/refseq/reflat dataset of the UCSC table browser. EdgeR was then used 
to normalize read counts by library size. Genes with a mean raw read count below 10 were 
excluded from the analysis, and the raw read counts were normalized using the TMM 
normalization (Robinson & Oshlack, 2010) and converted to log counts per million (CPM). To 
assess the differential expression between the sleep deprived and control  conditions, we used 
the R package limma (Ritchie et al, 2015) with the voom weighting function followed by the 
limma empirical Bayes method (Law et al, 2014). RNA-seq data are deposited in NCBI GEO 
(accession code GSE1xxxxx).  
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 The RNA-seq dataset was also used to complement the publicly available GeneNetwork 
genetic map (www.genenetwork.org), thus increasing its resolution. RNA-seq variant calling 
was performed using the Genome Analysis ToolKit (GATK) from the Broad Institute using the 
recommended workflow for RNA- seq data (McKenna et al, 2010). To improve coverage depth, 
two additional RNA-seq datasets from other projects using the same BXD lines were added 
(Picard et al, 2016). In total, six BXD datasets from four different tissues (cortex, hypothalamus, 
brainstem, and liver) were used. A hard filtering procedure was applied as suggested by the 
GATK pipeline (DePristo et al, 2011; McKenna et al, 2010; Van der Auwera et al, 2013). 
Furthermore, genotypes with more than 10% missing information, low quality (<5000), and 
redundant information were removed. GeneNetwork genotypes, which were discrepant with 
our RNAseq experiment, were tagged as ‘unknown’ (mean of 1% of the GeneNetwork 
genotypes/strain [0.05% ≤n≤ 8%]). Finally, GeneNetwork and our RNA-seq genotypes were 
merged into a unique set of 11’000 genotypes, which was used for all subsequent analyses. This 
set of genotypes was already used successfully in a previous study of BXD lines (Picard et al, 
2016), and is available through our ‘Swiss-BXD’ web interface (https://bxd.vital-it.ch; 
Downloads, Genotypes.GeneNetwork2005AndRNAseq.geno).  
QTL mapping  
The R package qtl/r (Broman et al, 2003) was used for interval mapping of behavioral/EEG 
phenotypes (phQTLs) and metabolites (mQTLs). Pseudo-markers were imputed every cM and 
genome-wide associations were calculated using the Expected-Maximization (EM) algorithm. 
p-values were corrected for false discovery rate (FDR) using permutations tests with 1000 
random shuffles. The significance threshold was set to 0.05 FDR, a suggestive threshold to 0.63 
FDR, and a highly suggestive threshold to 0.10 FDR according to (Burgess-Herbert et al, 2008; 
Lander & Kruglyak, 1995). QTL boundaries were determined using a 1.5 LOD support interval. 
To preserve sensitivity in QTL detection, we did not apply further p-value correction for the 
many phenotypes tested. We used the following calculation to obtain the variance explained for 
a single QTL effect:  1 - 10^(-(2/n)*LOD). To compute the additive effect of multiple 
suggestive, highly suggestive, and significant QTLs, we used the fitqtl function of the qtl/r 
package (Broman & Sen, 2009). For detection of expression QTLs (eQTLs), cis-eQTLs were 
mapped using FastQTL (Ongen et al, 2016) with a 2Mb window for which adjusted p-values 
were computed with 1000 permutations and beta distribution fitting. The R package qvalue 
(Bass JDSwcfAJ, 2015) was then used for multiple-testing correction as proposed by (Ongen 
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et al, 2016). Only the q-values are reported for each cis-eQTL in the text. Trans-eQTL detection 
was performed using a modified version of FastEpistasis (Schupbach et al, 2010), on several 
million associations (15K genes x 11K markers), applying a global, hard p-value threshold of 
1E-4.  
Protein damage prediction  
Variants detected by our RNA-seq variant calling were annotated using Annovar (Wang et 
al, 2010b) with the RefSeq annotation dataset. Non-synonymous variations were further 
investigated for protein disruption using Polyphen-2 version 2.2.2 (Adzhubei et al, 2010), 
which was adapted for use in the mouse according to recommended configuration.   
Hiveplot visualization  
Hiveplots were constructed with the R package HiveR (Krzywinski et al, 2012) for each 
phenotype. Gene expression and metabolite levels represented in the hiveplots come from either 
the Ctr (control) or SD (sleep deprivation) molecular datasets, according to the phenotype 
represented in the hiveplot, i.e., the Ctr dataset is represented for phenotypes related to the 
baseline (bsl) condition, while the SD dataset is shown for phenotypes related to recovery (rec 
and rec/bsl). For a given hiveplot, only those genes and metabolites were included (depicted as 
nodes on the axes) for which the Pearson correlation coefficient between the phenotype 
concerned and the molecule passed a threshold of 0.5 for genes and 0.4 for metabolites. Cross-
associations between genes and metabolites represented by the edges in the hiveplot were 
filtered using quantile thresholds (top 0.05% gene-gene associations, top 0.5% gene-metabolite 
associations). We corrected for cis-eQTL confounding effects, by computing partial 
correlations between all possible pairs of genes [see Results and Figure 4B,C for details]. 
Candidate-gene prioritization strategy  
In order to prioritize genes in identified QTL regions, we chose to combine the results of the 
following analyses: (i) QTL mapping (phQTL or mQTL, Figure 2C), (ii) correlation analysis, 
(iii) expression QTL (eQTL, Figure 2B), (iv) protein damaging variation prediction, and (v) 
differential expression (DE, Figure 3A). Each result was transformed into an “analysis score” 
using a min/max normalization, where the contribution of extreme values was reduced by a 
winsorization of the results (Appendix Figure S6A). These analysis scores were first associated 
with each gene (see below), and then integrated into a single "integrated score" computed 
separately for each tissue, yielding one integrated score in cortex and one in liver. The 
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correlation analysis score, eQTL score, DE score, and protein damaging variation score are 
already associated to genes and these values were therefore simply attributed to the 
corresponding gene. To associate a gene with the ph-/mQTL analysis score (which is associated 
to markers), we used the central position of the gene to infer the associated ph-/mQTL analysis 
score at that position. In case of a cis-eQTL linked to a gene or a damaging variation within the 
gene, we used the position of the associated marker instead (Appendix Figure S6B). To 
emphasize diversity and reduce analysis score information redundancy, we weighted each 
analysis score using the Henikoff algorithm. The individual scores were discretized before 
using the Henikoff algorithm, which was applied on all the genes within the ph-/mQTL region 
associated with each phenotype (Appendix Figure S6C). The integrated score (formula in 
Figure 4D) was calculated separately for cortex and liver. We performed a 10’000 permutations 
procedure to compute a FDR for the integrated scores. For each permutation procedure, all 5 
analyses scores were permutated and a novel integrated score was computed again. The 
maximal integrated score for each permutation procedure was kept, and a significance threshold 
was set at quantile 95. Applying the Henikoff weighting improved the sensitivity of the gene 
prioritization. E.g., among the 91 behavioral/EEG phenotypes quantified with one or more 
suggestive/significant QTL after sleep deprivation, 40 had at least 1 gene significantly 
prioritized with Henikoff weighting, against 32 without.  
Data accessibility and the ‘Swiss-BXD’ web interface  
Published data and interactive hiveplot figures can be visualized and data-mined through our 
web interface: https://bxd.vital-it.ch. See Appendix Figure S5 for an outline of the web 
interface. The help section in the interface provides a first-step guide. 
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FIGURE LEGENDS 
Figure 1. Experimental design. Thirty-three BXD lines plus the 2 parental strains and their 
reciprocal F1 progeny were phenotyped. Mice were submitted to either one of two experiments. 
In Experiment 1 (Left) EEG/EMG signals and locomotor activity (LMA) were recorded under 
standard, 12:12h light-dark conditions (white and black bars under Top-Left panel) for two 
baseline days (B1, B2), a 6h sleep deprivation (SD; red bar) from ZT0-6 (ZT0 = light onset), 
followed by two recovery days (R1, R2). The deep sleep-wake phenome consists of 341 sleep-
wake state-, LMA-, and EEG-related phenotypes quantified in each mouse, among which time 
spent in NREM sleep (grey area spans mean max and min NREM sleep time among BXD lines, 
respectively, for consecutive 90min intervals). Mice in Experiment 2 (Right) were used to 
collect cortex, liver, and blood samples at ZT6. Half of the mice were challenged with a SD as 
in Experiment 1, the other half was left undisturbed and served as controls (Ctr). Cortex and 
liver samples were used to quantify gene expression by RNA-sequencing (RNA-seq), blood 
samples for a targeted analysis of 124 metabolites by liquid chromatography–mass 
spectrometry (LC-MS) or with flow injection analysis-mass spectrometry (FIA-MS). For 
mapping of phenotypic, metabolic, and expression QTLs (i.e., ph-, m-, and eQTLs, 
respectively), a high-density genotype dataset (Genome; 11K SNPs) was created merging 
identified RNA-seq variants with a publicly available database (www.genenetwork.org). 
Systems genetics analyses draws on the four -omics datasets and the 3 types of QTLs.  
 
Figure 2. Genetic diversity in the BXD panel greatly impacts behavioral, metabolic, 
and molecular traits. The phenome was divided into 3 phenotypic categories: (i) locomotor 
activity (LMA), (ii) EEG features (EEG), and (iii) sleep-wake state characteristics (state), which 
were subdivided further (see Methods). The five classes of metabolites and the gene expression 
represent intermediate molecular phenotypic categories. (A) Heritability for EEG/behavioral 
and metabolite phenotypes. Dots represent single phenotypes within each category and sub-
category indicated along the x-axis. Red dots represent phenotypes recorded in baseline (bsl; 
B1 and B2), blue in recovery (rec; R1 and R2), purple during sleep deprivation (SD), and green 
dots refer to the recovery-to-baseline contrasts. Values represent narrow-sense heritability (B) 
Overview of significant and highly suggestive (FDR<0.1) QTLs obtained for all 341 
EEG/behavioral phenotypes (phQTLs: LMA in red, EEG in blue, and sleep-wake state in green) 
and 124 blood metabolite levels in baseline and recovery (mQTLs; purple). Note that overlap 
of neighboring QTLs render color shading darker. (C) Venn diagram of genes under significant 
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cis-eQTL effect in liver and cortex for the two experimental conditions [sleep deprived (SD) 
and controls (Ctr)].  
 
Figure 3. How to illustrate multi-dimensional networks and prioritize candidate genes? 
(A) Classical network visualization methods strongly depend on the layout algorithm used for 
positioning nodes, making structure interpretation and reproducibility difficult. (B) Hiveplot 
network visualization and structure strategy. See text for details. (C) The classical network 
visualization for the 3 phenotypes (blue nodes 1-3) in panel A can be represented with our 
method with 1 hiveplot per phenotype. Phenotype 1 showed more cortex-liver correlations than 
the two other phenotypes through one metabolite, connecting up- and down-regulated genes in 
cortex after SD and down-regulated genes in liver. Phenotype 2 shows genomic regions with 
strong allelic effect over multiple genes in liver and cortex through a high number of trans-
eQTLs. Phenotype 3 was mostly connected to cortically expressed genes correlating strongly 
with up-regulated metabolites; most cis/trans-eQTLs affected only cortical genes. The number 
of significant (sf) and suggestive (sg) phQTLs detected for each phenotype are indicated on 
Bottom Left. The 3 phenotypes were related to active wake behaviors during recovery 
(Phenotype 1 and 2: LMA per h awake and time in TDW, respectively, both during ZT12-24; 
Phenotype 3: Gain in time-spent-awake during ZT24-6). (D) Gene prioritization strategy to 
identify driver genes underlying phenotype/metabolite variation, illustrated for 6 genes. Five 
types of analyses were integrated into a single score for each gene reflecting its strength as 
candidate driver gene, namely from Left to Right (i) and (ii) QTL mapping for gene expression 
(eQTLs) and phenotypes/metabolites (ph- or mQTLs), respectively, (iii) differential expression 
(DE) after sleep deprivation, (iv) gene expression/phenotype correlations, and (v) analysis of 
protein damaging genetic variations relating genes to an allelic effect. See text for further 
details. (E) To illustrate and validate our scoring strategy, genes in liver were prioritized for 
levels of alpha-aminoadipic acid (αAAA) after sleep deprivation. Dhtkd1 was identified as top-
ranked driver gene. Results from QTL mapping (red line) and prioritization analysis (green 
line); red and black horizontal lines indicate significant thresholds for the QTL and 
prioritization, respectively.  
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Figure 4. Profound effects of sleep deprivation on transcriptome, metabolome, and 
phenome. EEG/behavioral phenotypes, metabolites, and transcripts are organized into 3 
‘columns’ (from Left to Right). Top 3 panels show the sleep-deprivation (SD) response 
(recovery/baseline fold-change). Bottom 3 panels depict examples of allelic effects on the SD 
responses with color-coding indicating the presence of a C57BL/6J or DBA/2J haplotype under 
the mapped QTL peaks (B6: grey for BXD and black for parental; D2: light brown for BXD 
and dark-brown for parental). White bars mark the F1s and hatched bars strain in which 
haplotype could not be unambiguously determined. (A) Phenotypic changes after SD. The top 
significantly changed phenotype was the increase in NREM sleep EEG delta power (1-4 Hz) 
after SD (far left blue data point). The most up-regulated phenotype was time spent in REM 
sleep during the first 6h of darkness (ZT12-18) after SD (highest green data point). (B) 
Metabolite changes after SD. Most amino acids (blue) were down-regulated and most 
sphingolipids (brown) up-regulated after SD. The acylcarnitines C18:1 and C18:2 (highest red 
dots) increased the most. Vertical red line: significant threshold (FDR adjusted p-value=0.05). 
(C) Differential gene expression (DE) analysis (SD/Ctr) for cortex (Left) and liver (Right). 
Genes were sorted according to their ranked p-value along the x-axis. Significantly affected 
transcripts in red (FDR adjusted p-value <0.05), non-significant results in black. Blue dots 
indicate 78 genes considered core molecular components of the sleep homeostatic response in 
the cortex (Mongrain et al, 2010). Note that no low fold-change threshold was applied. (D-F) 
Examples of genetically driven EEG/behavioral, metabolic, and transcriptional responses to 
SD, respectively. See text for details.  
 
Figure 5. EEG delta power in NREM sleep after sleep deprivation (SD) is associated 
with Kif16b and Wrn. (A) NREM sleep EEG spectra in the first 3h after SD (ZT6-9) for the 
2 BXD lines that displayed the lowest and highest EEG activity in the fast delta frequency band 
(2.5-4.25 Hz, δ2; Top, see panel E) and for the 2 BXD lines that displayed the smallest and 
largest increase (or gain) in EEG power in the slow delta band (1.0-2.25 Hz, δ1; Bottom, see 
panel E). Spectra were ‘1/f-corrected’ (and therefore not directly comparable to the values in 
panel E) for better visualization of activity in higher frequency bands [theta (5-9 Hz, θ), sigma 
(11-16 Hz, σ), beta (18-30 Hz, β), and slow (32-55 Hz, γ1) and fast gamma (55-80 Hz, γ2)]. 
Subsequent analyses were performed without this correction. (B) QTL mapping and 
prioritization for δ2-power identified a significant association on chromosome 2 and Kif16b in 
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cortex as top-ranked gene (Top). For the δ1-increase after SD, we obtained a suggestive QTL 
on chromosome 8 and a significant prioritization score for the DNA-helicase Wrn. (C) Hiveplot 
visualization of network connections for the δ1- and δ2-power after SD (Top Left panels) and 
the SD-induced increase in δ1 and δ2 power over baseline (Bottom Left panels). Note the 
marked differences in the networks and QTLs regulating the expression of these two delta 
bands. Right hiveplots highlight Kif16b in the δ2 power associated network (Top), and Wrn in 
the network associated with the δ1-increase (Bottom). Only Kif16b expression in the cortex 
was linked to the chromosome 2 cis-eQTL and was not associated with any metabolite. Wrn 
expression was significantly linked to the chromosome 8 cis-eQTL and to the long 
phosphatidylcholine, PC-ae-C38:5. (D) Kif16b is highly significantly down-regulated in cortex 
(Left), while it remains unchanged in liver after SD (p=0.15; not shown). Also Wrn expression 
was strongly down-regulated by SD in cortex (Right) and only marginally so, albeit 
significantly, in liver (p=0.02; not shown). (E) Strain distribution patterns. BXD lines carrying 
a B6-allele on the chromosome 2 associated region showed higher δ2 power after SD (Left) and 
a significantly higher Kif16b expression (p=1.3e-15; 2nd-to-Left) than D2-allele carriers. D2-
allele carriers of the chromosome 8-associated region showed a larger δ1-increase after SD 
(2nd-to-Right) as well as a significantly larger decrease in Wrn expression after SD (Right) 
than B6-allele carriers. For color-coding of genotypes see Figure 4. 
 
Figure 6. Changes in the frequency of theta oscillation during REM sleep after sleep 
deprivation are associated with Cyp4a32. (A) Spectral profiles of the REM sleep EEG for 
two strains displaying an opposite shift in the frequency of theta oscillations after SD relative 
to baseline. This shift was quantified by the decrease and increase in theta-peak frequency 
(TPF) for BXD61 and -101, respectively (see panel F). (B) Hiveplot for the SD-induced shift 
in TPF. (C) One significant QTL for the TPF-shift was detected on chromosome 4 and one 
suggestive QTL on chromosome 8. Prioritization yielded Cyp4a32 as the top-ranked significant 
gene, based on the significant cis-eQTL modifying its expression in liver and a predicted 
damaging variation (V314E). (D) Effects of SD and genotype on liver Cyp4a32 expression. 
Carrying a B6-allele at the Cyp4a32 cis-eQTL associated marker greatly decreased its 
expression. (E) Hiveplot for the SD-induced shift in TPF highlighting Cyp4a32’s links to the 
amino acid Valine and the chromosome 4 eQTL marker. (F) Strain distribution patterns for TPF 
differences and liver Cyp4a32 expression after SD. B6-allele carriers at the chromosome 4 
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associated region had lower Cyp4a32 liver expression and a decrease in TPF after SD, while 
D2-carriers increase TPF and have higher Cyp4a32 expression.  
 
Figure 7. NREM sleep gain in the first 6h of the dark period after sleep deprivation is 
associated with Acot11. (A) Time course of hourly values of time spent in NREM sleep in 
baseline, sleep deprivation (SD, red area) and recovery for the two BXD lines showing the 
largest (BXD70; green) and lowest (BXD83; blue) NREM sleep gain during ZT12-18 (Left). 
NREM sleep gain during 4 consecutive 6h intervals during recovery compared to corresponding 
baseline intervals shows that in the recovery dark period (grey area) BXD83 mice did not 
accumulate extra NREM sleep while BXD70 mice gain 88min (Middle). Strain distribution of 
ZT12-18 NREM sleep gain (Right). B6-allele carriers compensated less for NREM sleep lost 
during SD than D2-allele carriers. For color-coding see Figure 4. (B) Hiveplots for NREM sleep 
gain in four 6h recovery intervals after the end of SD at ZT6. Compared to the other 3 intervals, 
NREM sleep gain was strongly associated with a number of metabolites during the second 6h 
interval; i.e. ZT12-18. (C) NREM sleep gain during ZT12-18 mapped to a significant QTL on 
chromosome 4, explaining 45% of the total phenotypic variance (Top Left). The 
phosphatidylcholine C38:2 (PC-ae-C38:2) mapped suggestively to the same region (Top 
Right). Prioritization of liver transcripts for both phenotypes yielded Acot11 as top-ranked, 
significant gene (Bottom). (D) Hiveplot for the ZT12-18 NREM sleep gain, highlighting 
Acot11. Acot11 was positively correlated with several phosphatidylcholines and to Ovgp1 
expression in the cortex. (E) Allelic effect of the chromosome 4-associated region on Acot11 
expression and PC-ae-C38:2 levels in the BXDs. Acot11 expression in liver after SD was under 
a strong eQTL effect (p=1.6e-13) with B6-allele carriers showing a higher Acot11 expression 
than D2-allele carriers. B6-allele  
carriers also showed higher PC-ae-C38:2 levels after SD. (F) Both Acot11 and PC-ae-C38:2 
levels changed after SD. Acot11 in liver and PC-ae-C38:2 in blood were significantly down-
regulated. In the cortex, Acot11 was, however, significantly up-regulated and the chromosome 
4-associated region did not modulate cortical Acot11 expression. (G) Mice carrying one or two 
KO alleles for Acot11 displayed less extra NREM sleep during recovery. In contrast to the BXD 
panel, this difference was present in the second (ZT18-24, Right), and not during the first 
(ZT12-18, Left panel) 6h of the recovery dark period. 
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Chapter 3. A bioinformatics strategy to 
transform systems genetics data into a digital 
research object. 
 
3.1 Results summary 
In this chapter, we present a more detailed the bioinformatics strategies that have been 
applied to the systems genetics of sleep project and more particularly the techniques that have 
been used to enable the repeatability and reusability of the workflow, analyses and data. Much 
of our analytical pipeline were made of novel tools and methodologies, such as the EEG/EMG 
annotation approach, the sleep phenotypes nomenclature or the gene prioritization. To improve 
the reproducibility of these methods by the scientific community as well as the laboratory 
members, an important part of the analyses were moved to R and implemented within 
Rmarkdown reports. Segments of the data processing steps and analyses were done using more 
standard pipelines, but that needed to be handled in the context of a complete workflow to be 
truly reproductible. Thus, a workflow metadata was generated to further describe the 
comprehensive data processing and analyses procedures. Finally, the Swiss-BXD web 
application is presented in detail with tutorials for exploring the data and of our results. 
 
3.2 Contribution 
In this research paper, I developed part of the back-end scripts to mine the systems genetics 
and optimized code to allow more users at the time on the web application. I generated all 
markdown reports and workflow related metadata. I write the paper and generated all figures. 
 
3.3 Publication 
Maxime Jan, Nicolas Guex, Mark Ibberson, Frederic Burdet, Paul Franken, Alan Bridge, Lou 
Gotz, Martial Sankar, Robin Liechti, Ioannis Xenarios.  A bioinformatics application of the 
reusability and reproducibility principles for systems genetics In Preparation.   
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Abstract 
The principles of “data reusability” and “reproducible research” are currently two core 
doctrines for better science. Reusability and reproducibility ensure that a dataset as well as the 
associated methods are exploitable by the scientific community. Many directives were proposed 
to improve these two aspects such as the FAIR guidelines, however their practical applications 
on large state-of-the-art, multi -omics & -phenome data-sets were not particularly well defined. 
Here, we describe from a bioinformatic point of view the approaches that were adopted to 
advocate these principles in the context of a systems genetics design of the sleep homeostasis. 
We aimed to transform the mouse sleep biological resource into an advanced digital research 
object favoring open-source and markup language along with a rich data and workflow 
description using meta-data. Finally, the exposure of this digital-object as well as the tools for 
its data-mining were provided by latest cloud-technologies with data interactive visualization 
using data driven document (D3). 
 
Keyword: digital research object, reproducibility, reusability, systems genetics, knitr, data 
driven document, sleep homeostasis  
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Introduction 
Over the last years, *omics technologies evolved rapidly, with broader detection’s range, 
higher sensitivity and cost reduction which facilitate the generation of BigData. With the advent 
of web, data-bases and repositories were created to facilitate data-sharing and thus improving 
the scientific discoveries through data-integration. It becomes now clearer that data alone are 
hard to work with and have yet to be accompanied with other valuable information such as 
interpretations, results, workflows, publications and meta-data to produce a complete and 
operable digital research object (DRO) (Bechhofer, Buchan et al. 2013). In the same way, the 
reproducibility of the data-processing pipeline within the shared DRO is essential for scientific 
reliability of the results (Munafò, Nosek et al. 2017), but also to save time for the community, 
the lab and yourself when a workflow can be reiterated.  
However, both objectives for the DRO reusability and reproducibility are nearly impossible 
to attain with journal publications and thesis documents only, which requires additional time 
and effort to achieve compliance, e.g. changing working habits to move to a fully reproducible 
workflow can take up to many years (Lowndes, Best et al. 2017). Currently, many challenges 
confront the sharing of DRO (Figueiredo 2017) and some guidelines were provided to improve 
some aspects. Among popular initiatives, the FAIR principles by FORCE 11 (Wilkinson, 
Dumontier et al. 2016) proposed 4 basic principles to improve human or computer knowledge 
sharing. The DRO should be Findable, Accessible, Interoperable in order to be Reusable. The 
Big Data to Knowledge framework (BD2K) is another initiative that provide guidelines for 
biomedical workflow, meta-data structures and computer infrastructures to facilitate reusability 
and interoperability of digital resources (Jagodnik, Koplev et al. 2017). For a more complete 
list of available initiatives, see http://www.researchobject.org. This path is now followed by 
some funding organizations, like the Swiss National Science Foundation (SNSF) with the 
“Open Research Data” directives which now requires the integration of complete Data 
Management Plan (DMP) within funds requests for better data analysis, preservation and 
reusability. Whereas only a few biomedical journals currently have an explicit data-sharing 
requirement (Vasilevsky, Minnier et al. 2017) or reproducibility (Iqbal, Wallach et al. 2016) 
policy. 
These guidelines were often described and applied in the context of single assay repository 
structure (Wilkinson, Verborgh et al. 2017) but their practical application to propose a coherent 
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and united DRO over trans-disciplinary research project containing the integrations of 
heterogeneous data-type and novel methodologies was revealed to be challenging (Sansone, 
Rocca-Serra et al. 2012).  
 
The case of systems genetics 
The systems genetics method is described as a population based approach for deciphering 
the molecular mechanisms underlying the relationship between genetics and complex trait, with 
the integration of multiple *omics resources (Civelek and Lusis 2014) generally mentioned as 
intermediate phenotype (e.g. chromatin accessibility, transcriptomics, proteomics, 
metabolomics, microbiome).  Data integration is the keystone of systems genetics and can 
greatly benefits from the creation of DRO. Many improvements are still needed (Baliga, 
Björkegren et al. 2017), from a methodological point of view with the development of novel 
mathematical, statistical, computational (Gligorijević and Pržulj 2015) and visualization 
(Nekrutenko and Taylor 2012) strategies, but also to facilitate the data discovery and reusability 
amongst peers. 
In our case, the experiment was performed on recombinant inbred mice: the BXDs. At the 
biological level, this mouse reference panel is an example of suitable organism for systems 
genetics design as it is genetically diverse and can be used to investigate the interaction between 
genetics and the environment. Furthermore, the lines are maintained to be genetically long-time 
stable and reflect the efforts to produce biological resources reusable among labs. Many 
complex traits were observed in these mice like mitochondria proteomics (Williams, Wu et al. 
2016), glucose regulation (Picard, Soyer et al. 2016) or cognitive aging (Neuner, Garfinkel et 
al. 2016). In our case, to measure the genetics contribution to the sleep homeostatic process, the 
data were sampled from 33 different BXD lines, (plus the 2 parental strains C57Bl6/2J & 
DBA/2J and the 2 F1). Furthermore, the mice underwent 6h of Sleep Deprivation (SD) to 
challenge the sleep homeostat and evaluate the effect of prolonged wakefulness over mice 
transcriptome, metabolome and phenome in addition to the interaction between SD and 
genetics. The complete raw dataset was distributed among: (i) 156 illumina single reads RNA-
seq from cortex and liver tissues, (ii) 250 LC-MS blood metabolomic profiles, (iii) 256 
EEG/EMG spectral signals of 4 days recording, for sleep and brain activity measurement, and 
finally (iv) 256 PIR (Passive InfraRed) motion sensor for physical activity quantification (for 
101 
 
details, refer to our paper). The genes expression from RNA-seq and metabolites level were 
referred as intermediate phenotypes, and the physical activity, sleep aspects and EEG/EMG 
spectra were referred as end-phenotypes.  
Here we present the general bioinformatic strategy we applied to convert this systems 
genetics dataset into a better DRO. Our approach aimed at improving: (I) the exposure of the 
dataset, methods and results, (ii) the reproducibility of our pipeline, (iii) the reusability of the 
dataset to facilitate knowledge-sharing between scientists with different skills, from 
bioinformatician to geneticist and sleep scientist with little-to-no bioinformatics expertise. 
 
Summary of the bioinformatic process 
To facilitate the interpretation of the complete bioinformatic workflow that was performed 
for data processing in addition to their different sharing-problematics, the main steps involved 
as quickly summarized here. The analyses can be separated into 3 principal layers that each 
increased the level of data abstraction and interpretation. The first low-level layer contained the 
procedures we did to reduce and transform raw-data (i.e. RNA-seq reads alignment, machine 
learning approach for EEG/EMG annotation, sleep phenotyping or mouse genotyping) which 
allowed for the data exploitation by further analytical steps. This layer is characterized by long 
and quite computational intensive procedures that need multiple processor cores, large I.O. 
bandwidth and where most large intermediate files that were generated were deleted. When 
available, dedicated standard software were used but the development of novel non-standard 
methods was also needed.  
An intermediate layer contained some classical analyses that could be performed on the data 
such as gene expression normalization followed by differential expression or Quantitative Trait 
Locus (QTL) mapping. We explored the effect of sleep deprivation, genetic variations as well 
as their interaction over sleep phenotypes and intermediate phenotypes.  
The high-level layer contained the novel integrative methods that we developed, to 
prioritized gene driving the sleep regulation and the meta-dimensional visualization method to 
represent the multi-omics network underlying sleep phenotypes.  
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Standard workflow and semantics 
The processing of the raw molecular data within the low-level layer, could be performed 
using standard and well-established pipeline (Conesa, Madrigal et al. 2016). For example, the 
RNA-seq illumina reads alignment was done combining the splice aligner STAR (Dobin and C. 
2013) and the python read counter htseq-count (Anders, Pyl et al. 2015). To maximize the 
reusability of the alignment with other BXD projects in the department, we used common 
annotation files, i.e. the reference genome assembly MGSCv37 (mm9) and the RefSeq 
annotation for gene symbol & boundaries to quantify gene expression. The common genome 
assembly permitted to increase the genetic variant detection confidence and resolution during 
the mouse genotyping using the variant caller GATK (McKenna, Hanna et al. 2010). In total, 6 
RNA-seq samples per BXD lines were integrated, from our cortex (2x) and liver (2x) tissues, 
in addition of hypothalamus and brain-stem tissues from 2 different projects. 
The use of curated symbols for genes nomenclature by RefSeq allows a better semantic 
interoperability with other resources like the Uniprot protein ID, Mouse Genome Informatics 
(MGI), or GO terms using solution like R/biomaRt (Durinck, Spellman et al. 2009). 
Furthermore, it minimizes discordance between expression level among our different projects, 
thus increasing the reusability and comparison of the data and limiting mice sacrifices in the 
incoming BXD studies. This single RNA-seq workflow involved many other different scripts 
and software to format the files and to run the alignment and count algorithms properly and 
efficiently on a computer cluster. All the computation was performed at the Vital-IT Center for 
high-performance compute (HPC) of the Swiss Institute of Bioinformatics (https://www.vital-
it.ch/). This HPC structure provides a version control of the software used, thus enhancing the 
pipeline reproducibility. Moreover, an archiving system is available to ensure the sustainability 
of the data and results generated.  
 
Non-standard workflow and semantics 
The use of standardized workflow, format and terminologies are recommended for the 
generation of DRO (Bechhofer, Buchan et al. 2013) and could be achieved in most case for 
molecular data processing where lot of pipelines exist. However, our sleep phenotyping 
procedures could not be carried out using a standard computational workflow or rely on 
common semantics. 
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The sleep quantification is usually performed in our lab using an EEG/EMG spectra visual 
annotation by an expert using 4-seconds window (epoch). For this dataset a supervised 
classification algorithm had to be developed to annotate the 22.5 million epochs divided among 
the 262 recorded mice. The specificity of the hardware amongst sleep labs and by consequence 
the raw output format prevented the release of a packaged workflow for a public usage. 
However, our algorithms and scripts were versioned with git and transformed into a single user-
friendly command on our informatic infrastructure that permit our sleep colleagues to easily 
reuse this pipeline for other experiment. In total, 341 physiological phenotypes were derived 
from the EEG/EMG signal and the annotations, representing e.g. sleep duration or architecture. 
Currently, none existing nomenclature was defined for normal mouse sleep phenotypes. The 
nomenclature that was chosen for unique phenotype-IDs were a combination of the phenotype 
observed (e.g. EEG power during NREM sleep) and the feature observed in this phenotype (e.g. 
in delta bands, 1-4 Hz).  Some features could have identical name but the phenotype names 
were always unique, thus phenotype-IDs were unique. A complete meta-data document was 
created, categorizing and defining each of the 341 physiological phenotypes that were recorded. 
 
Generate reports with markdown language 
Once the data processed within low-level layer, the effect of sleep deprivation, genetics and 
their interaction were measured using different statistical models and computational methods. 
The programming language R was the best suited tools for the statistical analyses and figure 
generation that were required on these following steps. Beside the advantages of a license-free 
and portable language, R was already recommended as main tool for systems genetics analysis 
(Durrant, Swertz et al. 2012). Many available packages are particularly adapted for the systems 
genetics design, involving phenotype-genotype association (r/qtl), network analysis (WGCNA, 
SANTA, igraph), differential expression (EdgeR, DESeq, limma), bayesian network learning 
(bnlearn), visualization (ggplot2, grid), enrichment (topGO, topAnat), parallel computing 
(parallel) and many others. However, a few analyses were performed using others software, 
principally for efficiency reasons in eQTL analysis where the number of model to test is quite 
large (Schupbach, Xenarios et al. 2010, H., Buil et al. 2015). 
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With a reviewable source code, R is one of the flagship of open science and reproducible 
research. The development of 2 packages: knitr (Xie 2014) and rmarkdown (Baumer, 
Cetinkaya-Rundel et al. 2014) enabled the generation of human-friendly report known as 
‘Rmarkdown’ (Figure 1). This report format contains nice solutions for reproducible results 
(Sandve, Nekrutenko et al. 2013) like the combination of code (Figure 1A), figures (Figure 1B) 
and comments contained within a single markdown document that can be easily converted into 
pdf or html format. The data used for figure generation could also be easily displayed into tables 
(Figure 1C), where, in this example, the narrow-sense heritability (Hegmann and Possidente 
1981) was calculated for physiological and metabolic phenotypes. 
 
Figure 1: Rmarkdown for traits heritability 
(A) The figure illustrated in a published paper is displayed within the Rmakrdown. (B) Data behind the 
plot are displayed in a table format, containing the phenotypes file and name, the narrow-sense 
heritability and the broad-sense heritability. (C) the code used to compute the heritability values is 
display in a Rmarkdown chunk that can be hide or showed. 
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The production of Rmarkdown reports on a remote cluster infrastructure requires the use of 
a second script that will generate the document with the rmarkdown::render() function and pass 
the expected function arguments. Common functions shared between Rmarkdowns did not need 
to be copy/paste for each reports, they could be sourced within the code chunks and reported 
with the readLines() function. Finally, the use of sessionInfo() function at the end of the 
document allows to keep track of each packages version and environment variable used to 
perform an analysis. The Rmarkdowns were transformed into html document to gain 
interactivity with the information displayed. The author can set many option in the YAML (Yet 
Another Markup Language) header to: create dynamic and readable table that contains multiple 
rows, hide/show source code or integrated CSS style and table of contents. The report can be 
visualized using any web-browser. However, on github (https://github.com/) or gitlab, these 
documents must be downloaded locally or visualized using rawgit (https://rawgit.com/) as the 
current github’s version does not allows the direct visualization of html document. 
 
Digital Research Object & workflow metadata 
Systems genetics was an integrative project that implicated multiple collaborators, that each 
contributed to the final results, with their own working habit related to their field expertise. For 
a better reproducibility of the generated DRO, a critical goal was to keep track of the different 
files created, associated documents or analytical steps that were produced. For example, 
physiological phenotypes could be found within many files and reports, from low-level to high-
level layers, but their nomenclatures were still hard to interpret, in particular for non-sleep 
scientists (see File column in Figure 1B) or persons unrelated to this project. A new comer in 
this project should be able to easily recover the metadata document containing all the 
physiological phenotypes information (i.e understand that a metadata document exists, where 
to find it or who to ask for it). The notion to establish what was exactly performed, the 
inputs/outputs and where to locate the information distributed among different person or 
different directories on a digital infrastructure could be extended to each data, figures, results 
or scripts. A complete workflow meta-data would improve the reproducibility of the DRO 
(Cohen-Boulakia, Belhajjame et al. 2017). 
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A core meta-data file was generated containing the essential information and relationships 
between all the files, scripts, Rmarkdown, small workflow or database annotation (referred here 
simply as file-objects) used and produced in this project (Figure 2).  
 
 
The markdown format was kept as it was easy to write/read by a human or to generate via 
simple python script (so collaborators could easily understand it and integrate their own 
pipeline, comments, description and cross-reference). The metadata file was formatted into a 
simplified RDF-like triples structure, were each files-objects (subject) were linked to 
information (objects) by a property. This format allowed to use the following properties to 
describe each file-objects we had: The file-object name or identification, a brief description (i.e. 
about the software used or the data content), the file-object version, the input(s)/output(s), the 
Figure 2. Bioinformatics workflow metadata 
File: Data that can be described as a single text file. Multiple Files: Data data are splited into different 
text files (i.e. fastq reads for each BXD lines). Rmarkdown: Analysis that are performed in R and 
reported using Rmarkdown. Scripts/Software: A process that is run using a single command lines. 
Workflow: A process that is run using multiple command lines and softwares. Database: Public 
references (i.e. genome reference or BXD genotypes). Each file-object is annotated with its complete 
name and directory path, input/output, arguments passed, a short description, version and authors. 
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associated documents, hyperlink(s) to remote database or citation, the location of the file-object 
on the project directory or archiving system and the author(s) to contact for questions. These 
associations could be viewed as a graph (figure 2, only input/output) to display the important 
files and pipeline used. This meta-data is useful for an external user to understand how exactly 
was generated the final DRO. But also for a collaborator to recover the scripts and input files 
that were used even after prolonged periods and to use them again, which permit for example 
to reproduce data with novel or updated annotation files. Furthermore, if an error was detected 
within a script, the results and figures downstream that needed to be recomputed could be easily 
found. This metadata file is accessible here. 
 
Accessing data through web application & data-mining 
The DRO that was built for the systems genetics of sleep is constituted of the following 
collection: raw-data, processed data, Rmarkdown reports, results & interpretation (via 
publication), workflow, scripts and metadata. A web application was developed to further apply 
the FAIR principles, which promoted the exposure of our results, interpretations and associated 
method through findable and accessible web pages. Furthermore, a set of tools were developed 
for the exploratory data-mining of this dataset and reusability improvement of our results. 
The home page of the web application displays the information for the NREM sleep gain 
during the 24 hours (in four 6- hour intervals) after sleep deprivation (Figure 3D). This 
information is formatted with hiveplots (Figure 3G). The following tools allow to change the 
filtering parameters, explore and compare the hiveplots, explore the EEG/behavioral 
phenotypes and finally to search for specific genes: 
(Figure 3A) Search parameters - Tissue & cutoff: Sets the parameters for selection of genes 
in the specified tissue (cortex or liver) according to the specified cutoff for the pearson 
correlation coefficient and/ or a cis-eQTL q-value. 
(Figure 3B) Search parameters - Phenotypes or genes: One can search by phenotype(s) or 
by gene(s). A search by phenotype will output the genes that correlate to the submitted 
phenotype(s) with a correlation coefficient larger than the cutoff set in A). Search by gene(s) 
will output the most correlated phenotype(s) to the submitted gene(s).  
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(Figure 3C) Results - Heatmap: The results are displayed as heatmaps according to the 
selections made under Search parameters in A and B. 
(Figure 3D) Results - Hiveplots:  For each phenotype present in the heatmap in C, the 
corresponding hiveplot is displayed.  
(Figure 3E) Hiveplot-Filtering: Filtering options specific for the hive plots. 
(Figure 3F) Results – Table: Tables list all genes, markers, and metabolites and their relations 
for each hive-plot in D. 
 
Figure 3: Web interface home page 
(A) Search parameters - Tissue & cutoff, (B) Search parameters - Phenotypes or genes, (C) Results – 
Heatmap, (D) Results – Hiveplots, (E) Hiveplot-Filtering, (F) Results – Table, (G) hiveplot structure: 
Each plot represents one EEG/behavioral phenotype and its underlying associated molecular network; 
i.e., only the genes and metabolites strongly associated with a given phenotype are displayed. Each 
hiveplot is composed of 3 radial axes containing the molecular data with nodes assigned to the 2 bottom 
axis for genes expressed in the cortex (in blue) and liver (in red) and nodes on the vertical axis (in yellow) 
represent metabolites. On top, we added a separate ‘genetic’ axis (white) containing the genotypes. The 
node position on the 3 (molecular) radial axes was determined by the response to sleep deprivation; i.e., 
molecules closer to the center were down-regulated more strongly, while more upregulated 
genes/metabolites were closer to the axis’ edge. Edges connecting nodes represent positive/negative 
correlations (red/blue, respectively) between molecules using expression values. Genetic markers linked 
to genes by eQTLs connect the genetic and molecular space. 
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Three data-mining tutorials are described here and in more details on the web interface to: (i) 
mine a single phenotype, (ii) search for gene and (iii) compare hiveplots. 
 
Single phenotype mining: 
In this section, we assume that we are interested in a single sleep phenotype. We will 
approach the data by multiple filtering steps. Compared to the 3 other sleep intervals, NREM 
gain was strongly associated with metabolites during the 2nd 6h interval; i.e., the 1st 6h of the 
recovery dark period (ZT12-18, Figure 3D). We will focus on this phenotype only, other 
phenotypes can be removed using filtering options in Fig.3B. The heatmap (Figure 3C) displays 
all genes for which the expression is correlated to this sleep phenotype (note that liver is the 
default tissue). You can explore genes in cortex by changing the filtering parameters (Figure 
3A). You can sort genes by correlation strength by clicking on the phenotype name in the 
heatmap. The default thresholds are: absolute pearson r equal or above 0.5 for genes and 
absolute pearson r equal or above 0.4 for metabolites. Given the high number of genes displayed 
in the heatmap, the pearson r coefficient cutoff can be increased under Search parameters 
(Figure 3A). In this case, we select an absolute pearson r of 0.6 for genes and 0.5 for metabolites. 
The user might be interested in genes that are driven by genetic variation (cis-eQTL). Genes 
are then also filtered according to cis-eQTL association with an FDR adjusted p-value equal or 
below 1e-5. Five genes remain in cortex and liver: Acot11, Tceanc2, Aldh9a1, Mroh7, and 
Btf3l4 (highlighted in Figure 4A). Further filtering can be applied to the hiveplot. We can select 
for genes that have a minimum number of links (edges), e.g. 6 edges on our unfiltered hiveplot 
(Figure 3E). Acot11 is the only highlighted gene that is kept after applying these filtering 
options (Figure 4B). Other options are available, such as keeping only top differentially 
expressed genes in the selection:  The hiveplots can be investigated using 'mouseover' the 
different edges and nodes. This will display the node name (gene name, metabolite name, or 
marker name), or the nodes connected to an edge. All nodes and edges within the displayed 
hiveplot are listed in the table (Figure 3F). The table gives the following information: i) the type 
of node: genes in cortex, genes in liver, metabolites, and markers, ii) effects of sleep deprivation 
on genes and metabolites are indicated by fading color. A new tab is created for each highlighted 
gene selection and shows additional information concerning gene function, i.e. the 5 genes with 
the highest partial-correlation (Figure 4D), within the same tissue, across-tissue, and metabolite. 
The tab (Figure 4C) contains the gene name (1), the Uniprot description of the gene (2), 
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Synonyms (3), a Uniprot and MGI access ID links (4) and related GO terms (5). Here the 
network of the highlighted gene (Acot11) with the 5 top genes partially-correlated to within the 
same tissue (blue), 2 top genes partially-correlated to the highlighted gene within the other 
tissue (orange) and the top correlated metabolite (green). Red edges indicate positive correlation 
and blue edges indicates negative correlation. The size of the nodes indicates the correlation 
coefficient with the phenotype. 
 
Gene search: 
The interface allows also to search for specific genes associated with a sleep phenotype at a 
specific correlation cutoff (Figure 3E). Here are a 2 examples of sleep related genes:  
1. Per2 is a well known circadian gene. It is associated in the BXD set with NREM sleep 
gain after SD [ZT12-18], and is associated with 2 metabolites: PC aa C36:3 & PC ae 
C40:0. 
2. Sik3 KO mice were associated with the increase total of NREM sleep (minutes/24h) and 
a decrease in total wake in mouse by (Funato, Miyoshi et al. 2016) using random genetic 
screening. With our extended database, we found that: Sik3 cortical expression in baseline 
was correlated (r=0.55) with the wake amount at the beginning of light (BXDw24bsl.h1). 
 
Figure 4: Single phenotype filtering results 
 
(A) Highlight selected genes (in black). (B) Hiveplot filtering, (C) Selected gene additional information, (D) 
close neighbor of the selected gene. 
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Compare hiveplots with edges filtering: 
Hiveplot filtering parameters allow to recover common edges among hiveplots or to exclude 
common edges. In the first example, we select phenotypes of EEG power after SD for all the 
bands using search option in Figure 3B. Here we are interested in slow delta power after sleep 
deprivation (δ1: 1.0-2.25Hz) during NREM sleep, and we want to remove all genes, metabolites 
that are present also within other bands. Therefore, we exclude other phenotypes using the “ex” 
button in the hiveplot filtering options (Figure 5A). 
 
 Finally, we keep only genes differentially expressed and genes connected to 3 other 
elements, the remaining genes are Strada, Mapk4 and Fhit in cortex and Susd4 in liver. These 
genes thus correlate only to slow delta and not to other EEG frequency bands of the EEG spectra 
during NREM sleep after sleep deprivation. Inspection of Strada (Figure 5B) in cortex informed 
Figure 5: Hiveplot comparison 
(A) Options to select common ‘in’ edges and nodes, or to exclude ‘ex’ common edges and nodes (B) 
selected gene after excluding common edge for EEG slow delta power after SD (C) Neighbor of Strada, 
(D) Filter only common edges for delta power bands gain and after sleep deprivation. Wrn is the 
highlighted common gene to 3 phenotypes 
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us that Homer1 is among the 5 closest genes of Strada (Figure 5C). Homer1 has been implicated 
in the homeostatic regulation of EEG delta power. The second example shows how to inspect 
common edges:  In this case we are interested in genes common to slow delta gain (r/b) during 
NREM sleep correlated within other delta bands.  Using the “in” button in the hiveplot filtering 
option for slow delta gain after SD, the common edges and nodes within other bands will be 
kept. We also filter for genes differentially expressed after SD. Inspecting the table (F), we see 
that only 1 gene is connected to 3 other bands. Wrn is present in the hiveplot 1, 2, and 3 [NREM 
sleep EEG power aSD δ1, NREM sleep power aSD δ2 and NREM sleep EEG power gain (r/b) 
δ1] (Figure 5D). 
 
Discussion: 
We presented here a data-management strategy for the application of the reproducibility and 
reusability principles in a context of a systems genetics dataset. The reproducibility of our 
workflow to create a complete digital research object from a mouse biological resource was 
supported with the use of dynamic reports using Rmarkdown when it was feasible, but also 
version control with git and rich metadata description for the total data-processing pipeline.  
With the development of web-interface, the systems genetics digital research object is findable 
and accessible with web-browser. Moreover, the dataset is reusable with data-mining tools 
available on the web-interface. This bioinformatic strategy stands as a real case application 
example for trans-disciplinary projects, but which is likely to change over the next years with 
novel annotation version, standard workflow and novel integrative methods. 
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Discussion & Perspectives 
 
The systems genetics approach is still a young scientific strategy with great potential for 
dissecting the complexity of the molecular machinery underlying phenotypic variation. 
Currently, no accepted analytical directives have been adopted to guide the researcher through 
this Terra Incognita, and no gold-standard dataset exists to accurately compare methods beyond 
the single gene regulatory network inference (Pinna, Soranzo et al. 2011). Accordingly, many 
experimental protocols and methodological tools have yet to be developed, considered, tested 
and evaluated (Baliga, Björkegren et al. 2017). In the following section I will first discuss our 
strategy to systems genetics. In a second part, I will discuss our newly developed analytical, 
integrative, and communicative schemes with their strengths and limitations compared to 
existing methods, as well as the biological resource we used, i.e. the BXD panel. Finally, I will 
highlight some of our findings., linking metabolism to sleep regulation and the perspectives for 
novel regulatory network research. 
 
Systems genetics, a multifaceted approach 
The systems genetics approach stands at the intersection of many disciplines, from the 
experimental/biological to data/computational science. In our study, we aimed at gaining 
insight into the molecular factors driving sleep. The extraction and transformation of the 
relevant biological information into the findable, understandable and exploitable knowledge 
resource that we aimed for involved multidisciplinary expertise for each of the steps of the 
project, with its own challenges (Figure 6).  
First, the experimental design aimed at capturing factors driving sleep within a multi-
dimensional molecular network, nested within different tissues and modulated by 
environmental, genetic, and time factors. Therefore, a data-driven type of study was selected 
necessitating a large sample number, because of the dimensional aspects mentioned earlier and 
to obtain the statistical power needed to attain reproducibility of the results (Halsey, Curran-
Everett et al. 2015). Among the challenges faced were the ability to scale the experiment over 
250 mice divide among 33 different genotypic backgrounds. To limit potential technical and 
experimental bias, and guarantee an optimal data quality over 2 years of data acquisition, a 
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randomization strategy was applied between the experimental cohorts for the sleep deprivation, 
tissues sampling and EEG implementation/recording. Furthermore, experiment on parental 
strains were replicated at the beginning and end of the experiment. On the computational side, 
the capacity to scale the EEG/EMG annotation for behavioral phenotyping, while keeping a 
high accuracy compared to manual annotation was covered by the development of a supervised 
machine learning algorithm. The use of multiple SVMs with a training process using partially 
annotated signal by our expert and the high resolution of the annotation (1 second epoch) 
ensured that this algorithm was generalizable for the high EEG/EMG signal diversity that was 
found the BXD panel. 
 
Figure 6 : Schematic design to transform biological resource into knowledge resource with 
systems genetics. 
Schematic representation of our systems genetics approach to generate hypothesis, using 
experimental and computational expertise (big circle). A knowledge resource was built to access and 
data mine our results, which allows other research studies to reuse these data (small circles). And the 
implementation of a reproducible strategy allows to replicate the workflow that was developed.  
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Among the existing systems genetics publications, the focus was mostly on specific 
mechanical aspect of cellular regulation, thus, often limiting the dimensionality of the resulting 
datasets. While the genetic diversity component is a constant in each systems genetics design, 
some adopted single tissue exploration (Andreux, Williams et al. 2012, Taneera, Lang et al. 
2012), single condition (Krishna, Biryukov et al. 2014) or single physiological phenotype 
(Chintalapudi, Maria et al. 2017). At this moment, this dataset is unique, at least in the mouse 
sleep field given its multi-dimensionality over genetics, tissues, conditions, time, and large 
physiological phenotypes within a single project. The challenge of data integration on so many 
levels necessitated the development of novel integrative strategies besides the more traditional 
data analysis. Our strategy for data-integration and suggestion for improvement are discussed 
below. In addition, an effort was made to guarantee the reproducibility of the methods used 
with the implementation of open and dynamic reports containing the programming code used. 
This ensured that the workflow at the origin of our knowledge resource was reviewable. 
Among the intriguing systems genetics relationships detected for the phenotypic response to 
sleep deprivation, we identified effects on brain slow-waves dynamics by cortical glutamate 
receptor recycling and DNA-helicase enzyme, specifically after sleep loss. But also, an 
association between NREM sleep recovery dynamics after sleep loss in the dark phase, with 
lipids metabolism through the action of acyl-thioesterase enzyme Acot11 in the liver. A 
validation procedure using complementary or orthogonal experimental designs is recommended 
to strengthen the overall quality of the dataset given the many possible and different steps taken 
in processing the data. But also, to evaluate the robustness of the conclusion using novel 
methods, as mentioned earlier. Accordingly, we tested the hypothesis of Acot11 to be part of 
the sleep homeostatic regulatory network using knock-out mice, and could confirm the 
differential NREM sleep recovery dynamics of the KO mice in the dark phase following sleep 
deprivation. This validation step confirmed that the relation we discovered was likely to be 
causative and opens the door for other hypotheses testing like the cross-relationship between 
the homeostatic regulation of sleep alongside with fatty-acid turnover and possible metabolic 
disorder like obesity or type-2 diabetes. 
 
The systems genetics phenotypes that we highlighted in Chapter 2 are only the tip of an 
iceberg given the scale of the dataset and the numerous other examples that still await further 
exploration. Tools were developed to allows the exploration of all end-phenotypes and the data-
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mining of the underlying molecular networks, therefore transforming raw and processed data 
into a knowledge resource that can be interrogated. Using cloud-based technologies, a set of 
web-based tools were developed to enable a user to search for a specific gene or sleep 
phenotypes and perform interactive filtering on the data-base and on our novel visualization 
methods. The resulting database and associated web interface ensures the reusability of the data 
and associated methodologies and facilitates the distribution of this unique integrated system-
level genetics knowledge base to the public. This strategy of resource building which respects 
the principles of the FAIR approach enables researchers working on the same topic or using the 
same mouse lines to reuse this dataset for their own research. 
 
Phenomics integration, methods and limitations   
A crucial step in the systems genetics general strategy is the integration of large, 
heterogenous information with mathematical and computational frameworks to strengthen 
data-exploitation. It is one of the greatest challenges for multi-omic datasets where increasing 
numbers of data-types will also highly increase analyses effort (Palsson and Zengler 2010). The 
addition of supplementary and broader predictive variables within a model is expected to yield 
a more comprehensive insight into the biological processes at work. Two general categories of 
integrative approaches are regularly followed in multi-omics design: multi-staged and meta-
dimensional methods (Ritchie, Holzinger et al. 2015). In multi-staged methods the analytical 
workflow is divided into multiple and independent analysis that are later hierarchically 
integrated. Our approach of data integration in this project can be viewed as following this 
multi-staged approach with: QTL mapping, statistical analysis of sleep deprivation 
consequences or hierarchical integration of analysis outcome within a prioritization strategy. 
Meta-dimensional methods are larger, more complex, multivariate models that can stand on 
machine learning algorithms (based on supervised or unsupervised methods, i.e. that can use or 
not prior knowledge as learning step) or network-based approaches  (Li, Wu et al. 2016, Huang, 
Chaudhary et al. 2017). In our project, the visualization method we implemented can be viewed 
as a meta-dimensional method, integrating all genetic, transcriptomic, metabolomic and end-
phenomic layers within a single figure. Both methods are further described in the two following 
sections. 
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Multi-staged approaches, improvement of our methods:  
One of the main advantages of a multi-staged approach is an easier integration of the state-
of-the-art methods for data-processing or data-analysis committed to simpler (i.e. with less 
dimensions) problems. The use of outdated software, annotation or methods strongly affect 
reproducibility of the results (Offord 2018) and is therefore to be avoided as much as possible 
as it generates unwanted technical noise and impedes the assembly of a serviceable resource. 
Each processing step we performed continues to be developed further with periodical updates, 
reviews and evaluations like RNA-seq (Williams, Baccarella et al. 2017), and some parts of our 
analyses pipeline can be improved, like reads alignments, association mapping, trans-eQTL or 
epistatic detection. 
 
Reads alignment and transcript expression 
For the BXD panel, a common pipeline for RNA-seq analysis is to align reads on the mouse 
reference assembly MGSCv37 (mm9) or more recently GRCm38.p6 (mm10) (Fan, 
Waizenegger et al. 2017). The mouse strain used for the assembly is C57BL/6J, which may 
introduce a reference bias during the alignment and change the read mapping success rate for 
some lines, considering the C57BL/6J and DBA/2J genome admixture of the BXD. This bias 
is often observed for region with indels, were splice aligners have most alignment difficulty, 
even when using the STAR methods (Sun, Bhagwate et al. 2017). The use of an individualized 
genome reference for each BXD line would improve gene expression analysis (Munger, 
Raghupathy et al. 2014). The haplotype sequence reconstruction and genome assembly of the 
BXD panel could be performed using PacBio reads with the use of phasing algorithm like 
FALCON (Chin, Peluso et al. 2016) or a reference guided assembly like CrossStitch 
(https://github.com/schatzlab/crossstitch). 
In this project we quantified gene expression, which reduced the quantity of parameters to 
evaluate within integrative methods and facilitated the validation procedure by selecting mice 
with gene KO compared to condition allele KO. However, recent transcript quantification 
methods like Kallisto (Bray, Pimentel et al. 2016) show good accuracy. It could be used in 
combination with gene & transcript aggregating approach (Van den Berge, Soneson et al. 2017, 
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Yi, Pimentel et al. 2017) which would increase the accuracy of eQTL analysis or sleep 
deprivation effect on transcriptome. 
 
Association mapping: 
For QTL mapping, we used a linear model by associating the gene expression, metabolite 
levels or EEG/behavioral phenotypes with genetic markers. Other statistical models were 
developed and recently used for the BXD panel to take into account the stratification and 
genetic covariance that can be found in this panel (Kang, Zaitlen et al. 2008, Segura, 
Vilhjálmsson et al. 2012, Li, Wang et al. 2017). However, in such mixed models the estimation 
of the degree of freedom and therefore the significance of fixed effect using p-values can be 
difficult, and the methods used tend to be non-conservative (high type I error) when sample 
size is small (Luke 2017). In our project, this type of approach could be used for end-phenotypes 
and metabolites where replicates are used but would be inappropriate for genes expression that 
were evaluated using pooled samples.   
 
Trans-eQTL:  
Cis-eQTL associations and interactions with sleep deprivation were described in details in 
our resource and used for gene prioritization within associated ph-QTLs. However trans-eQTL 
remained mostly descriptive and primarily used for visualization purposes. Still, trans-eQTL 
are expected to importantly contribute to the gene expression heritability  (Grundberg, Small et 
al. 2012) and could be integrated within our prioritization method to evaluate the effects of 
transcriptome-wide variation. Clustering methods between cis- and trans-eQTLs were proposed 
to assess their combined effects using bipartite community networks (Platig, Castaldi et al. 
2016). 
 
Epistasis: 
Epistasis (GxG) is considered as an important contributor of the regulatory network 
complexity (Mackay and Moore 2014). But epistatic analysis tends to be under-represented 
compared to single association in science (Carlborg 2004) because of the related computational 
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and statistical complexity (Upton, Trelles et al. 2015) resulting from the billion possible 
associations that have to be considered if no filtering is performed before  (Sun, Lu et al. 2014).  
In this project, epistasis is partially considered for gene co-expression within hiveplots. A 
partial correlation method was used to disentangle the cis-eQTL effects between pairs of genes. 
This method allows to ‘decorrelate’ genes that are functionally unrelated but located within the 
same haplotype region and under cis-eQTL effect, or to associate co-expressed genes under 
different cis-eQTL effect. Similar strategies were used in combination with gene co-expression 
network (Vanderlinden, Saba et al. 2013) or using small bayesian networks approach (Wang 
and Michoel 2017). However, both methods model single marker effects, whereas it is highly 
likely that within our list of 5000+ genes with a significant cis-eQTL effect, many of them will 
interact. 
More advanced methods are now being developed using machine learning approachrd which 
optimize the number of Fisher exact tests, chi-square tests or anova F-test performed. It restricts 
the computation and statistical tests to SNP-pairs that can possibly reach the required adjusted 
p-value (Zhang, Zou et al. 2008, Zhang, Zou et al. 2009). These methods work with binary 
SNPs which fit perfectly inbred lines like BXD, and thus could be applied to our design (Zhang, 
Huang et al. 2011) to build epistatic network (Tyler, Ji et al. 2017). 
 
 
 
 
 
 
 
 
 
 
 
122 
 
Meta-dimensional analysis: 
Deep supervised learning: 
The stratification of the analyses for each intermediate phenotypic layer as it is performed 
with the multiple staged approach is in general easier to implement and interpret. It is often 
used for its biological logic where the information flows directly from genotype toward end-
phenotypes (Figure 7A). Meta-dimensional analysis allows for detection of non-linear 
interaction between all omics layers (Figure 7B) and more likely reflects reality of complex 
trait.  
Many machine learning methods can be 
used for their predictive capacity and 
successful integration of non-linear 
relationship (Li, Wu et al. 2016). Frameworks 
like MOMA (Kim, Rai et al. 2016) or 
ATHENA (Kim, Li et al. 2013) could integrate 
multi-omics layers for E.coli end-phenotype 
prediction using recurrent neural network or 
cancer clinical outcome using grammatical 
evolution neural networks. But they often 
come with costly limitations for the 
exploratory approach like our systems genetics 
design. 
These methods often require large number of samples in combination with a good filtering 
strategie for dimensionality reduction to avoid overfitting, a recurrent problem for predictive 
methods in data-driven science considering thousands of parameters extracted. Another 
difficulty of deep machine learning algorithms is the interpretation of the results. Knowing 
which parameters were selected and how they interact with other parameters is currently 
difficult as these algorithms are mostly black-boxes. Until white-box algorithms will be 
developed, these methods seems limiting for mechanistic inference and thus limiting for 
explorative and hypothesis-building approaches. 
 
Figure 7 : Complex trait models: 
Hypothesis from complex trait investigation. 
(Adapted from (Ritchie, Holzinger et al. 2015) 
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Network-based models: 
Network-based models are other powerful investigative methods for meta-dimensional 
designs. In the BXD, the Similarity Network Fusion (SNF) R package  (Wang, Mezlini et al. 
2014) combined with unsupervised clustering shows good predictive capacity for mitochondrial 
metabolism (Tini, Marchetti et al. 2017). SNF is specifically designed to integrate and merge 
multiple data-types that are in a network format, into a meta-network without supervision. 
These network based approaches that are based on gene co-expression like WGCNA 
(Langfelder and Horvath 2008) could be used in combination with our partial correlation 
method. Finally, many improvements can be implemented for the analysis of metabolic data 
with e.g. genome scale metabolic network models that could greatly clarify some of the many 
metabolic change that were observed after sleep deprivation. 
 
Data & knowledge sharing for systems genetics: 
Data accessibility is a second big challenge in systems genetics. Currently, there are no 
centralized repositories that contains all type of phenotypic data that could be extracted within 
a project. Most maintained repositories are dedicated to a single data-type, like the NCBI Gene 
Expression Omnibus (GEO) for sequencing data. Such a repository would need to be highly 
flexible to accommodate highly diverse phenotypes, and deeply metadata centered to permit 
and facilitate data-integration while controlling for similar experimental condition (e.g. 
sampling time). Finally, setting up a software infrastructure for data-process standardization 
would generate better analysis and better reproducibility of results. 
Present data-bases for systems genetics are mostly designed to map and mine genotype-
phenotype association. GeneNetwork is one good example of a web-based repositoriy that 
provides tools for QTL mapping and offer a structure for processed mouse phenotypes. An 
extension of GeneNetwork is http://www.systems-genetics.org (Li, Wang et al. 2017), that 
provides more developed tools to mine the QTL collection of GeneNetwork and also detect 
PheWas association (i.e. the association between one selected marker across many phenotypes) 
(Flintoft 2013). The UCLA Systems Genetics Resource (https://systems.genetics.ucla.edu/) is 
another web resource for mouse and human studies that contains tools for transcripts and eQTL 
mining, but also contains meta-data for samples and protocols used to generate the data. 
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Swiss-BXD interface:  
In our web resource, we provide an advanced interactive interface for end-phenotypes and 
their associated molecular network data-mining. Compared to other web-resources in systems 
genetics, the focus exceeded the QTL mining and allows to move within and between our novel 
visualization models using hiveplots. The advantage of end-results data-mining is mainly for 
the user to easily access processed data without having to regenerate the complete dataset that 
can be computationally demanding. Furthermore, the direct interaction with novel methods is 
likely to improve the comprehension of the results, and thus improve knowledge distribution. 
Some of our analyses are not directly reproducible on this web site, like the prioritization 
strategy we developed. However, the code is available via the Rmarkdown format and could be 
easily inspected.  
 
Fatty acid metabolism & sleep: 
Acot11 is an interesting target for the bidirectional communicative pathways between liver 
and cortex in the context of sleep regulation via blood metabolite transport. This acyl-CoA 
enzyme is differentially regulated in cortex and liver: the sleep deprivation will upregulate 
Acot11 cortical expression but downregulate liver expression. At the genetic level, only Acot11 
expression in the liver is driven by a cis-eQTL and predict the NREM sleep gain. With an 
Acot11 KO, we showed a strong GxE effect on NREM sleep gain after sleep deprivation (Figure 
8). 
The exact function of Acot11 is not yet totally clear, but it was associated with cell 
proliferation (Hung, Chiang et al. 2017), body temperature (Lau, Tuong et al. 2015) and mainly 
with lipid metabolic functions.  Acot11 KO mice displayed increased energy expenditure and 
obesity resistance (Zhang, Li et al. 2012). In brown adipose tissue of C57BL/6J strains, Acot11 
is upregulated during short and prolonged period of high fat diet (HFD) and low fat or standard 
diet (LFD). However the response was reversed in ddY, ICR, and KK-Ay strains after HFD, 
with a downregulation of Acot11 (Ohtomo, Ino et al. 2017). The strains ddY stain is a model 
for postprandial hypertriglyceridemia and KK-Ay mice for type-2 diabetes. These results show 
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a rather complex GxE effect in BAT but also in our own data with a tissue specific regulation 
of Acot11 expression. 
 
 
Acot11 is not the only gene linking sleep and fatty acid metabolism identified in our analysis. 
Cpy4a32 is involved in the arachidonic acid metabolism and is suggested to modulate the REM 
sleep theta peak frequency shift after sleep deprivation in our data. The Arachidonic acid is one 
of the main free fatty acids that can be found in the brain and some of the derived forms like 
prostaglandin D2 play a role in sleep-wake regulation (Urade and Hayaishi 2011). 
 
Figure 8 : Reduced NREM gain in Acot11 KO. 
(A) NREM sleep amount for Acot11 KO, HT, WT in baseline and after sleep deprivation. (B), 
cumulated NREM sleep gain per 6h bin, for Acot11 KO, HT and WT. (C) Significant NREM sleep gain 
difference between WT mice vs KO or HT in second phase of the dark. 
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Phenotypic variability in the BXD panel 
The BXD mice are very convenient for studying complex traits, with a large choice of lines, 
available genotypes and dedicated tools for phenotype mapping, however it also comes with 
some caveats. Even more advanced lines recombinant inbred lines were developed like the 
Collaborative Cross (CC) panel (Threadgill, Miller et al. 2011), were parental lines are 
composed of the classic C57BL/6J but also 7 other strains (A/J, 129S1/SvImJ, NOD/ShiLtJ, 
NZO/HILtJ, CAST/EiJ, PWK/PhJ, WSB/EiJ). This greater genetic diversity is also reflected 
on behavioral and physiological phenotypes, with greater variability in the CC panel than the 
BXD panel that is composed of B6 and D2 allele only (Philip, Sokoloff et al. 2011).  
The BXD panel is also heterogeneous for its Y and mitochondrial chromosomes which 
should be considered in further analysis including population stratification. The parental origin 
of the BXD mitochondrial chromosome was typed using SNP marker and a majority of BXD 
lines inherited the maternal C57BL/6J mitochondrial chromosome. However, 10 lines inherited 
a DBA2/J maternal chromosome (BXD32, 61, 74, 76, 82, 89, 90, 91, 95, and BXD99) and 
should be considered as DXB. This difference can be explained with different methods for the 
generation of AIL in Princeton and UTHSC, that used fixed paternal/maternal strains or used 
reciprocal crosses (Peirce, Lu et al. 2004).  
The true genetic nature of the phenotypic variability that is found within the BXD panel may 
have multiple origins that is not always evident to untangle. The molecular and physiological 
regulatory difference might be the result of single allelic effect that we measured with QTL 
analysis. It might result from higher order interaction (GxG) due to the different B6-D2 
combination in the BXD allelic background. The different parental D2 sub-strains used in ‘old’ 
and ‘new’ BXD may also affect the reproducibility of the results. Finally, the chromosomal Y 
and mt heterogeneity can also introduce phenotypic variability in the panel. 
   
The purpose of systems genetics 
The exact definition and purpose of the systems genetics approach seems to depend on the 
biological question asked. Among the various definitions the one by Michael Boutros 
particularly suits our approach: 
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“Systems genetics in my view is an exciting and emerging field that combines many state-
of-the art approaches in genetics and genomics, systems biology and what can be termed 
‘‘phenomics’’—methods to capture phenotypes, either at the molecular or organismal level. 
The field builds upon recent advances in genomics, imaging, and related fields. System 
genetics studies can rely on natural variation as a source of genetic differences, or systematic 
perturbation studies that are done in model organisms …. Together, these advances will allow 
a better understanding of the link between genotypes and phenotypes—in my view the core 
question in systems genetics.” (Baliga, Björkegren et al. 2017)  
 
In our design, systems genetics is used to uncover novel regulatory pathways, with a 
mechanistic approach focused on gene expression and metabolic levels. The main purpose of 
systems genetics is not only a better characterization of the existing genotype-phenotype 
relationship in BXD, but mostly a better characterization of the molecular systems underlying 
end-phenotypes (the links). In this case, genetics should be considered as a tool or a method to 
perturb biological systems, to observe where variation effect(s) propagate within the system 
and identify links that are persistent under different conditions and genetic backgrounds. The 
genetic marker composition is prone to change among individuals, which will change the way 
a molecular system is perturbed or will adapt, but the nature of the systems should remain stable. 
In the context of our study, systems genetics is used to aggregate liver, plasma blood and 
cortical systems, we could summarize this into a biological system scaffolding. Where the 
organism is examined more broadly with different regulatory structures that at some point will 
contribute to sleep regulation (given in this case a highly interconnected phenotype: sleep).  
Deeper mechanistic exploration using chromatin accessibility 
A better description of the relation between marker and gene expression regulation can be 
conducted with the integration of epigenetic signal. In the next months we aimed at measuring 
the chromatin accessibility using ATAC-sequencing (Buenrostro, Giresi et al. 2013) in the 
BXD. The set up of the analysis tools is currently under investigation using ATAC-seq time-
course and sleep deprivation effect on chromatin accessibility on C57BL/6J strains. This project 
is under preparation and further described in Annex.   
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Conclusion 
 
In conclusion, systems genetics is a trans-disciplinary approach that need novel 
methodologies at many levels for proper data interpretation. This approach should greatly 
benefit from the joint effort to develop workflows and datasets that can be shared. Open 
questions have still to be answered from the results we found such as the contribution of 
epigenetics to gene regulation, the dynamic contribution of free fatty acid to sleep regulation or 
the different pathways underlying fast and slow EEG delta power bands. Often defined as a 
holistic approach (Civelek and Lusis 2014) opposed to reductionist approaches, systems 
genetics and associated methods currently still stand on discrete and selected sampling strategy 
and should be considered to certain extend as an advanced reductionist approach, on a 
continuous scale toward holistic science. The reductionist and systems  approaches should be 
considered as complementary (Fang and Casadevall 2011) and not exclusive, as exposed with 
our Acot11 example, merging systems genetics and reverse genetics. 
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eQTL : Expression QTL 
mQTL : Metabolite QTL 
phQTL : Phenotypic QTL 
(EEG/Behavioral)  
SD : Sleep Deprivation 
rec : Recovery time 
bsl : Baseline time 
Ctl : Control 
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B2 : Baseline Day 2 
R1 : Recovery Day 1 
R2 : Recovery Day 2 
EEG : ElectroEncephaloGram 
TPF : Theta Peak Frequency 
D(G)E : Differential (Gene) Expression 
LOD : Logarithm Of Odds 
FDR : False Discrovery Rate 
FC : Fold-Change 
ZT : Zeitgeber Time 
REM sleep : Rapid Eye Movement sleep 
NREM sleep : Non-Rapid Eye Movement 
sleep 
TDW : Theta Dominated Wakefulness 
h2 : Narrow-sense heritability 
H2 : Broad-sense heritability 
SVM : Support Vector Machine 
 
LDLA : Diagonal Linear Discriminant 
Analysis 
D3 : Data Driven Document 
A.A. : Amino-Acids 
ACT : Acylcarnitines 
BA : Biogenic Amines 
GPL : Glycerophospholipids 
SM : Sphingomyelins 
Mb : Mega-base 
B6 : C57BL6/J 
D2 : DBA2/J 
n.s. : not significant 
CPM : Count Per Million 
FPKM : Fragment Per Kilobase Million 
PC : PhosphatidylCholine 
SNP : Single Nucleotide Polymorphism 
Indel : Insertion/Deletion 
LMA : LocoMotor Activity 
GATK : Genome Analysis ToolKit 
MGI : Mouse Genome Informatics 
LRS : Likelihood Ratio Statistics 
GxG : Gene – Gene Interaction 
GxE : Gene – Environment Interaction 
BXD : B6 X D2 Recombinant inbred line 
GRP : Genetic Reference Population 
GWAS : Genome-wide association study 
HFD: High Fat Diet 
LFD: Low Fat Diet 
  
131 
 
Online resources: 
 
Systems genetics of sleep web interface: https://bxd.vital-it.ch 
Open source code, Rmarkdown report and project meta-data : https://gitlab.isb-
sib.ch/majan/Systems_Genetics_of_Sleep 
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Appendix 1: Web interface usage 
 
BXD web interface informations: 
Home page displays the information for the NREM sleep gain during the 24 hours (in four 
6- hour intervals) after sleep deprivation. 
 
 
(A) Search parameters - Tissue & cutoff: Sets the parameters for selection of genes in the 
specified tissue (cortex or liver) according to the specified cutoff for the pearson correlation 
coefficient and/ or a cis-eQTL q-value. 
(B) Search parameters - Phenotypes or genes: One can search by phenotype(s) or by 
gene(s). A search by phenotype will output the genes that correlate to the submitted 
145 
 
phenotype(s) with a correlation coefficient larger than the cutoff set in A). Search by gene(s) 
will output the most correlated phenotype(s) to the submitted gene(s).  
(C) Results - Heatmap: The results are displayed as heatmaps according to the selections 
made under Search parameters in A and B. 
(D) Results - Hiveplots:  For each phenotype present in the heatmap in C, the corresponding 
hiveplot is displayed.  
(E) Hiveplot-Filtering: Filtering options specific for the hive plots. 
(F) Results – Table: Tables list all genes, markers, and metabolites and their relations for 
each hive-plot in D. 
Hiveplots details: 
 
 
Each plot represents one EEG/behavioral phenotype and its underlying associated molecular 
network; i.e., only the genes and metabolites strongly associated with a given phenotype are 
displayed. Each hiveplot is composed of 3 radial axes containing the molecular data with nodes 
assigned to the 2 bottom axis for genes expressed in the cortex (in blue) and liver (in red) and 
nodes on the vertical axis (in yellow) represent metabolites. On top, we added a separate 
‘genetic’ axis (white) containing the genotypes. The node position on the 3 (molecular) radial 
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axes was determined by the response to sleep deprivation; i.e., molecules closer to the center 
were down-regulated more strongly, while more upregulated genes/metabolites were closer to 
the axis’ edge. Edges connecting nodes represent positive/negative correlations (red/blue, 
respectively) between molecules using expression values. Genetic markers linked to genes by 
eQTLs connect the genetic and molecular space. 
 
Notes: 
- URLs can be easily send to share search options and results among users  
- History of your search is kept during your working session 
 
Tutorial 1. Single phenotype mining 
In this section, we assume we are interested in a single sleep phenotype only. We will 
approach the data by multiple filtering steps.  
1. Visual comparison of hiveplot: 
 
 
 
 
 
 
 
Hive-plots for NREM sleep gain in 4 consecutive 6h recovery intervals after the sleep 
deprivation ending at ZT6. Compared to the other 3 intervals, NREM gain was strongly 
associated with metabolites during the 2nd 6h interval; i.e., the 1st 6h of the recovery dark 
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period (ZT12-18). We will focus on this phenotype. These hiveplots (and phenotypes) are set 
as the default on the homepage.  
 
2. Remove other phenotypes  
 
 
Only the NREM sleep gain between ZT12-18 is kept. Other phenotypes can be 
removed clicking  
 
To apply filtering selection, press  
 
3. Heatmap: 
 
Now we only have a single hiveplot that we can explore further. The heatmap (C) displays 
all genes for which the expression is correlated to this sleep phenotype (note that liver is the 
default tissue). You can explore genes in cortex by changing the filtering parameters (see 
below). You can sort genes by correlation strength by clicking on the phenotype name in the 
heatmap. A similar heatmap can be displayed for the metabolites. 
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4. Increase filtering stringency: 
Default thresholds are: absolute pearson r equal or above 0.5 for genes and absolute pearson 
r equal or above 0.4 for metabolites.  
Given the high number of genes displayed in the heatmap, the pearson r coefficient cutoff 
can be increased under Search parameters (A). Here we select an absolute pearson r of 0.6 for 
genes and 0.5 for metabolites. The user might be interested in genes that are driven by genetic 
variation (cis-eQTL). In the example, genes are also filtered according to cis-
eQTL association with an FDR adjusted p-value equal or below 1e-5. Apply the filtering option 
by clicking on 
 
 
 
 
Heatmap results for liver genes:    Heatmap results for cortex genes: 
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Notes: More genes are displayed in the hiveplot than in the heatmap. The heatmap contains 
all the genes that pass the search parameters selected. The hiveplot is filtered according to the 
following rules: i) the genes and metabolites must pass the pearsons r cutoff, ii) the nodes 
(genes/metabolites/ markers) that are unconnected (no edges) are removed, and iii) the eQTL 
threshold is not applied in order to keep cross-tissue associations. 
 
5. Save and highlight potential targets: 
 
Once you applied your filtering parameters, you can save a target of interest to highlight it 
within the hiveplot. Double-clicking on genes within the heatmap will select the genes to 
highlight. A new tab will be created for each target saved. You can remove these saved targets 
by again double clicking the gene within the heatmap or pressing    
 
 
 
Here we highlight all genes that passed our filtering parameters: 
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These genes can be highlighted in the filtered hiveplot (1) or the user can reset the filtering 
parameters (2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Hiveplot filtering: 
 
Further filtering can be applied to the hiveplot. We can select for genes that have a minimum 
number of links (edges), e.g. 6 edges on our unfiltered hiveplot.  
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Acot11 is the only highlighted gene that is kept after applying these filtering options. Other 
options are available, such as keeping only top differentially expressed genes in the selection:  
 
 
 
7. Hiveplot investigation: 
 
The hiveplots can be investigated using 'mouseover' the different edges and nodes. This will 
display the node name (gene name, metabolite name, or marker name), or the nodes connected 
to an edge. All nodes and edges within the displayed hiveplot are listed in the table (F). 
 
The table gives the following information: i) the type of node: genes in cortex (blue), genes 
in liver (orange), metabolites (green), and markers (white), ii) effects of sleep deprivation on 
genes and metabolites are indicated by fading color: upregulated (solid color on top, fading 
down to white), downregulated (solid color on bottom)   
 
 
 
 
Expression of Acot11 in liver is downregulated after sleep deprivation and is highly 
correlated with 13 metabolites, one cortical transcript, and 3 SNPs. The correlation was positive 
for all (red symbol with phenotype number). Negative correlations would have been indicated 
in blue. 
 
 
 
 
8. Target investigation: 
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The tab containing the highlighted genes shows additional information concerning gene 
function, the 5 genes with the highest partial-correlation, within the same tissue, across-tissue, 
and metabolite. The tab contains the gene name (1), the Uniprot description of the gene (2), 
Synonyms (3), a Uniprot and MGI access ID links (4) and related GO terms (5). 
 
 
 
Here the network of the highlighted gene (Acot11) with the 5 top genes partially-correlated 
to within the same tissue (blue), 2 top genes partially-correlated to the highlighted gene within 
the other tissue (orange) and the top correlated metabolite (green). Red edges indicate positive 
correlation and blue edges indicates negative correlation. The size of the nodes indicates the 
correlation coefficient with the phenotype. 
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Tutorial 2. Gene search: 
The interface allows you also to search for specific genes associated with a sleep phenotype 
at a specific correlation cutoff. 
If you previously made some filtering and research, you can reset your settings by pressing 
the RESET button.  
 
Then select the relevant "search by genes” area 
 
 
 
Below are a 2 examples of sleep related genes: 
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1. GWAS search for Per2: Per2 is a well known circadian gene. It is associated in the BXD 
set with NREM sleep gain after SD [ZT12-18] (Per2 BXD search), and is associated 
with 2 metabolites: PC aa C36:3 & PC ae C40:0 
2. Sik3 KO mice were associated with the increase total of NREM sleep (minutes/24h) and 
a decrease in total wake in mouse by (Funato, Miyoshi et al. 2016) using random genetic 
screening. With our extended database, we found that: Sik3 cortical expression in 
baseline was correlated (r=0.55) with the wake amount at the beginning of light 
(BXDw24bsl.h1). 
Cortical Sik3 in baseline       
 
 
 
 
 
 
 
 
 
Tutorial 3. Edges filtering: 
 
Hiveplot filtering parameters allow to recover common edges among hiveplots or to exclude 
common edges.  
The first example shows how to exclude common edges: 
1. First we select phenotypes of EEG power after SD for all the bands. 
 
 
2. Here we are interested in slow delta power after sleep deprivation (δ1: 1.0-2.25Hz) 
during NREM sleep, and we want to remove all genes, metabolites that are present also 
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within other bands. Therefore, we exclude other phenotypes using the “x” button in the 
hiveplot filtering options (E): 
 
 
 
3. Finally, we keep only genes differentially expressed and genes connected to 3 other 
elements. 
  
4. Remaining known genes are Strada, Mapk4 and Fhit in cortex and Susd4 in liver. 
 
 
 These genes thus correlate only to slow delta and not to other EEG frequency bands of the 
EEG spectra during NREM sleep after sleep deprivation.  
 
Inspection of Strada in cortex informed us that Homer1 is among the 5 closest genes of 
Strada. Homer1 has been implicated in the homeostatic regulation of EEG delta power. 
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The second example shows how to inspect common edges: 
1. In this case we are interested in genes common to slow delta gain (r/b) during NREM 
sleep correlated within other delta bands. 
 
 
2. Using the “in” button in the hiveplot filtering option (E) for slow delta gain after SD, 
the common edges and nodes within other bands will be kept. We also filter for genes 
differentially expressed after SD. 
 
 
3. Inspecting the table (F), we see that only 1 gene is connected to 3 other bands. Wrn is 
present in the hiveplot 1, 2, and 3 [NREM sleep EEG power aSD δ1, NREM sleep power aSD 
δ2 and NREM sleep EEG power gain (r/b) δ1]. 
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Annex 1: The epigenetic consequences of sleep 
loss. 
 
Preliminary results: 
In this project, we asked which regulatory elements were involved in the response to sleep 
deprivation. The cortical chromatin accessibility and transcriptomic landscape was monitored 
in C57BL/6J mice using ATAC-seq and RNA-seq. We identified a total of 215'045 ATAC-
positive regions (peaks) over all time points using Macs2. We examined the differential 
accessibility at each time point (Figure 9), 1542 peaks were differentially accessible in SD at 
ZT3 (T27, after 3h SD), 1906 in SD at ZT6 (T30, end of 6h SD), and 678 at ZT12 (T36, after 
6h recovery.  
 
 
 
Figure 9 : Differential chromatin accessibility after sleep deprivation 
Volcano plot of ATAC differential activity at T27, T30 and T36 (sleep deprivation 
is performed from T24-T30). Red points: Significant differentially accessible peak  
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To associate ATAC-seq peaks with target genes, we looked for gene-peak correlations within 
topologically associating domains (TADs) defined in cortex. Genes associated with slow delta 
power gain after SD (Wrn) and fast delta power after SD (Kif16b) have a temporal expression 
that is significantly associated with a temporal chromatin accessibility (Figure 10). 
 
 
 
Figure 10 : Example of temporal patterns association between ATAC-seq peaks and mRNA 
Temporal patterns of correlated gene-peak pairs. Red curves: gene; blue curves: ATAC peak. Red 
shaded box: SD, shade lines are replicated baseline values (Time 0-24).  
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Publication:  
Charlotte N. Hor, Jake Yeung, Yann Emmenegger, Maxime Jan, Jeffrey Hubbard, Felix Naef, 
Paul Franken. Never the same again: long-term molecular dynamics after acute sleep 
deprivation in mouse.  In Preparation  
 
Contribution: 
I processed and analysis ATAC-seq data, integrated ATAC-seq peaks and mRNA expression, 
participated to the data interpretation and figure generation. 
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Annex 2: Fgf15 drives glucagon secretion in 
BXD 
 
Publication:  
Picard, A., J. Soyer, X. Berney, D. Tarussio, S. Quenneville, M. Jan, E. Grouzmann, F. Burdet, 
M. Ibberson and B. Thorens (2016). A Genetic Screen Identifies Hypothalamic Fgf15 as a 
Regulator of Glucagon Secretion. Cell reports 17(7): 1795-1806. 
 
Contribution: 
I mapped glucagon secretion phenotype and generated QTL figures. 
 
  
